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Abstract 
Lens epithelium-derived growth factor (LEDGF) is a critical co-factor of 
lentiviral integration that accounts for the characteristic bias of the retroviral genus 
towards integration within active transcription units of the host genome. It’s well-
characterised role in viral replication notwithstanding, cellular functions of LEDGF 
are poorly understood. In this study gene expression profiling and proteomic analysis 
have been used to elucidate cellular functions of LEDGF.  
Gene expression profiling of mouse embryonic fibroblasts (MEFs) derived 
from Psip1
-/-
 (LEDGF-null) embryos revealed that less than 200 genes were 
significantly up- or down-regulated compared to wild type (WT) MEFs. The changes 
in gene expression of a subset of affected genes were confirmed by quantitative 
reverse transcription-polymerase chain reaction (qRT-PCR) assays. However, these 
changes could not be reversed by re-introduction of LEDGF into knockout MEFs. 
Furthermore, in vitro knockout of Psip1 did not reproduce the effects of in utero 
knockout, suggesting that LEDGF ablation per se does not account for the observed 
perturbations in gene expression. Collectively, these data strongly indicate that in 
spite of its apparent ubiquitous association with active transcription units, LEDGF 
does not play an essential nor direct role in the regulation of gene expression.  
Tandem affinity purification (TAP) of a cTAP-tagged truncation mutant of 
LEDGF (residues 326-530) identified the heterodimeric S-phase kinase, termed cell 
division cycle 7 (Cdc7):activator of S-phase kinase (ASK), as a novel interactor of 
LEDGF. Both kinase subunits co-immunoprecipitated with LEDGF from human 
cells, and endogenous Cdc7 and LEDGF proteins displayed nuclear co-localisation in 
G1 and S phases of the cell cycle. Moreover, Cdc7:ASK was enriched on chromatin 
when ectopically co-expressed with LEDGF in human cells, suggesting that LEDGF 
may affect chromatin binding of the kinase. Truncation analyses identified the 
integrase-binding domain (IBD) of LEDGF as essential and minimally sufficient for 
the interaction with Cdc7:ASK. Reciprocally, the interaction required auto-
phosphorylation of the kinase and the presence of fifty C-terminal residues of ASK. 
LEDGF potently stimulated the kinase activity of Cdc7:ASK, increasing 
phosphorylation of one of its substrates, mini-chromosome maintenance 2 (MCM2), 
in vitro by more than 10-fold. The effect strictly depended on the interaction, as 
LEDGF mutants unable to bind Cdc7:ASK also failed to promote its kinase activity. 
Intriguingly, removing the C-terminal region of ASK, involved in the interaction 
with LEDGF, resulted in a hyper-active kinase. These results indicate that the 
interaction with LEDGF relieves autoinhibition of Cdc7:ASK kinase activity, 
imposed by the C-terminus of ASK. 
 While more work is required to fully elucidate the natural cellular functions 
of LEDGF, this study has provided some insight into its role in cell biology. In 
particular, understanding the role of LEDGF in Cdc7:ASK kinase regulation and the 
implications of this interaction during S phase of the cell cycle are promising 
avenues of investigation highlighted in this study. 
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1 Chapter I: Introduction 
 
1.1 Overview of the human immunodeficiency virus (HIV) lifecycle 
HIV-1 along with its close relative HIV-2 are human pathogens from the family of 
Retroviridae and belong to the genus Lentivirus. HIV-1 and HIV-2 specifically infect 
and deplete CD4
+
 T-lymphocytes, a subset of cells that are essential for the 
coordination of the immune response (Coffin et al., 1997). As such, viral entry 
begins with binding of the surface subunit of the viral envelope glycoprotein, gp120, 
to the CD4 receptor on the host cell surface. This brings the viral envelope 
glycoprotein in contact with its co-receptor (CCR5 or CXCR4), triggering complex 
conformational changes in the transmembrane portion of the envelope glycoprotein, 
gp41, leading to fusion of viral and cellular membranes (reviewed in Moore and 
Doms, 2003). Following fusion between the lipid bilayers of the viral envelope and 
host cell plasma membrane, the viral core is released into the cell cytoplasm, where it 
undergoes uncoating. The viral RNA genome is converted into linear double-
stranded DNA by the virally encoded enzyme reverse transcriptase. Viral DNA in 
association with IN and other viral and cellular proteins is referred to as the pre-
integration complex (PIC). Following nuclear import of the PIC, IN catalyses the 
insertion of the viral DNA into a host cell chromosome. The integrated provirus 
serves as a template for the synthesis of spliced and unspliced viral RNA species, 
which when translated using the host cell machinery, provide the full complement of 
viral proteins required to assemble new viral particles. Two copies of full-length, 
unspliced viral transcript are also encapsidated into new particles to serve as viral 
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genomic RNA. New viral particles assemble at the cell surface; viral Gag and Gag-
Pol polyproteins associate with the cell membrane, encapsidate the viral genomic 
RNA and associate with envelope glycoproteins inserted into the host cell plasma 
membrane. Immature virions egress by budding, pinching off the plasma membrane. 
Shortly after the virions are released from the host cell, protease cleavage of viral 
Gag and Gag-Pol polyproteins produces mature viral proteins and the characteristic 
cone-shaped viral core (reviewed in Freed, 2001). See Figure 1.1 for a schematic of 
the retroviral lifecycle. 
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Figure 1.1 – The retroviral lifecycle 
The pre-integration complex (PIC) is composed of viral DNA, obtained by reverse transcription of the 
viral RNA genome, IN and other viral and host proteins, which are indicated by black and grey ovals. 
Adapted from Coffin et al., 1997. 
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1.1.1 HIV DNA Integration 
A hallmark of the retroviral lifecycle is integration of the viral DNA, produced 
during reverse transcription, into the host cell genome. This essential step is 
catalysed by IN, an essential viral enzyme, encoded within the 3’ portion of the POL 
gene. The mature form of IN is derived from the Gag-Pol polyprotein following its 
cleavage by viral protease (Figure 1.2) (Freed, 2001). Retroviral IN has three 
canonical structural and functional domains: an N-terminal domain (NTD, residues 
1-50 [henceforth, residue numbering corresponds to HIV-1 IN]) which contains an 
HHCC-type zinc-binding motif, the catalytic core domain (CCD, residues 51-212) 
which contains the active site and a C-terminal domain (CTD, residues 213-288) 
(Figure 1.2) (reviewed in Poeschla, 2008).  
 
pol INLTR LTRgag
envvif vpr
vpu
nef
rev
tatGag-Pol
HIV-1 genome
CCDNTD CTD
501 212 288
Integrase
 
Figure 1.2 – HIV-1 Integrase 
Schematic of the HIV-1 genome (proviral form). Integrase (IN) is encoded on the POL gene and is 
expressed as part of the Gag-Pol precursor. Mature IN protein is derived by viral protease cleavage of 
the Gag-Pol polyprotein. IN is composed of three structural domains: an N-terminal domain (NTD), 
the catalytic core domain (CCD) and a C-terminal domain (CTD). Adapted from Poeschla, 2008. 
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Retroviral INs catalyse two distinct reactions, 3’-processing and DNA strand 
transfer, which results in formation of the integrated provirus (Poeschla, 2008). The 
first reaction, 3’ processing, takes place in the cytoplasm immediately after reverse 
transcription. During this step, HIV-1 IN hydrolyses a dinucleotide from each 3’-end 
of the viral DNA. Following entry into the nucleus, IN uses both 3’-OH groups of the 
viral DNA to cut opposing strands of chromosomal DNA, at the same time ligating 
the viral DNA ends to 5’ overhangs generated in the chromosomal DNA (Figure 
1.3). Single-stranded gaps flanking the viral DNA are then repaired by host cell 
enzymes, completing formation of a stable provirus (Figure 1.3). A number of host 
factors have been implicated in HIV-1 DNA integration (Van Maele et al., 2006). In 
particular, the discovery of LEDGF as the dominant interactor of HIV-1 IN seven 
years ago (Cherepanov et al., 2003) led to intensive studies of its function in the 
retroviral lifecycle and cell biology (reviewed in Engelman and Cherepanov, 2008; 
Llano et al., 2009). 
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Figure 1.3 – The HIV-1 DNA integration pathway 
The PIC contains viral DNA (light blue), IN (grey oval), as well as other viral and cellular proteins 
(not shown). Within the PIC, the active sites of IN (red ovals) activate water molecules for 
nucleophilic attack of the phosphodiester backbone resulting in removal of a dinucleotide from both 3’ 
ends of the viral DNA, referred to as 3’ processing (1). Following nuclear import, the PIC comes into 
contact with chromosomal DNA (orange) (2). The IN active sites activate the free hydroxyl groups at 
the 3’ ends of the viral DNA to cut phosphodiester bonds of opposing strands of chromosomal DNA 
(3). The resulting intermediate contains viral DNA joined at each 3’ end to chromosomal DNA, 
flanked by short gaps and 5’ overhangs (4). Host DNA repair enzymes join the 5’ viral DNA ends to 
the host DNA (5). Adapted from (Hare and Cherepanov, 2009). 
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1.2  Lens epithelium-derived growth factor (LEDGF) 
Lens epithelium-derived growth factor (LEDGF), also referred to as transcriptional 
co-activator p75, is a ubiquitous nuclear chromatin-associated protein. LEDGF is 
encoded by the PSIP1 gene, located on the human chromosome 9 (the corresponding 
murine orthologue Psip1 is found on the mouse chromosome 4) and belongs to a 
family of hepatoma-derived growth factor (HDGF)-related proteins (HRPs). Five 
other human HRPs have been described to date: HDGF, HRP1, HRP2, HRP3, as 
well as p52, a smaller alternative splice form of LEDGF (Cherepanov et al., 2004; 
Dietz et al., 2002; Izumoto et al., 1997). HRPs are characterised by a highly-
conserved N-terminal PWWP domain, named after the signature Pro-Trp-Trp-Pro 
motif (Figure 1.4) (Stec et al., 2000). In addition, LEDGF/p75 and HRP2 contain a 
second evolutionarily-conserved domain within their C-terminal regions, which 
mediates their interaction with HIV-1 integrase (IN) (Figure 1.4) (Cherepanov et al., 
2004). LEDGF and HRP2 are found throughout Vertebrata, and a divergent 
orthologue was recognised in insects (Cherepanov et al., 2004).  
LEDGF has been implicated in several human pathologies including 
autoimmunity, cancer and HIV infection. Thus, it was identified as a nuclear antigen 
targeted by auto-antibodies in atopic dermatitis, and other inflammatory conditions 
(Ayaki et al., 2002; Ganapathy and Casiano, 2004; Ganapathy et al., 2003; Muro, 
2001; Muro et al., 2006; Muro et al., 2008; Ochs et al., 2000; Yamada et al., 2001); 
auto-antibody responses to LEDGF were observed in prostate cancers (Daniels et al., 
2005). A recurrent chromosomal translocation, t(9;11)(p22;p15), resulting in fusions 
of nucleoporin Nup98 and LEDGF was reported in patients with acute and chronic 
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myeloid leukaemia. Importantly, NUP98-LEDGF fusion transcripts were detected at 
presentation and relapse, but not during remission of the cancer (Ahuja et al., 2000; 
Grand et al., 2005; Hussey et al., 2001; Morerio et al., 2005). Moreover, expression 
of LEDGF/p75 and its smaller splice variant p52 was shown to be up-regulated in 
blasts from patients with chemotherapy-resistant acute myelogenous leukaemia 
(Huang et al., 2007). Transfection experiments demonstrated that LEDGF/p75 and 
p52 can protect leukaemia cells from daunorubicin-induced apoptosis in vitro; 
suggesting that over-expression of these proteins may contribute to resistance against 
anti-leukaemic drugs (Huang et al., 2007).  
Most of the currently known details about the molecular biology of LEDGF 
and its structure were discovered during the course of HIV research as outlined in the 
following sections. We will return to discussion of the cellular functions of LEDGF 
in Section 1.6. 
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1.3 LEDGF: structure and function in HIV replication 
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Figure 1.4 – Domain organisation of LEDGF 
Schematic of LEDGF and related proteins, p52 and HRP2. Locations of the functional elements are 
indicated: Pro-Trp-Trp-Pro domain (PWWP), nuclear localisation signal (NLS), IN binding domain 
(IBD). 
 
LEDGF/p75 is a modular protein consisting of 530 amino acids and 4 defined 
functional and/or structural elements (Figure 1.4). The N-terminal PWWP domain, 
implicated in chromatin association (Turlure et al., 2006), makes up the first 93 
residues. Residues 148-156 comprise a functional nuclear localisation signal (NLS) 
(Maertens et al., 2004), while residues 178-197 contain a pair of AT-hook-like motifs 
implicated in DNA binding (Turlure et al., 2006). The IN-binding domain (IBD), 
necessary and sufficient for the interaction with HIV-1 IN, is contained within the C-
terminal region of LEDGF/p75 (residues 347-429) (Cherepanov et al., 2004; 
Vanegas et al., 2005). In addition to LEDGF/p75, an alternatively-spliced product, 
p52, is expressed from the same gene. LEDGF/p52 shares residues 1-325 with 
LEDGF/p75, followed by eight unique C-terminal amino acid residues (indicated in 
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grey in Figure 1.4). LEDGF/p52 lacks the IBD and therefore lacks the ability to bind 
IN (Maertens et al., 2003). 
 
1.4 LEDGF is an important cellular co-factor for HIV integration 
 
1.4.1 LEDGF is the major cellular binding partner of HIV-1 Integrase (IN) 
The interaction between LEDGF and HIV-1 IN has been well-characterised. 
Endogenous LEDGF was found in a stable nuclear complex with HIV-1 IN, when 
the viral protein was ectopically expressed in human cells (Cherepanov et al., 2003). 
Recombinant LEDGF robustly stimulated HIV-1 IN strand transfer activity in vitro, 
strongly indicating a functional interaction (Cherepanov et al., 2003). Moreover, a 
direct interaction between LEDGF and IN was confirmed by pull-down analyses 
using recombinant proteins (Maertens et al., 2003). GFP fusions of full-length HIV-1 
IN and IN/ΔC, lacking the C-terminal domain of IN, co-localised with HcRed1-
LEDGF in the nuclei of human cells exhibiting a characteristic irregular nuclear 
distribution pattern (Maertens et al., 2003). Moreover, corroborating earlier reports 
that HIV-1 IN and LEDGF associate with condensed chromosomes during mitosis, 
fluorescent fusions of HIV-1 IN and LEDGF displayed strong chromosomal staining 
in mitotic cells (Cherepanov et al., 2000; Maertens et al., 2003). Knockdown of 
LEDGF using RNA interference (RNAi) resulted in a striking defect in nuclear 
accumulation and chromatin association of HIV-1 IN in human cells indicating that 
LEDGF is required for chromosomal tethering of IN (Llano et al., 2004b; Maertens 
et al., 2003).  
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Additionally, the interaction with LEDGF protects HIV-1 IN from 
proteasomal degradation (Llano et al., 2004a). The ectopic expression levels of HIV-
1 IN were much lower in LEDGF-deficient cells compared to controls, despite 
equivalent mRNA levels (Llano et al., 2004a). Proteasome inhibition or restoration 
of LEDGF expression rescued IN stability, strongly suggesting that the interaction 
with LEDGF prevents proteasome-mediated degradation of IN (Llano et al., 2004a).  
HRP2, the only other member of the HRP family known to possess an IBD, 
has been shown to interact with and stimulate the activity of recombinant HIV-1 IN 
in vitro (Cherepanov et al., 2004). Ectopically-expressed HRP2 and HIV-1 IN could 
be co-immunoprecipitated from whole cell extracts, although their interaction 
appeared weaker than that of LEDGF and HIV-1 IN under similar conditions.  
 
1.4.2 Structural basis for the IN-LEDGF interaction 
Initial mutational analyses indicated that the catalytic core domain of HIV-1 IN 
(residues 51-212) is necessary and sufficient for interaction with LEDGF (Maertens 
et al., 2003), and subsequently the crystal structure of the HIV-1 IN CCD in complex 
with the LEDGF IBD was determined (Cherepanov et al., 2005a). LEDGF residues 
Ile-365, Asp-366 and Phe-406 within the IBD are involved in critical contacts with 
the CCD of IN; mutations of these residues abolish or drastically reduce the 
interaction with IN (Cherepanov et al., 2005a; Cherepanov et al., 2005b). In addition 
to the CCD, the NTD of IN also contributes to the interaction with LEDGF, greatly 
enhancing its affinity (Maertens et al., 2003). Subsequently, a crystal structure 
containing the N-terminal and catalytic core domains of HIV-2 IN in complex with 
the IBD of LEDGF was determined by our group, extending the known LEDGF-IN 
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interface (Figure 1.5) (Hare et al., 2009b). In particular, the charge-charge 
interactions between the NTD of IN and the IBD were shown to be critical for the 
high affinity interaction (Hare et al., 2009b). A patch of acidic residues on the 
surface of the NTD (Glu-6, Glu-10, Glu-13) face positively charged residues on the 
surface of the IBD (Lys-401, Lys-402, Arg-404, Arg-405) (Figure 1.5) and mutations 
within the IBD that remove or reverse the positive charges facing the NTD disrupt 
binding to IN (Hare et al., 2009b). 
 
 
Figure 1.5 – The IN-LEDGF interface 
Crystal structure of a two domain fragment of HIV-2 IN (NTD+CCD) in complex with LEDGF IBD. 
In addition to the primary CCD-IBD interface, this structure shows the interaction between the IBD 
and the NTD. Positively charges residues on the surface of the IBD (Lys401, Lys402, Arg404, 
Arg405) make contacts with negatively charged residues within the IN-NTD (Glu6, Glu10, Glu13). 
IN chains A and B are coloured green and blue, respectively; the IBD subunits are pink; zinc atoms 
are shown as grey spheres. Adapted from Hare et al., 2009b. 
 
1.4.3 LEDGF interacts with divergent lentiviral INs 
Another IN protein from feline immunodeficiency virus (FIV), a lentivirus, was also 
shown to bind LEDGF in cells and in vitro, while INs from Moloney murine 
leukaemia virus (MoMLV, a gammaretrovirus) and human T-cell leukaemia virus 
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type 2 (HTLV-2, a deltaretrovirus), failed to interact with the host factor (Busschots 
et al., 2005; Llano et al., 2004b). Interestingly, non-primate FIV IN and LEDGF co-
localised in the nuclei and on condensed chromosomes of feline and human cells, 
identical to the pattern seen with HIV-1 IN (Llano et al., 2004b). Moreover, both 
HIV-1 and FIV INs were restricted to the cytoplasm of cells depleted of LEDGF, 
indicating that the nuclear accumulation and chromosomal targeting of lentiviral INs 
is dependent on the host protein (Llano et al., 2004b; Maertens et al., 2003).  
A later and more detailed study that included INs from a wide range of 
retroviruses confirmed that the interaction with LEDGF is conserved among and 
limited to members of the Lentivirus genus (Cherepanov, 2007). In both in vitro pull-
down and yeast-two hybrid assays, only the INs of lentiviral origin (HIV-1, HIV-2, 
FIV, equine infectious anaemia virus (EAIV), maedi-visna virus (MVV) and bovine 
immunodeficiency virus (BIV)) interacted with LEDGF. Importantly, the D366N 
mutant of LEDGF, which is deficient for binding HIV-1 IN, did not bind any of the 
lentiviral INs, strongly indicating that the divergent lentiviral INs share the structural 
basis for LEDGF recognition. Furthermore, LEDGF potently stimulated strand 
transfer activity of the lentiviral INs in vitro. Subsequently, the crystal structure of 
the N-terminal and catalytic core domains of the highly divergent MVV IN in 
complex with LEDGF IBD was determined (Hare et al., 2009a). Although MVV IN 
shares less than 30% overall sequence identity with HIV-1 IN, the architecture of the 
MVV IN-LEDGF complex was indeed highly similar to those described for HIV-1 
and HIV-2 INs, but some interesting adaptations were also noted (Cherepanov et al., 
2005a; Hare et al., 2009a; Hare et al., 2009b). 
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1.4.4 The interaction with LEDGF is important for lentiviral replication and 
accounts for the characteristic preference of lentiviruses to integrate within 
active transcription units 
Consistent with a role for LEDGF in lentiviral integration, LEDGF was detected as a 
component of functional HIV and FIV pre-integration complexes isolated from 
infected cells (Llano et al., 2004b). Furthermore, the strand transfer activity of HIV-1 
PICs isolated from infected cells and inactivated with high ionic strength conditions 
could be reconstituted in vitro by addition of recombinant LEDGF or HRP2 
(Vandegraaff et al., 2006). Mutational analyses further revealed that both the IN-
binding and DNA-binding activities of LEDGF contributed to the functional PIC 
reconstitution (Vandegraaff et al., 2006).  
Studies carried out using human CD4
+
 T cell lines depleted of LEDGF by 
RNAi (Llano et al., 2006a) or mouse embryonic fibroblasts (MEFs) derived from 
Psip1-knockout animals (Marshall et al., 2007; Shun et al., 2007) clarified the role of 
the co-factor in the lifecycle of HIV-1. Viral infection was reduced as much as 10-30 
fold in cells devoid of LEDGF (Llano et al., 2006a; Shun et al., 2007). Importantly, 
re-expression of LEDGF rescued HIV-1 replication while deletion mutants lacking 
functional PWWP or IBD domains failed to rescue viral replication presumably due 
to their inability to bind to chromatin or IN. The block to integration in LEDGF-
deficient cells was confirmed by a reduction in integrated viral DNA. Although HIV-
1 integration was significantly reduced it was not completely ablated; thus, residual 
levels of integration (up to ~10% of the level of integration achieved in control cells) 
were observed even in the genetic knockout condition (Shun et al., 2007).  
Similar to the effect on HIV, the infectivity of FIV, a non-primate lentivirus 
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with a LEDGF-interacting IN, was blocked in cells depleted of LEDGF (Llano et al., 
2004b). In contrast, MLV, a gammaretrovirus, was completely unimpaired in the 
absence of LEDGF, consistent with the lack of interaction between MLV IN and 
LEDGF (Cherepanov, 2007; Llano et al., 2006a; Llano et al., 2004b; Shun et al., 
2007).  
HIV-1 as well as other lentiviruses preferentially integrate within active 
transcription units (TUs) (Ciuffi and Bushman, 2006; Mitchell et al., 2004; Schroder 
et al., 2002). In agreement with its proposed role as a tether between IN and 
chromatin, LEDGF was shown to strongly affect the distribution of HIV-1 
integration sites on the genomic scale (Ciuffi et al., 2005; Shun et al., 2007). In one 
early study that relied on human cells partially depleted for LEDGF using RNAi, 
HIV-1 integration within TUs was slightly reduced while becoming more biased 
towards GC-rich regions (Ciuffi et al., 2005).  
More recently, mouse Psip1-knockout models afforded studies of HIV-1 
integration in the absence of LEDGF. In Psip1
-/-
 cells, HIV-1 and EIAV displayed 
reduced replication and lost their characteristic bias towards integrating into TUs 
and, furthermore, displayed an increase affinity for promoter regions and CpG 
islands (Marshall et al., 2007; Shun et al., 2007). Additionally, a bioinformatic study 
of 15 HIV integration site data sets from different cell types showed a positive 
correlation between the frequency of integration into TUs and cell-type specific 
levels of LEDGF expression (Marshall et al., 2007). Taken together, these results 
established that LEDGF plays a crucial role in lentiviral DNA integration and site 
selection. The interaction between IN and LEDGF is thought to channel integration 
towards LEDGF-associated regions, accounting for the preference of lentiviruses to 
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integrate within active transcription units. 
 
1.5 Potential therapeutic applications of the IN-LEDGF interaction 
 
1.5.1 Targeting lentiviral DNA integration for use in gene therapy 
Recent results have collectively validated LEDGF as a targeting factor for lentiviral 
DNA integration and opened up the potential to use the DNA tethering properties of 
LEDGF to help manipulate integration site selection for human gene therapy. This is 
a topic of intense interest, in part due to the adverse clinical events that occurred 
during gammaretrovirus mediated gene therapy resulting in the activation of LMO2, 
a proto-oncogene (Hacein-Bey-Abina et al., 2003).  
In an initial study carried out by Bushman and colleagues a chimeric protein 
containing LEDGF IBD and the DNA-binding domain of λ phage repressor enabled 
directed integration into target DNA in vitro, indicating that LEDGF can be used to 
re-target lentiviral integration (Ciuffi et al., 2006). A later work replaced the N-
terminal domain of LEDGF with divergent chromatin binding modules, either 
variants of the human linker histone H1 or a peptide derived from Kaposi’s sarcoma 
herpes virus (KSHV) latency associated nuclear antigen (LANA) (Meehan et al., 
2009). The linker histone binds to DNA outside of the nucleosome, while KSHV 
LANA binds to the nucleosome core. Fusion of the C-terminal region of LEDGF 
containing the IBD to these alternative chromatin binding domains resulted in 
chimeric proteins that rescued HIV-1 IN chromatin tethering and replication when 
expressed in LEDGF-deficient human CD4
+
 T cells, apparently recapitulating the 
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function of wild type (WT) LEDGF (Meehan et al., 2009). These results 
demonstrated that the chromatin tethering property of LEDGF rather than association 
with specific chromatin ligands is crucial to its co-factor function (Meehan et al., 
2009). 
Subsequently, several studies have used LEDGF chimeras to control the 
integration site selection of HIV-1-derived retroviral vectors. Thus, fusion of the C-
terminal integrase binding portion of LEDGF to the chromodomains of 
heterochromatin proteins 1α or 1β successfully re-directed lentiviral integration away 
from genes and towards regions enriched in histone H3 trimethylated at Lys-9, an 
epigenetic modification associated with heterochromatin and intergenic regions 
(Ferris et al., 2010; Gijsbers et al., 2010; Silvers et al., 2010). Similarly, fusion of the 
IBD to the plant homeodomain finger of ING2 targeted lentiviral integration near 
transcription start sites of expressed genes, indicating that lentiviral integration can 
be efficiently re-directed by LEDGF chimeras in a manner dependent on the choice 
of chromatin binding domain (Ferris et al., 2010). Importantly, lentiviral vector 
transduction and transgene expression remained efficient under these conditions 
(Ferris et al., 2010; Gijsbers et al., 2010). Taken together, these studies open up the 
possibility of engineering tools to manipulate the integration site preferences of 
lentiviral vectors. 
 
1.5.2 Antiretroviral therapy 
Several point mutations within the catalytic core domain of HIV-1 IN (e.g. Q168A, 
V165A or R166A) that affect its interaction with LEDGF are lethal to the virus 
(Busschots et al., 2007; Cherepanov et al., 2005b; Emiliani et al., 2005). While the 
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Q168A point mutation does not affect the catalytic activities of IN, disruption of the 
interaction with LEDGF abolishes chromosomal tethering of IN and viral integration 
resulting in replication defective virus (Busschots et al., 2007; Cherepanov et al., 
2005b; Emiliani et al., 2005). Additionally, over-expression of LEDGF fragments 
containing the IBD severely inhibits HIV-1 viral replication, presumably by 
competing with endogenous LEDGF for the interaction with IN (De Rijck et al., 
2006). An HIV-1 variant selected for its ability to replicate in the presence of over-
expressed IBD acquired a mutation in IN, which reduced its affinity for LEDGF 
(Hombrouck et al., 2007). Surprisingly, the mutant virus still depended on LEDGF 
for replication. This result indicated that HIV-1 might not be able to circumvent the 
requirement for LEDGF for efficient replication.   
Considering the catastrophic replication defects associated with some 
mutations in the vicinity of the LEDGF binding site of IN, it has been proposed that 
small molecules binding within the LEDGF-interacting pocket of IN may block viral 
replication (Cherepanov et al., 2005a). Subsequently, recent studies have identified 
small molecule inhibitors and LEDGF-derived inhibitory peptides that interfere with 
the HIV-1 IN-LEDGF interaction, potentially giving rise to a new class of anti-
retroviral drugs. Thus, a benzoic acid derivative D77, inhibited the IN-LEDGF 
interaction in two-hybrid assays, disrupted HIV-1 IN nuclear distribution and 
inhibited viral replication in cell culture (Du et al., 2008). An inhibitory peptide 
derived from the IN-binding loops of LEDGF, reportedly inhibited IN catalytic 
activity in vitro as well as HIV-1 integration and replication in infected cells 
(Hayouka et al., 2010; Hayouka et al., 2007). More recently, highly potent small 
molecule inhibitors of the IN-LEDGF interaction, capable of completely blocking 
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HIV-1 replication in cell culture were reported by Debyser and colleagues (Christ et 
al., 2010). Hopefully, the lead compounds described in these early studies will be 
useful for the development of novel anti-HIV agents.  
 
1.6 Cellular functions of LEDGF 
The significance of LEDGF for HIV-1 replication and the potential of using LEDGF-
derived constructs to guide integration of lentiviral vectors lends importance to the 
need to understand the biological role of this cellular protein. Indeed it is impossible 
to evaluate the potential toxicity involved in the use of small molecule inhibitors 
targeting this host protein or introduction of chimeric proteins carrying fragments of 
LEDGF into target cells without knowing its natural function.  
Although the role of LEDGF in viral replication has been extensively studied, 
we know only little about its natural cellular functions. LEDGF was initially 
identified as a 75-kDa polypeptide (p75) by co-purification with transcriptional co-
activator PC4 from HeLa cell nuclear extracts (Ge et al., 1998). In the same work, 
both LEDGF and its alternative splice variant p52 were shown to facilitate 
transcriptional activation in vitro, implicating these proteins in transcription 
regulation. 
Early studies focussed on the role of LEDGF as a “pro-survival factor”. Thus, 
LEDGF was shown to enhance the survival of a wide range of cell types under 
conditions of cellular stress such as serum starvation, thermal or oxidative stress 
(Singh et al., 1999; Singh et al., 2000). Much of this early work studied the growth 
and survival effects of LEDGF on mouse lens epithelial cells and retinal pigmented 
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epithelial cells in cell culture, as well as its effects on retinal photoreceptor cells both 
in cell and organ culture and in vivo in rats (Ahuja et al., 2001; Machida et al., 2001; 
Matsui et al., 2001; Nakamura et al., 2000; Singh et al., 2000). All of these cell types 
showed enhanced survival in the presence of LEDGF when subjected to cellular 
stress and LEDGF was shown to protect retinal photoreceptor cells against light 
damage in rats (Ahuja et al., 2001; Machida et al., 2001; Matsui et al., 2001; 
Nakamura et al., 2000; Singh et al., 2000). Elevated levels of heat shock proteins 
(Hsps) were detected when cells were cultured in the presence of exogenous LEDGF 
or when rats were injected with recombinant LEDGF, suggesting that LEDGF 
enhances cell survival by stimulating the expression of Hsps. Although these studies 
primarily used ocular-derived cell types, LEDGF is in fact a ubiquitously-expressed 
nuclear chromatin-associated protein, not restricted to lens epithelium. Therefore, the 
name lens epithelium-derived growth factor is a misnomer. 
It was suggested that LEDGF protects cells against stress-induced death via 
transcriptional co-activation of stress-related genes such as heat shock proteins, αβ-
crystallin, antioxidant protein 2, alcohol dehydrogenase and aldehyde dehydrogenase 
(Fatma et al., 2004; Fatma et al., 2001; Shin et al., 2008; Shinohara et al., 2002; 
Singh et al., 2001). Experiments using affinity chromatography to isolate DNA 
fragments binding LEDGF indicated that the protein has specificity for heat shock 
elements (HSE) and stress-related elements (STRE) found in the promoters of stress 
response genes (Fatma et al., 2001; Shin et al., 2008; Singh et al., 2001). However, 
these results are controversial, as independent studies could not confirm this 
sequence-specific DNA binding activity of LEDGF (Turlure et al., 2006). Thus, the 
mechanism behind the pro-survival activity of LEDGF is not clear. 
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  LEDGF is a substrate of caspases and caspase-induced cleavage of LEDGF 
inactivates its pro-survival function, in some cases enhancing apoptosis (Wu et al., 
2002; Wu et al., 2001). While over-expression of LEDGF in human cells conferred 
resistance to serum-starvation-induced apoptosis, expression of deletion mutants 
corresponding to caspase-cleaved LEDGF fragments failed to rescue cells from cell 
death (Wu et al., 2002). Additionally, a mutant corresponding to a 65-kDa cleavage 
fragment appeared to enhance apoptosis under serum-deprivation conditions (Wu et 
al., 2002). 
Recently, Bickmore and colleagues scrutinised phenotypes associated with 
Psip1 gene disruption in mice (Sutherland et al., 2006). The majority of mice 
homozygous for the disrupted Psip1 gene died perinatally. Those surviving to 
adulthood exhibited a range of abnormalities, such as low fertility and a tendency to 
develop blepharitis, had multiple craniofacial and skeletal abnormalities as well as 
motor and behavioural defects. These data strongly indicated that LEDGF may be 
involved in embryonic development and suggested a role for LEDGF in the control 
of Hox gene expression. Of note, the mutant mice had no abnormalities in eye 
development.  
Several studies focussed on characterising cellular binding partners of 
LEDGF. The protein was shown to interact with JPO2, a known binding factor of the 
proto-oncogene and transcription factor cMyc (Bartholomeeusen et al., 2007; 
Maertens et al., 2006). Remarkably, akin to its effect on HIV-1 IN, LEDGF strongly 
affected the intracellular distribution of JPO2 and was required for association of 
JPO2 with chromatin. Binding to JPO2 is mediated by the IBD of LEDGF, although 
several LEDGF point mutants (I365A, D366A, F406A) which are defective for the 
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interaction with HIV-1 IN maintained the ability to bind JPO2 (Bartholomeeusen et 
al., 2007; Maertens et al., 2006). LEDGF also interacts with pogo transposable 
element-derived protein with zinc finger (PogZ), again via its C-terminal IBD 
(Bartholomeeusen et al., 2009). As the cellular functions of JPO2 and PogZ are 
currently unknown, these results did not shed light on the cellular functions of 
LEDGF.  
  A more recent study described the functional interaction between LEDGF 
and the menin:MLL (mixed-lineage leukaemia) histone methyltransferase (HMT) 
complex, which promotes trimethylation of Lys-4 on histone H3, an epigenetic 
marker associated with transcriptionally active chromatin (Yokoyama and Cleary, 
2008). Uniquely, menin is essential for MLL-dependent transcription regulation and 
leukaemic transformation and furthermore, LEDGF was shown to be essential for 
both of these discordant functions. LEDGF interacted conjointly with MLL and 
menin, with menin serving as a molecular adaptor linking MLL with LEDGF. 
Moreover, its interaction with menin was mediated by the IBD. Chromatin 
immunoprecipitation (ChIP) experiments suggested that LEDGF co-localises with 
menin:MLL on the chromatin of cancer-associated genes to mediate MLL-dependent 
transcription pathways. A chimeric protein in which the menin binding motif of MLL 
was replaced with the PWWP domain of LEDGF no longer associated with menin or 
LEDGF, nevertheless ChIP analyses showed that this chimeric protein associated 
with MLL-regulated genes, implicating the PWWP domain of LEDGF in targeting 
the menin:MLL HMT complex to chromatin (Yokoyama and Cleary, 2008). In 
addition, as the epigenetic mark placed by MLL is involved in maintaining chromatin 
in a transcriptionally active state, its association with LEDGF may provide the 
 37 
molecular basis for the preference of HIV-1 to integrate into actively transcribed 
genes.  
Collectively, the reports published to date have not created a coherent 
explanation for the cellular function of LEDGF. However, they do seem to converge 
on a model wherein the protein would serve as a multifunctional DNA-associated 
adaptor protein able to tether various factors to chromatin.  
 
Cellular factor
or
Lentiviral IN
 
Figure 1.6 – LEDGF tethers various factors to chromatin 
LEDGF (pink) is a chromatin associated protein. The AT-hooks and PWWP domain, located within 
the N-terminal region of the protein, mediate its binding to DNA (orange) and as yet unknown 
components of chromatin (grey box). The C-terminal IBD mediates binding to various cellular factors 
as well as lentiviral INs (grey oval), thus, tethering them to chromatin.   
 
 
1.7 Overview of the cell cycle 
The function of the cell cycle is to accurately duplicate the genetic material of a cell 
and segregate it equally into two identical daughter cells. The eukaryotic cell cycle 
can be divided into four phases, termed G1, S, G2 and M (Figure 1.7) (Alberts et al., 
2007). Actively dividing human cells can complete the entire cycle in less than 24 
hours.  
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Figure 1.7 – The Phases of Cell Cycle 
The eukaryotic cell cycle is divided into four phases. In G1 phase cells grow, duplicating their 
organelles and proteins. Under favourable conditions, cells progress into S phase in which their 
chromosomes are duplicated, each chromosome now consists of a pair of sister chromatids. Following 
G2 phase in which duplicated chromosomes are checked to ensure no errors were made the cell gets 
ready to divide and enters M phase. During mitosis sister chromatids segregate and two identical 
nuclei are formed, after which, the cytoplasm is pinched in two to produce two identical daughter 
cells. 
  
 
During G1 phase, cells grow, doubling their mass of proteins and organelles 
required for cell division. In addition, the intracellular and extracellular environments 
are closely monitored to ensure that conditions are favourable for proceeding with 
DNA replication in S phase. If conditions are unfavourable, cells can delay progress 
through G1 and enter a specialised resting state termed G0. If conditions are 
favourable, cells receive signals to grow and divide. Cells progress through a point 
near the end of G1 following which they are committed to DNA replication. DNA 
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replication takes place during S phase, a process which is highly regulated to ensure 
that the genome is duplicated precisely once per cell cycle. Cells then enter G2 
phase, during which they ensure that their chromosomes have been duplicated 
without error and prepare to divide. During M phase, which is the shortest phase of 
the cell cycle (less than an hour for mammalian cells), cells undergo mitosis and 
cytokinesis to produce two daughter cells. Mitosis begins with chromosome 
condensation in which duplicated DNA within elongated chromosomes becomes 
much more compact to form a pair of sister chromatids. The nuclear envelope breaks 
down and sister chromatids become attached to microtubules of the mitotic spindle 
emanating from opposite poles of the cell. This sequence of events encompasses 
prophase and prometaphase. The chromosomes are then aligned at the equator of the 
mitotic spindle during metaphase and sister chromatids are separated and moved to 
opposite poles of the cell during anaphase. During telophase, chromosomes 
decondense and the nuclear envelope reforms to form intact nuclei. The cell is 
pinched in two, a process referred to as cytokinesis, to produce two genetically 
identical daughter cells. 
 
1.8 Cell cycle regulation of the initiation of DNA replication 
Much of what is known about the regulation of eukaryotic DNA replication has been 
gleaned using the power of yeast molecular genetics or the Xenopus laevis oocyte 
extract system (Blow, 1988; Blow and Laskey, 1988; Forsburg, 2001; Harland and 
Laskey, 1980; Walter et al., 1998).  
Briefly, the origin recognition complex (ORC) binds to DNA, serving as the 
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mark for the replication origins. During G1 phase, Cdc6 and Ctd1 proteins load the 
mini-chromosome maintenance (MCM) complex onto the ORC to form the pre-
replication complex (pre-RC). During S phase, DNA replication is initiated by 
activating the MCM helicase activity via the coordinated action of S-phase specific 
cyclin-dependent kinases (S-CDKs, corresponding to Cdk2-cyclin E and Cdk2-cyclin 
A in mammals) and Dbf4-dependent kinase (DDK). Activation of the MCM complex 
results in the loading of the replisome (including DNA polymerase holoenzymes and 
the single-strand DNA binding protein) unwinding of origin DNA, and DNA 
synthesis. Re-replication is prevented by blocking MCM loading during S, G2 and M 
phases, such that pre-RCs can only be assembled in G1 phase and are activated only 
during S phase (Sclafani and Holzen, 2007) (Figure 1.8). 
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Figure 1.8 – Cell cycle regulation of eukaryotic DNA replication 
Model of the regulation of eukaryotic DNA replication. Origin DNA is recognised by ORC, then 
Cdc6 and Ctd1 proteins load the hexameric MCM2-7 helicase to form the pre-RC in G1 phase. 
Geminin inhibits Cdt1 and pre-RC formation. During S phase, S-CDK- and DDK-mediated 
phosphorylation result in activation of the MCM helicase, which unwinds origin DNA and promotes 
loading of the replisome. Adapted from Sclafani and Holzen, 2007. 
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1.8.1 The origin recognition complex marks origins of replication 
The ORC is composed of six proteins, Orc1-6, at equal stoichiometry (Bell and 
Stillman, 1992; Stillman, 2005). During S to early G1 phases of the cell cycle, ORC 
binds to DNA, marking potential sites of initiation of DNA replication, referred to as 
origins (Austin et al., 1999; Bell and Stillman, 1992; Ogawa et al., 1999). In budding 
yeast, ORC recognises and binds to specific DNA sequences, which are evenly 
spaced to allow for complete genome replication (Brewer and Fangman, 1987; Feng 
et al., 2006; Raghuraman et al., 2001; Wyrick et al., 2001; Xu et al., 2006a; Yabuki 
et al., 2002). However, S. cerevisiae is clearly an exception, as most other 
eukaryotes, including S. pombe, Xenopus and mammals, have many inefficient 
origins without any identifiable sequence specificity, randomly spread throughout 
their genomes (Cvetic and Walter, 2005; Dai et al., 2005; Gilbert, 2001; Heinzel et 
al., 1991; Hyrien and Mechali, 1992; Krysan et al., 1993; Mahbubani et al., 1992; 
Remus et al., 2004; Sasaki et al., 1999; Schaarschmidt et al., 2004; Segurado et al., 
2003; Todorovic et al., 1999; Vashee et al., 2003). Thus, although Orc1-6 proteins 
are highly conserved in evolution, their DNA sequence dependence is not. 
In addition, while yeast ORCs are bound to origins throughout the cell cycle 
(Sclafani and Holzen, 2007), their mammalian counterparts are regulated in a cell 
cycle-dependent manner. The mammalian ORC subunits 2 through 5 form a stable 
core complex that interacts weakly with Orc1 and Orc6 (Giordano-Coltart et al., 
2005; Ohta et al., 2003). The Orc2-5 complex remains chromatin bound throughout 
the cell cycle while Orc1 dissociates and is degraded in cells following G1 phase (Li 
et al., 2004). This subunit re-associates with chromatin during the M to G1 transition 
(DePamphilis, 2005). 
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Most ORC subunits belong to the superfamily of ATPases associated with 
various cellular activities (AAA
+
), except Orc6 (Bell and Dutta, 2002; Koonin, 
1993). The ATP binding activity of Orc1, Orc4 and Orc5 subunits have been shown 
to be required for replication (Giordano-Coltart et al., 2005). Importantly, during 
early G1, binding of cell division cycle 6 (Cdc6), also an AAA
+
 ATPase, to the ORC 
ensures its specificity for origin DNA (Speck et al., 2005; Speck and Stillman, 2007). 
On nonorigin DNA, ATP hydrolysis by Cdc6 results in disassembly of the ORC-
Cdc6-DNA complex. In the absence of the ORC-Cdc6 complex, the MCM complex 
cannot be loaded. On the other hand, origin DNA inhibits Cdc6 ATPase activity, 
allowing pre-RC formation. 
 
1.8.2 Assembly of the pre-replication complex 
The MCM DNA helicase is a heterohexamer, composed of 6 distinct subunits 
MCM2-7 (see Section 1.13.1 for more details) (Bochman and Schwacha, 2009; 
Chong et al., 1995). Its loading onto the origins is dependent on prior binding of 
Cdc6 as well as Cdt1 (chromatin licensing and DNA replication factor 1) to the 
ORC. It has been proposed that the Cdt1-MCM complex associates with the ORC-
Cdc6-origin complex, triggering the release of Cdt1 and Cdc6; ATP hydrolysis by 
ORC would then complete the loading of the MCM helicase and the formation of the 
pre-RC (Randell et al., 2006; Speck et al., 2005; Speck and Stillman, 2007).  
 Crucially, pre-RC assembly can only occur in G1 and is blocked during S, G2 
and M phases of the cell cycle, which ensures that chromosomal DNA is replicated 
only once per cell cycle. S-CDKs act at many levels to block replication licensing, 
including degradation and localisation of several pre-RC components (Nguyen et al., 
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2001). Thus, yeast Cdc6 is degraded following phosphorylation by CDK, while 
mammalian Cdc6 is excluded from the nucleus upon phosphorylation (Delmolino et 
al., 2001; Drury et al., 2000; Jallepalli et al., 1997; Pelizon et al., 2000). Geminin, a 
protein only found in metazoans, provides an additional block to re-replication 
(McGarry and Kirschner, 1998). Geminin binds to and inhibits Cdt1, preventing 
MCM loading on origins throughout the cell cycle, except in G1, when it is actively 
degraded (McGarry and Kirschner, 1998).  
 
1.8.3 Activation of MCM DNA helicase activity and licensing of DNA 
replication 
Following pre-RC assembly in G1, activation of the MCM helicase activity and 
loading of the replisome to form the pre-initiation complex (pre-IC) at individual 
origins takes place throughout S phase.  
This very complex process is tightly controlled by the combined actions of S-
CDKs and DDK (Sclafani and Holzen, 2007). S-CDK and DDK kinase activities are 
regulated in a cell cycle-dependent manner via availability of the respective 
activating unit, cyclin and dumbbell forming 4 (Dbf4) proteins, respectively (Bloom 
and Cross, 2007; Masai and Arai, 2002; Sclafani and Holzen, 2007). Stability of the 
activating subunits is maximal during S phase resulting in maximal kinase activity. 
The CDKs are subject to additional levels of regulation, including inhibitory protein 
binding, phosphorylation by other kinases and subcellular localisation of their 
cognate cyclins (Bloom and Cross, 2007).   
The MCM heterohexamer appears to be the primary target of phosphorylation 
by DDK, in particular, MCM2, MCM4 and MCM6 have been validated as targets 
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both in vitro and in vivo (Cho et al., 2006; Masai and Arai, 2002; Montagnoli et al., 
2006; Sheu and Stillman, 2006). Phosphorylation of any one of these subunits by 
DDK was hypothesised to result in a conformational change within the helicase (see 
Section 1.13.2 for more details) (Hardy et al., 1997; Hoang et al., 2007; Sheu and 
Stillman, 2010). In addition to phosphorylation of the MCM complex, many other 
factors regulate replisome loading and activation of helicase activity, including cell 
division cycle 45 (Cdc45), the GINS complex, DNA Polymerase B possible subunit 
(Dpb11; the human equivalent being topoisomerase 11β binding protein 1 
(TopoBP1)), Sld2 and Sld3 (although Sld3 is absent in metazoans) (Pospiech et al., 
2010; Sclafani and Holzen, 2007). The GINS complex is named after the numbers 5, 
1, 2 and 3 in Japanese: Go, Ichi, Nii, San, and is composed of synthetic lethal with 
Dpb11 (Sld5), Partner with Sld5 (Psf1), Psf2 and Psf3. 
Together, these complexes load the replisome, which in turn activates the 
MCM helicase, already phosphorylated by DDK, to start unwinding the DNA and to 
commence DNA synthesis. MCM2-7, Cdc45 and the GINS complex are carried 
away from the origins within the progressing DNA replication forks (Aparicio et al., 
1997; Pospiech et al., 2010). The replisome contains all the factors required to form 
functional replication forks, including DNA polymerase α, δ and ε holoenzymes, 
proliferating cell nuclear antigen (PCNA; the polymerase clamp), replication factor C 
(Rfc) 1-5 complex (the PCNA clamp loader) and replication protein A (RPA) 1-3 
complex (single-stranded DNA binding protein). 
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1.9 Temporal program of DNA replication 
Compared to budding yeast, replication origins of most eukaryotes are inefficient, 
such that, only a fraction of the origins established in G1 are fired in S phase and 
origin usage differs between each cell in a population and from one cell cycle to the 
next (DePamphilis, 1993; Rhind, 2006). In mammals, for example, the origin located 
within the dihydrofolate reductase gene fires approximately 20% of the time, while 
most origins in fission yeast fire about 30% of the time (Dijkwel and Hamlin, 1995; 
Patel et al., 2006). Conversely, budding yeast possess well-defined, efficient origins 
that fire in as many as 90% of S phases (Fangman and Brewer, 1991).  
Nevertheless, the coordinate activation of adjacent replication origins gives 
rise to large chromosomal regions that are replicated at approximately the same time, 
referred to as replication time zones. Thus, eukaryotic DNA replication proceeds in a 
temporal fashion with certain chromosomal domains being replicated early in S 
phase and others being replicated late in S phase (Mendez, 2009).  
Detailed analysis of the replication timing of individual genes established a 
strong correlation between active transcription and early replicating DNA 
(Braunstein et al., 1982; Gilbert, 1986; Goldman et al., 1984; Schmidt and Migeon, 
1990). Highly expressed genes, such as housekeeping genes, replicate early in S 
phase (Goldman et al., 1984), whereas tissue-specific genes replicate late in most 
tissues and become early replicating only in the expressing tissue (Hatton et al., 
1988; Holmquist, 1987). Additionally, in the case of imprinted genes, in which only 
one of the two parental alleles is expressed, the expressed allele replicates early 
while the repressed allele replicates late (Simon et al., 1999).  
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DNA replication timing is associated with chromatin structure. Fractionation 
experiments suggested that early replicating zones are associated with open 
chromatin (Gilbert et al., 2004). In turn, open chromatin was shown to be gene-dense 
and correlated with higher G/C-content. Genomic studies have found a general 
association between early replication and epigenetic marks found in open, 
transcriptionally-active euchromatin (Hiratani et al., 2008; Karnani et al., 2007), 
while other studies have found an association between repressive chromatin marks 
and late replication (Belyaev et al., 1996; Cowell et al., 2002; Karnani et al., 2007). 
Additionally, histone acetylation has also been shown to correlate with replication 
timing (Bickmore and Carothers, 1995; Goren et al., 2008). 
The relationship between replication timing and chromatin structure can be 
related to the subnuclear positioning of chromosomes in the nucleus, reflecting 
higher order chromosome organisation. Early replicating chromosomal regions are 
enriched in the nuclear interior whereas late replicating regions are enriched in the 
perinucleolar regions and nuclear periphery (Dimitrova and Gilbert, 1999; Grasser et 
al., 2008; O'Keefe et al., 1992). Several studies have demonstrated that chromosomal 
organisation correlates with gene density, such that gene-poor chromosomes are 
sequestered at the nuclear periphery while gene-rich chromosomes are located in the 
nuclear interior (Boyle et al., 2001; Cremer et al., 2003; Croft et al., 1999; Gilbert et 
al., 2005; Grasser et al., 2008). Thus, DNA replication timing, chromatin structure 
and gene expression are inextricably linked. 
More recent studies using microarray technology to analyse newly 
synthesised DNA from S phase cells have enabled the genome-wide mapping of 
DNA replication timing. Studies of Drosophila, mouse and human genomes 
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confirmed positive correlations between early DNA replication and gene expression, 
G/C content and gene density (Farkash-Amar et al., 2008; Hiratani et al., 2008; Jeon 
et al., 2005; MacAlpine et al., 2004; Schubeler et al., 2002; White et al., 2004; 
Woodfine et al., 2004). DNA replication-timing profiles of both human and mouse 
genomes revealed that G/C-rich, gene-dense DNA replicated earlier in S phase 
(Farkash-Amar et al., 2008; Hiratani et al., 2008; Jeon et al., 2005; White et al., 
2004; Woodfine et al., 2004). However, these studies also identified transcription 
from late replicating regions as well as cases of silenced genes that reside in early 
replicating regions (Farkash-Amar et al., 2008; Hiratani et al., 2008; Jeon et al., 
2005; MacAlpine et al., 2004; White et al., 2004; Woodfine et al., 2004). 
Consequently, the relationship between early DNA replication and transcription is 
not clear cut. 
 49 
1.10 The Cdc7:Dbf4 kinase complex: An essential S phase kinase 
required for initiation of DNA replication 
 
1.10.1 Initial identification of cell division cycle 7 (Cdc7) and dumbbell forming 
4 (Dbf4) in budding yeast 
The cdc7 gene was originally identified in budding yeast where, when grown in non-
permissive conditions, cdc7 mutants arrested with a defect in S phase initiation 
(Hartwell, 1971; Hartwell, 1973). In budding yeast, Cdc7 kinase function was shown 
to be essential for initiation of DNA replication as mutants arrest with 1C DNA 
content (Hereford and Hartwell, 1974). Cloning of the cdc7 gene and characterisation 
of its transcriptional product showed that it encoded a serine/threonine kinase 
(Bahman et al., 1988; Hollingsworth and Sclafani, 1990; Patterson et al., 1986; Yoon 
and Campbell, 1991). Subsequently, it was shown that its kinase activity was 
essential for its function in both mitosis and meiosis (Buck et al., 1991).    
Dbf4 was independently identified in a screen for mutant strains of S. 
cerevisiae that arrest with dumbbell shapes, indicative of a defect in initiation of 
DNA replication (Johnston and Thomas, 1982a; Johnston and Thomas, 1982b). 
When synchronous cultures of temperature sensitive (ts) dbf4 mutants were 
transferred from the permissive to the restrictive temperature before the start of S 
phase, no DNA synthesis occurred (Johnston and Thomas, 1982a). Thus, the 
phenotypes of cdc7 and dbf4 mutants closely resembled each other, suggesting that 
they may function at a similar point in the cell cycle, the G1 to S phase transition. 
Accordingly, temperature-sensitive dbf4 mutants were found to be synthetically 
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lethal with temperature sensitive cdc7 mutants, while over-expression of Dbf4 
protein could suppress cdc7(ts) (Kitada et al., 1992). This study suggested that cdc7 
and dbf4 products interact to form a complex which facilitates the initiation of DNA 
replication and furthermore, Dbf4 functioned to activate or modulate Cdc7 kinase 
activity (Kitada et al., 1992).  
Subsequently it was shown that Cdc7 kinase activity, which peaks at the G1/S 
phase boundary, is controlled in a cell-cycle dependent manner by binding to Dbf4 
(Jackson et al., 1993; Oshiro et al., 1999).  Temperature inactivation of Dbf4 protein 
from a dbf4(ts) yeast strain resulted in a decrease in Cdc7 kinase activity, which was 
not seen with wild type (WT) Dbf4, clearly demonstrating that Cdc7 kinase activity 
is dependent on Dbf4 (Jackson et al., 1993). Moreover, temperature inactivation of 
Dbf4 in protein extracts from a dbf4(ts) strain and reconstitution with extract taken 
from a cycling culture of a cdc7(ts) strain showed that the Dbf4 protein from a 
cdc7(ts) extract was capable of binding to the Cdc7 protein from the dfb4(ts) extract 
and reactivating its kinase activity (Jackson et al., 1993). This interaction was cell 
cycle regulated as reconstitution with protein extract from cells arrested in G1 did not 
reactivate Cdc7 kinase activity (Jackson et al., 1993).  
Moreover, Dbf4 protein levels were shown to oscillate during the cell cycle 
and this accounted for cell cycle changes in Cdc7 kinase activity (Ferreira et al., 
2000; Oshiro et al., 1999; Weinreich and Stillman, 1999). Cdc7:Dbf4 complexes 
were immunoprecipitated from synchronous cultures of cycling cells or from cells 
blocked at various time points throughout the cell cycle, assayed for kinase activity 
and immunoblotted for Cdc7 and Dbf4 (Oshiro et al., 1999; Weinreich and Stillman, 
1999). While Cdc7 protein levels remained constant, Cdc7 kinase activity was low 
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during G1 and increased as cells entered S phase (Oshiro et al., 1999; Weinreich and 
Stillman, 1999). Changes in kinase activity corresponded to changes in the amount of 
Dbf4 co-immunoprecipitating with Cdc7 and also mirrored total levels of Dbf4 in the 
cells (Oshiro et al., 1999; Weinreich and Stillman, 1999). Dbf4 protein was shown to 
be highly unstable during G1 phase, but not during S and G2/M phases (Oshiro et al., 
1999; Weinreich and Stillman, 1999). Additionally, Dbf4 protein was stabilised in 
mutant strains in which the anaphase-promoting complex (APC), an E3 ubiquitin 
ligase complex that targets proteins for degradation, is inactivated. This suggested 
that Dbf4 protein levels are regulated by APC-dependent degradation during G1 
(Ferreira et al., 2000; Oshiro et al., 1999; Weinreich and Stillman, 1999). Cell-cycle 
regulation of Dbf4 protein levels and its requirement for Cdc7 function led to the 
conclusion that Dbf4 is a regulatory subunit essential for Cdc7 kinase activity 
(Jackson et al., 1993; Oshiro et al., 1999). Hence, the Cdc7:Dbf4 complex is also 
referred to as Dbf4-dependent kinase (DDK). 
Further analyses of its role in the initiation of DNA replication revealed that 
DDK is essential for activation of individual origins throughout S phase, and is 
required not just for the initiation of S phase but also its completion (Bousset and 
Diffley, 1998; Donaldson et al., 1998). As such, the origin-bound MCM 
heterohexamer, a key component required for origin firing, has been shown to be the 
primary physiological target for DDK (Section 1.13.2).  
 
 
 52 
1.10.2 The Cdc7:Dbf4 kinase complex is functionally conserved among 
eukaryotes  
In accordance with its essential role in initiation of DNA replication, homologues of 
Cdc7 and Dbf4 have been identified in fission yeast and metazoans including 
humans. 
 The gene for homologue of Cdc7 kinase 1 (Hsk1), the fission yeast 
orthologue of Cdc7, was initially identified by degenerate oligonucleotide-directed 
PCR screening using oligonucleotides that targeted the conserved kinase domains or 
the third kinase insert domain of budding yeast Cdc7 (See Section 1.11) (Masai et al., 
1995). Its functional partner, Dbf4 in Pombe 1 (Dfp1), was first discovered as a 
polypeptide co-purifying with Hsk1 (Brown and Kelly, 1998). The same molecule 
was identified independently by yeast two-hybrid screening and was termed Hsk1-
interacting molecule 1 (Him1) (Takeda et al., 1999). Dfp1/Him1 protein levels are 
cell cycle regulated; being low in G1, increasing at the G1/S phase boundary and 
remaining high throughout S phase and binding of this regulatory subunit to Hsk1 
stimulates its kinase activity (Brown and Kelly, 1998; Brown and Kelly, 1999; 
Takeda et al., 1999). Both Hsk1 and Dfp1/Him1 were shown to be essential for the 
viability of fission yeast cells and null mutant cells arrested with 1C DNA content 
(Brown and Kelly, 1998; Masai et al., 1995; Takeda et al., 1999).   
The cDNA encoding the human homologue of Cdc7 was first identified in a 
cDNA library using cross-hybridisation (Sato et al., 1997). In an independent study, 
the coding sequence for human Cdc7 was cloned based on homology to budding 
yeast Cdc7 (Jiang and Hunter, 1997). The human homologue of Dbf4, usually 
referred to as activator of S phase kinase (ASK), was identified by two-hybrid 
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screening in two independent studies (Jiang et al., 1999; Kumagai et al., 1999).  
In human cells, transcription of ASK oscillates during the cell cycle, ASK 
mRNA is low in G2/M and rises steadily as cells progressed into S phase (Kumagai 
et al., 1999). Western blot analysis of extracts from synchronised human cells 
showed that ASK protein levels are lowest during M phase, increase at late G1 and 
remain high during S phase (Kumagai et al., 1999). Anti-Cdc7 immunoprecipitates 
from the same extracts were analysed for kinase activity and shown to have very low 
kinase activity at G2/M and G1 phases whereas vigorous kinase activity was 
recovered from S-phase cells (Kumagai et al., 1999). Corroborating these data, ASK 
protein was only detected in immunoprecipitate from S-phase cells and furthermore, 
pre-immunodepletion of ASK protein from the extracts largely eliminated the kinase 
activity (Kumagai et al., 1999). Conversely, Cdc7 protein levels remained constant 
throughout the cell cycle, indicating that the cell cycle-regulation of Cdc7 kinase 
activity was a result of increased ASK protein levels during S phase (Kumagai et al., 
1999). Taken together, these data show that ASK is indeed the regulatory subunit 
required for activation of human Cdc7 kinase activity.  
Microinjection of an antibody against ASK or human Cdc7 led to inhibition 
of DNA replication and cells failed to enter S phase, indicating an essential role for 
Cdc7:ASK in regulation of DNA replication during the mammalian cell cycle (Jiang 
et al., 1999; Kumagai et al., 1999). More direct evidence for the essential role of 
Cdc7 kinase in mammalian cell proliferation came from the fact that mice lacking the 
murine homologue of the Cdc7 gene are early embryonic lethal (Kim et al., 2002). 
Using mutant mouse embryonic stem (ES) cells in which Cdc7 can be conditionally 
inactivated, this study showed that loss of Cdc7 resulted in an accumulation of cells 
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in S phase and cessation of DNA synthesis (Kim et al., 1998). Similarly, inactivation 
of ASK in mouse ES cells results in cessation of DNA synthesis and growth arrest 
(Yamashita et al., 2005). Thus, the Cdc7:Dbf4/ASK kinase complex is functionally 
conserved from yeast to humans and is essential for initiation and elongation stages 
of DNA replication throughout S phase. 
 In addition to ASK, human Cdc7 has an alternative regulatory subunit, 
termed Dbf4-related factor 1 (Drf1) (Montagnoli et al., 2002). Alignment of ASK 
and Drf1 amino acid sequences showed that the N-terminal portions of these proteins 
are very similar, both containing conserved Dbf4 motifs N, M and C (See Section 
1.12). However, the proteins differed greatly in their C-terminal portions 
(Montagnoli et al., 2002). A homologue of Drf1 was also identified in Xenopus and 
subsequently shown to be developmentally-regulated (Silva et al., 2006; Takahashi 
and Walter, 2005; Yanow et al., 2003). In Xenopus egg extracts, Cdc7:Drf1 was far 
more abundant than Cdc7:Dbf4 (Silva et al., 2006; Takahashi and Walter, 2005). 
Using in vitro fertilised Xenopus eggs, it was shown that after the gastrulation stage 
of development, Drf1 levels decreased significantly and the Cdc7:Dbf4 complex 
became more abundant (Takahashi and Walter, 2005). These data indicated that 
Cdc7:Drf1 plays a role in DNA replication in the early embryonic cell cycle, while 
Cdc7:Dbf4 is predominant in somatic cells (Silva et al., 2006; Takahashi and Walter, 
2005). 
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1.11 Structural features of Cdc7 
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Figure 1.9 – Schematic of S. cerevisiae and human Cdc7 structures 
Grey segments represent non-conserved N- and C-terminal regions, light blue segments represent 
conserved kinase domains I – XI and dark blue segments represent non-conserved kinase insert (KI) 
regions, which are characteristic of Cdc7 orthologues. Cdc7 segments are numbered according to Sato 
et al., 1997.  
 
Cdc7 is a Ser/Thr kinase whose primary structure is unique among protein kinases. 
The Cdc7 protein is composed of eleven conserved kinase domains (indicated by 
Roman numerals I – XI) which are characteristic of Ser/Thr kinases, however, these 
conserved domains are interrupted by kinase insert (KI) sequences (KI-1, KI-2 and 
KI-3), which are unique to the Cdc7 kinase family (Figure 1.9) (Faul et al., 1999; 
Guo and Lee, 1999; Hanks et al., 1988; Jiang and Hunter, 1997; Masai et al., 1995; 
Patterson et al., 1986; Sato et al., 1997). The length and sequence of the N- and C-
terminal regions of the protein are not conserved amongst the various Cdc7 
orthologues (Figure 1.9) (Masai et al., 1995; Sato et al., 1997). The C-terminal 
regions of budding yeast Cdc7 and fission yeast Hsk1 are rich in acidic residues and 
are essential for the functions of these two kinases (Masai et al., 1995; Sato et al., 
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1997). Two-hybrid analysis indicates that the Dbf4 regulatory subunit interacts with 
the C-terminal tail of budding yeast Cdc7 (Jackson et al., 1993). It was therefore 
unexpected to find that human and Xenopus Cdc7 orthologues do not contain similar 
C-terminal tails (Sato et al., 1997).  
 Budding yeast Cdc7 and Hsk1 from fission yeast share 58% identity within 
their kinase conserved domains (Masai et al., 1995). When confined to the kinase 
conserved domains, human and Xenopus Cdc7 share 80% sequence identity with 
each other and ~44% identity with budding yeast Cdc7 and Hsk1 (Jiang and Hunter, 
1997; Sato et al., 1997). The location of the kinase insert sequences, between kinase 
domains I and II, VII and VIII and X and XI for kinase insert 1, 2 and 3, 
respectively, are the same for all Cdc7 orthologues. However, the length and 
sequence of the kinase inserts are not conserved (Figure 1.9) (Faul et al., 1999; Guo 
and Lee, 1999; Jiang and Hunter, 1997; Masai et al., 1995; Sato et al., 1997). Unlike 
their yeast counterparts, the presence of kinase insert 1 was not obvious in human 
and Xenopus orthologues of Cdc7, while kinase inserts 2 and 3 were clearly detected 
(Figure 1.9) (Jiang and Hunter, 1997; Masai et al., 1995; Sato et al., 1997).  
 In accord with its essential function as a Ser/Thr kinase, mutations of key 
residues within conserved kinase domains of budding yeast Cdc7 and fission yeast 
Hsk1 cause accumulation of cells with 1C DNA content (Brown and Kelly, 1998; 
Buck et al., 1991; Hollingsworth et al., 1992; Ohtoshi et al., 1997). 
Kinase inserts 2 and 3 have been implicated in regulation of nuclear import, 
chromatin binding and nuclear export of human Cdc7 (Kim et al., 2007; Kim and 
Lee, 2006). These three regulation steps are mediated by a nuclear localisation signal 
(NLS), a nuclear retention signal (NRS) and two nuclear export signals (NES), 
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respectively (Kim et al., 2007; Kim and Lee, 2006). Importin-β binds to the NLS 
(residues 203-370), which spans kinase insert 2, and mediates import of Cdc7 into 
the nucleus (Kim and Lee, 2006). The NRS (residues 306-326) is present within the 
NLS and is essential for chromatin binding following nuclear import (Kim et al., 
2007). A Cdc7 deletion mutant lacking the NRS, Cdc7(Δ300-332), was not retained 
in the nucleus although it retained the ability to bind to importin-β and to be 
imported into the nucleus (Kim et al., 2007). Moreover, the NRS was shown to be 
essential for the preferential binding of Cdc7 to an origin in mammalian cells (Kim et 
al., 2007). Chromatin immunoprecipitation showed that both endogenous and over-
expressed WT Cdc7 associated with origin DNA about 2-fold more frequently than 
with the non-origin DNA, while the NRS-defective mutant, Cdc7(Δ300-332), did not 
show any preference (Kim et al., 2007). Two nuclear export sequences, NES1 and 
NES2, are located within the C-terminal region and are required for effective export 
of Cdc7 to the cytoplasm (Kim et al., 2007). NES1 (residues 458-467) is located 
within kinase insert 3 while NES2 (residues 545-554) is located within kinase 
conserve domain XI (Kim et al., 2007).  
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1.12 Dbf4/ASK: Protein domain organisation and function 
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Figure 1.10 – Structures of Dbf4 orthologues 
Schematic of Dbf4 from S. cerevisiae, Him1/Dfp1 from S. pombe and human ASK. Locations of 
conserved Dbf4 motifs -N, -M and -C are indicated. Adapted from Masai and Arai, 2000. 
 
While there is substantial sequence homology among Cdc7 orthologues, the Dbf4-
related regulatory subunits are surprisingly divergent (Kumagai et al., 1999; Masai 
and Arai, 2000; Takeda et al., 1999). Amino acid sequence alignments of Dbf4 
orthologues identified only three conserved regions, termed Dbf4 motifs N, M and C 
(Figure 1.10) (Kumagai et al., 1999; Masai and Arai, 2000; Takeda et al., 1999).  
 The M and C motifs, characterised as Pro-rich and C2H2-type zinc-binding 
domains, respectively, are essential for kinase activation and its mitotic functions in 
S. pombe (Ogino et al., 2001). In vivo, the ability of Him1/Dfp1 deletion mutants to 
rescue the growth defect of him1 null cells indicated that Dbf4 motifs M and C are 
essential for mitotic functions while motif N was dispensable (Ogino et al., 2001). In 
vitro, an 86 residue segment of motif M and a 58 residue segment of motif C 
individually bound to Hsk1 while kinase activation required the concomitant binding 
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of these two motifs to Hsk1 (Ogino et al., 2001). The segment connecting the two 
motifs is not conserved and could be varied in length and sequence without 
compromising mitotic activity (Ogino et al., 2001). Similarly, in the budding yeast 
model, two-hybrid and biochemical experiments showed that Dbf4 motif C together 
with motif M plus an additional ~ 100 amino acids downstream of motif M are 
required for binding to Cdc7 while the N motif does not interact with Cdc7 (Harkins 
et al., 2009). In budding yeast, motif C contributes substantially to Cdc7 kinase 
activation (Harkins et al., 2009).  A small fragment of human ASK spanning motifs 
M and C (residues 174-350) is minimally sufficient to support Cdc7 kinase activity 
in vitro, while a slightly larger fragment (residues 134-350) was capable of inducing 
hyperphosphorylation of MCM2 in vivo (Sato et al., 2003). Taken together these data 
strongly indicate that Dbf4 motifs M and C are sufficient for binding to Cdc7 and 
activating its kinase activity (Harkins et al., 2009; Ogino et al., 2001; Sato et al., 
2003).  
Moreover, two-hybrid analysis has demonstrated that Dbf4 motif M is 
required for interaction with MCM2, a critical Cdc7 substrate and component of the 
pre-RC (Varrin et al., 2005). Dbf4ΔM, lacking only motif M, was unable to 
complement growth and acted in a dominant-negative fashion in S. Cerevisiae 
(Varrin et al., 2005). A single point mutation (P277L) in motif M greatly impaired 
the ability of Dbf4 to interact with MCM2 without affecting its interaction with Cdc7 
(Varrin et al., 2005). Thus, in addition to binding to Cdc7, the interaction with 
MCM2 can account for the fact that motif M is essential for mitotic functions in 
yeast. 
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The long C-terminal tail following motif C is characteristic of metazoan 
orthologues of Dbf4 (identified in human, mouse, hamster, Xenopus and Drosophila 
orthologues) (Figure 1.10) (Guo and Lee, 2001; Jares et al., 2004; Landis and Tower, 
1999; Masai and Arai, 2000). Dbf4 from budding yeast and Him1/Dfp1 from fission 
yeast do not possess a C-terminal tail; rather Dbf4 motif C is located very close to 
the C-terminus in these molecules (Figure 1.10) (Masai and Arai, 2000). A small 
segment of the C-terminus of human ASK (residues 614-674), lacking any of the 
conserved motifs but rather derived from the C-terminal tail, was shown to be able to 
bind to Cdc7 in addition to motifs M and C (Sato et al., 2003).  
Motif N, distantly related to the BRCA1 C-terminal (BRCT) domain, has 
been implicated in the interactions with the replication machinery and origins in 
yeast (Dowell et al., 1994; Duncker et al., 2002; Francis et al., 2009; Ogino et al., 
2001; Pasero et al., 1999; Varrin et al., 2005). Indeed, the BRCT repeats of BRCA1 
have been shown to function as phosphopeptide-binding modules (Rodriguez and 
Songyang, 2008; Williams et al., 2005). Thus, the N motif may be involved in 
mediating phosphorylation dependent protein-protein interactions. 
One-hybrid assays indicated that Dbf4-motif N was required for sequence-
specific interactions with replication origins in S. cerevisiae (Dowell et al., 1994; 
Ogino et al., 2001). Immunostaining of yeast nuclei showed that Dbf4 co-localises 
with Orc2, exhibiting the same punctuate staining pattern as Orc2 (Pasero et al., 
1999). Dbf4 was shown to co-fractionate with Orc2 in the chromatin insoluble 
fraction, and was almost entirely displaced to the soluble fraction upon disruption of 
the ORC complex, indicating that Dbf4 requires ORC to bind chromatin (Pasero et 
al., 1999). Subsequently, yeast two-hybrid and co-immunoprecipitation assays have 
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shown a direct interaction between Dbf4 and Orc2 and Orc3 subunits of the ORC 
(Duncker et al., 2002; Varrin et al., 2005). Moreover, this interaction is mediated by 
motif N (Duncker et al., 2002; Varrin et al., 2005). Furthermore, the N terminal 
region of Dbf4 (residues 110-296) is required for association of the Cdc7:Dbf4 
complex with pre-RC loaded MCM helicase (Francis et al., 2009).  
Association of Xenopus Cdc7 with chromatin requires the presence of MCM 
and activated origins (Jares and Blow, 2000). In contrast, Xenopus Dbf4 associates 
with chromatin very early in the cell cycle, before Cdc7, and this association is not 
dependent on licensing or pre-RC proteins (Jares et al., 2004). Immunodepletion of 
Dbf4 prevented Cdc7 chromatin loading and this defect was rescued by the addition 
of recombinant Dbf4 in a licensing-dependent manner, suggesting that chromatin 
association of Cdc7 is dependent on both licensing and Dbf4 (Jares et al., 2004). 
Collectively, results obtained in yeast and Xenopus models, indicate that Cdc7 is 
recruited to replication origins via its regulatory subunit although the mechanisms by 
which the kinase associates with chromatin likely differs between the species.  
 
1.13 Mechanism of origin activation by Cdc7:Dbf4 kinase 
 
1.13.1 The MCM DNA helicase 
Replicative helicases are motor proteins that bind and hydrolyse ATP in order to 
unwind duplex DNA into single-stranded DNA templates for polymerases. The 
MCM complex is the putative eukaryotic DNA replicative helicase, required for both 
initiation and elongation stages of DNA replication (Bochman and Schwacha, 2009; 
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Chong et al., 1995). The MCM genes were initially identified in yeast genetic 
screens for mutants defective in maintenance of mini-chromosomes, revealing 
mutations in MCM2, MCM3 and MCM5 (Maine et al., 1984). MCM4 and MCM7 
were isolated as cell cycle division mutants (Hennessy et al., 1991; Moir et al., 
1982), and MCM6 was isolated as a chromosome segregation mutant in S. pombe 
(Takahashi et al., 1994). These six paralogous genes, numbered MCM2-7, are 
conserved in eukaryotes and belong to the family of AAA
+
 motor proteins (Bochman 
and Schwacha, 2009; Liu et al., 2009; Sclafani and Holzen, 2007). The six 
eukaryotic MCM proteins share significant sequence similarity with one another, all 
containing a ~250 amino acid region encoding the ATPase active site (Koonin, 
1993).   
 MCM2-7 can be co-purified as a heterohexamer from both yeast cells and 
Xenopus egg extracts (Adachi et al., 1997; Prokhorova and Blow, 2000; Thommes et 
al., 1997). Reconstitution of purified recombinant yeast proteins indicated that 
MCM2-7 proteins form a heterohexameric complex in a 1:1:1:1:1:1 stoichiometry 
with an inferred subunit order of MCM5-MCM3-MCM7-MCM4-MCM6-MCM2 
(Figure 1.11A) (Bochman et al., 2008; Davey et al., 2003). This subunit order is 
consistent with yeast two-hybrid studies of Drosophila, mouse and human MCM 
proteins (Crevel et al., 2001; Kneissl et al., 2003; Yu et al., 2004). Biochemical and 
structural studies indicate that the MCM2-7 complex is a planar, hexameric ring that 
can accommodate DNA through its central channel (Figure 1.11B) (Bochman et al., 
2008; Costa and Onesti, 2009; Davey et al., 2003; Fletcher et al., 2003).  
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Figure 1.11 – The hexameric MCM DNA helicase 
(A) Model of the eukaryotic MCM2-7 hexamer. The catalytic arginine of one subunit is clockwise of 
the ATP site in the other, forming a functional interaction which constitutes the ATPase active site. 
SRF represents the catalytic arginine motif and the P-loop represents the ATP binding site. Adapted 
from Davey et al., 2003. (B) Crystal structure of the N-terminal domain of Methanobacterium 
thermautotrophicus MCM. The archaeal complex has a single MCM-related protein, which forms a 
homohexamer (Chong et al., 2000; Kelman et al., 1999; Shechter et al., 2000). The crystal structure 
shows a hexameric ring that contains a channel, wide enough to accommodate double-stranded DNA. 
Much structural information has been gained from the study of such simple archaeal MCM 
complexes, providing a model system for eukaryotic MCM2-7. Adapted from Fletcher et al., 2003.  
 
Purified recombinant S. cerevisiae MCM heterohexamer as well as S. pombe, 
mouse and human MCM subcomplexes composed of dimers of MCM4/6/7 were 
shown to possess ATP-dependent DNA helicase activity (Davey et al., 2003; Ishimi, 
1997; Lee and Hurwitz, 2001; Schwacha and Bell, 2001; You et al., 2003). A stable 
complex comprising Cdc45, MCM heterohexamer and GINS purified from 
Drosophila embryo extracts displayed ATP-dependent helicase activity (Moyer et 
al., 2006). Furthermore, reconstitution of the Drosophila Cdc45-MCM2-7-GINS 
complex using recombinant proteins showed that the helicase activity was activated 
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by association with Cdc45 and GINS (Ilves et al., 2010). These data suggest that 
binding of Cdc45 and GINS may provide an allosteric scaffold, which triggers the 
activation of the replicative helicase in vivo.  
 In S. cerevisiae, the MCM complex was shown to be a component of the pre-
RC, associating with origin DNA during G1 but not G2/M in a manner dependent on 
ORC and Cdc6 (Aparicio et al., 1997; Wyrick et al., 2001). Using Xenopus egg 
extracts, the hexameric MCM complex was shown to be required for replication 
licensing (Prokhorova and Blow, 2000). Immunoprecipitation of MCM proteins from 
Xenopus eggs extracts revealed that MCM2-7 forms a tight complex with Cdc45 
following initiation of DNA replication and this complex has DNA helicase activity 
(Masuda et al., 2003). Furthermore, recombinant MCM heterohexamer was able to 
assemble onto chromatin, load Cdc45 and replicate DNA in MCM-depleted Xenopus 
egg extracts (Ying and Gautier, 2005). Conversely, depletion of MCMs after 
initiation of DNA replication blocked progression of the replication fork, indicating 
that MCM helicase activity is required for elongation (Labib et al., 2000). 
Corroborating this, chromatin immunoprecipitation experiments demonstrated that 
all six MCM subunits co-localise with DNA polymerase as the replication fork 
progresses during elongation (Aparicio et al., 1997). Moreover, neutralisation of 
MCMs or Cdc45 in Xenopus egg extracts following initiation of DNA replication 
blocked further replication, indicating that MCM and Cdc45 are required throughout 
replication elongation in vertebrates (Pacek and Walter, 2004). These data, together 
with biochemical experiments demonstrating DNA helicase activity, strongly 
suggests that the MCM2-7 complex is the replicative helicase in eukaryotic cells. 
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1.13.2 Cdc7 kinase promotes origin firing by phosphorylating components of 
the MCM2-7 complex 
MCM2 appears to be the critical target of Cdc7:Dbf4, although other MCM2-7 
subunits can also be phosphorylated by the kinase. Yeast two-hybrid and affinity 
chromatography experiments showed that budding yeast Cdc7:Dbf4 physically 
interacts with MCM2 (Lei et al., 1997). Recombinant Cdc7:Dbf4 phosphorylated 
MCM2, MCM3, MCM4 and MCM6 in vitro (Lei et al., 1997). Moreover, 
inactivation of Cdc7 kinase activity at the G1-to-S phase transition blocked 
phosphorylation of MCM2 in yeast cells, indicating that MCM2 is targeted by Cdc7 
kinase in vivo (Lei et al., 1997). Recombinant fission yeast Hsk1 also efficiently 
phosphorylates MCM2 (Brown and Kelly, 1998; Takeda et al., 1999).  
 Recombinant human Cdc7:ASK can efficiently phosphorylate uncomplexed 
MCM2 as well as MCM2, MCM4 and MCM6 within the quaternary MCM2-MCM4-
MCM6-MCM7 complex (Jiang et al., 1999; Kumagai et al., 1999; Masai et al., 2000; 
Sato et al., 1997). Prior phosphorylation of mammalian MCM2 by CDK2 
significantly increased the efficacy of MCM2 phosphorylation by Cdc7 (Masai et al., 
2000). Similarly, prior dephosphorylation of yeast MCM2 led to a loss of 
phosphorylation by Cdc7 (Kihara et al., 2000). These results indicated that both CDK 
and Cdc7 kinase activity may be required to achieve efficient phosphorylation of 
MCM2. Additionally, while a purified mammalian MCM heterohexamer displayed 
detectable ATPase activity, a complex containing a nonphosphorylatable mutant of 
MCM2, MCM2A-7, showed very poor ATPase activity, indicating that 
phosphorylation of MCM2 by Cdc7 kinase is critical for the ATPase activity of the 
MCM heterohexamer (Tsuji et al., 2006).  
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 Human Cdc7 kinase phosphorylates serine and threonine residues within the 
N terminal region of human MCM2 and the phosphorylation sites indentified in vitro 
have been validated in vivo (Table 1.1) (Cho et al., 2006; Montagnoli et al., 2006; 
Tsuji et al., 2006). Analysis of MCM2 phospho-sites indicated that Cdc7 
preferentially phosphorylates serine residues which are adjacent to acidic amino 
acids (Cho et al., 2006). Furthermore, additional phosphorylation sites can be 
generated in MCM2 via prior phosphorylation of MCM2 by CDKs, providing a 
phosphorylated serine residue, which can play the same role as an acidic amino acid 
(Cho et al., 2006; Montagnoli et al., 2006). 
Table 1.1 – Major Cdc7 target sites within human MCM2  
MCM2 residues 
phosphorylated 
by Cdc7 kinase 
Contribution of other kinases References 
Ser40 Phosphorylation of Ser41 facilitates 
phosphorylation by Cdc7 kinase by addition 
of negative charge 
 
Cho et al., 2006, Montagnoli et 
al., 2006 
Ser53  Cho et al., 2006, Montagnoli et 
al., 2006, Tsuji et al., 2006 
 
Ser108 This site is also phosphorylated by ATR 
(ataxia telangiectaisa and Rad3-related 
kinase) 
Cho et al., 2006, Montagnoli et 
al., 2006, Tsuji et al., 2006 
 
Importantly, phosphorylation of MCM2 by Cdc7:ASK is essential for 
initiation of DNA replication (Tsuji et al., 2006). Thus, siRNA-mediated suppression 
of endogenous MCM2 expression in HeLa cells resulted in the inhibition of DNA 
replication which could be rescued by ectopic expression of a phosphomimetic but 
not by a nonphosphorylatable MCM2 mutant (Tsuji et al., 2006). Additionally, 
phosphorylation of MCM2 has been shown to be required for yeast cell growth as 
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expression of a nonphosphorylatable mutant of MCM2 in yeast cells lacking 
endogenous MCM2 is lethal (Bruck and Kaplan, 2009).  
Studies in yeast indicate that phosphorylation of components of the MCM2-7 
complex by Cdc7 kinase results in structural changes which promotes loading of 
Cdc45 and activates helicase activity, key events in origin firing (Hardy et al., 1997; 
Hoang et al., 2007; Sheu and Stillman, 2010). The S. cerevisiae mutant, mcm5-bob1, 
contains a single point mutation (P83L) in the mcm5 gene that specifically bypasses 
the requirement for Cdc7:Dbf4 while maintaining the requirement for CDK activity 
to initiate DNA replication (Hardy et al., 1997; Hoang et al., 2007). Although MCM5 
is the only subunit that is not phosphorylated by Cdc7, phosphorylation of one or 
more of MCM2, MCM4 or MCM6 causes a structural change in the MCM5 subunit 
(pushing out of the A subdomain of the MCM5 protein) that allows Cdc45 loading 
and helicase activation (Geraghty et al., 2000; Hoang et al., 2007; Lei et al., 1997; 
Sclafani et al., 2002). The mcm5-bob1 mutation mimics the effect of Cdc7 
phosphorylation, producing the required conformational change in the MCM5 
protein in the absence of Cdc7:Dbf4 (Geraghty et al., 2000; Hoang et al., 2007; 
Sclafani et al., 2002).  
Another study in S. cerevisiae demonstrated that the N-terminal domain of 
MCM4 (residues 2-174) blocks activation of licensed origins and phosphorylation of 
this domain by Cdc7:Dbf4 alleviates this inhibition to promote Cdc45 loading and 
origin firing (Sheu and Stillman, 2006; Sheu and Stillman, 2010). Replacing 
chromosomal MCM4 with mcm4
Δ2-174 
bypasses the essential function of Cdc7:Dbf4 
in budding yeast (Sheu and Stillman, 2010). Moreover, the N-terminal domain of 
MCM2 can functionally replace that of MCM4 and the mcm2
1-200
mcm4
Δ2-174
 fusion 
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protein can support Cdc7:Dbf4-independent cell proliferation to an extent that 
surpasses mcm4
Δ2-174
, indicating that MCM2 has a positive role in activating DNA 
replication (Sheu and Stillman, 2006; Sheu and Stillman, 2010).  
Taken together, these data strongly suggest that phosphorylation of the 
MCM2-7 complex by Cdc7 kinase, in cooperation with S-CDKs, alters is 
conformation, ultimately activating its helicase activity.  
 
1.13.3 Cdc7:Dbf4 function is required for loading of Cdc45 onto chromatin 
While phosphorylation of the MCM2-7 complex by Cdc7:Dbf4 kinase is essential for 
origin firing, activation of the pre-RC also requires recruitment of several other 
factors, including Cdc45 and the GINS complex (Sclafani and Holzen, 2007). 
Indeed, reconstitution of the Drosophila Cdc45-MCM2-7-GINS complex suggested 
that Cdc45 and GINS can activate MCM helicase activity allosterically (Ilves et al., 
2010). Moreover, an early study in S. cerevisiae showed that Cdc7:Dbf4 and Cdc45 
are dependent on one another for the execution of their replication functions (Owens 
et al., 1997). Subsequently, several studies have shown that both Cdc7 and S-CDK 
are required for loading of Cdc45 and GINS onto chromatin and subsequent origin 
firing (Im et al., 2009; Jares and Blow, 2000; Masai et al., 2006; Nougarede et al., 
2000; Yabuuchi et al., 2006). Thus, Cdc7 kinase, in cooperation with S-CDKs, 
executes its essential functions during S phase by phosphorylating components of 
pre-RC bound MCM2-7 and facilitating loading of Cdc45 onto licensed origins 
which then leads to replisome loading and activation of MCM helicase activity.  
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1.14 Other functions of Cdc7 kinase 
Aside from its essential role in the initiation of DNA replication throughout S phase, 
Cdc7 kinase in also involved in the replication checkpoint and chromosome 
cohesion, as well as playing a role in recombination and chromosome segregation 
during meiosis.   
 
1.14.1 Cdc7 kinase and the S-phase DNA replication checkpoint 
The S-phase checkpoint is induced in response to aberrant DNA replication and 
damage, resulting in suppression of late origin firing and stabilisation of stalled 
replication forks to ensure proper fork restart following removal of the replication 
error (Segurado and Tercero, 2009).  
Mutation or deletion of the N motif of S. pombe Dfp1/Him1 resulted in 
impaired S-phase checkpoint control (Takeda et al., 1999). Treatment with 
hydroxyurea (HU), which arrests replication forks, activates the checkpoint kinase 
Cds1 (S. pombe homologue of S. cerevisiae Rad53) and results in Cds1-dependent 
hyperphosphorylation of Dfp1/Him1 (Brown and Kelly, 1999). Hsk1 also undergoes 
Cds1-dependent phosphorylation in response to HU treatment (Snaith et al., 2000). 
Moreover, Hsk1 activity was required for recovery from replication arrest and 
completion of mitosis following HU treatment (Snaith et al., 2000). In turn, Cds1 has 
been found to be dependent on Hsk1 activity for full activation during exposure to 
HU (Takeda et al., 2001). Thus, Hsk1 kinase may induce the S-phase checkpoint via 
activation of Cds1.  
In budding yeast, deletion of cdc7 results in hypersensitivity to HU in a 
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mcm5-bob1 background (Weinreich and Stillman, 1999). Moreover, deletion of the 
N motif of Dbf4 results in a defect in HU-induced checkpoint responses (Ogino et 
al., 2001). Akin to Dfp1/Him1 in fission yeast, Dbf4 is phosphorylated in a Rad53 
dependent manner, when cells are treated with HU (Dohrmann et al., 1999; Kihara et 
al., 2000; Weinreich and Stillman, 1999). Phosphorylation of Rad53 is important for 
its checkpoint functions and Cdc7:Dbf4 has been shown to phosphorylate Rad53 
during checkpoint activation and was required for full activation of Rad53 (Ogi et al., 
2008). 
 Yeast two-hybrid and co-immunoprecipitation experiments suggest that Dbf4 
interacts with Rad53 (Dohrmann et al., 1999; Duncker et al., 2002; Varrin et al., 
2005). In particular, Dbf4 motif N is required for the interaction with Rad53, the 
same domain that mediates the interaction with ORC (Duncker et al., 2002; Varrin et 
al., 2005). As such, Rad53-dependent phosphorylation of Dbf4 following HU 
exposure displaces it from origins (Santocanale and Diffley, 1998; Weinreich and 
Stillman, 1999). 
Deletion of the Cdc7 gene in mouse ES cells abrogates HU- and UV-induced 
phosphorylation of the checkpoint kinase Chk1, and HU-induced Chk1 activation is 
also impaired in human cells depleted of Cdc7 by siRNA, indicating that Cdc7 
kinase is important for checkpoint responses in mammalian cells (Kim et al., 2008). 
Moreover, Cdc7 depletion resulted in loss of phosphorylation and chromatin 
association of Claspin, a protein that is essential for regulation of Chk1 (Kim et al., 
2008). These studies suggest that Cdc7 may activate the ATR-Chk1 checkpoint 
pathway through regulation of Claspin (Gold and Dunphy, 2010; Kim et al., 2008).  
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1.14.2 Cdc7 kinase and meiosis 
Meiosis is a specialised cell cycle in which two consecutive chromosome segregation 
events, meiosis I and meiosis II, follow a single round of DNA replication to produce 
haploid gametes from a diploid cell (Sakuno and Watanabe, 2009). In addition to 
initiation of DNA replication during both mitotic and meiotic cell cycles, Cdc7 
kinase function is required during meiosis I for initiation of meiotic recombination 
and for chromosome segregation, implicating Cdc7 kinase as a global coordinator of 
meiosis I. 
 Studies in yeast have shown that Cdc7:Dbf4 is required for initiation of 
meiotic recombination by promoting the formation of double strand breaks (DSBs) 
(Buck et al., 1991; Ogino et al., 2006; Sasanuma et al., 2008; Wan et al., 2008). 
Meiotic recombination is initiated at DSBs generated by the Spo11 endonuclease, 
and this process requires Cdc7:Dbf4 (Sasanuma et al., 2008; Wan et al., 2008). 
Cdc7:Dbf4 was shown to phosphorylate the Spo11 accessory factor, Mer2 
(Sasanuma et al., 2008; Wan et al., 2008). Phosphorylation of Mer2 by both 
Cdc7:Dbf4 and S-CDKs is essential for Mer2-dependent recruitment of Spo11 to 
DSB sites, suggesting that these kinases control loading of DSB proteins onto 
chromatin by modulating Mer2 activity (Sasanuma et al., 2008). 
 Use of the mcm5-bob1 mutation, which bypasses the requirement for 
Cdc7:Dbf4 during DNA replication, allowed analysis of chromosome segregation 
during meiosis in the absence of Cdc7 (Lo et al., 2008; Matos et al., 2008). These 
studies showed that Cdc7:Dbf4 is required for segregation of homologous 
chromosomes during meiosis I (Lo et al., 2008; Matos et al., 2008; Valentin et al., 
2006). In the absence of Cdc7, homologue segregation fails in meiosis I and sister 
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chromatids are then segregated during meiosis II, in a single round of cell division, to 
form a pair of diploid spores, much like what happens in mitosis (Lo et al., 2008; 
Matos et al., 2008).  
 Intriguingly, while Cdc7:Dbf4 activity is required for DNA replication as 
well as recombination and homologous chromosome segregation during meiosis, 
studies have shown that these processes are differently sensitive to quantitative 
changes in kinase levels (Lo et al., 2008; Matos et al., 2008; Sasanuma et al., 2008; 
Wan et al., 2008). It appears that much higher Cdc7 kinase activity is required for 
formation of DSBs and chromosome segregation than is required for initiating DNA 
replication (Lo et al., 2008; Matos et al., 2008; Sasanuma et al., 2008; Wan et al., 
2008). Thus, when meiosis is induced and Cdc7 kinase activity begins to increase, 
the threshold for DNA replication may be reached before the threshold required for 
downstream processes. 
 
1.14.3 Cdc7 kinase and chromosome cohesion 
Hsk1:Dfp1 has been shown to promote heterochromatin function and cohesion at 
centromeres in S. pombe, while Cdc7:Drf1 has been shown to be required for sister 
chromatid cohesion in Xenopus (Bailis et al., 2003; Takahashi et al., 2008).  
Yeast two-hybrid and co-immunoprecipitation experiments demonstrated that 
Hsk1:Dfp1 interacts with Swi6 (heterochromatin protein 1 [HP1] equivalent in 
fission yeast) via the C-terminus of Dfp1 (Bailis et al., 2003). Moreover, Swi6 is 
efficiently phosphorylated by Hsk1:Dfp1 in vivo and in vitro (Bailis et al., 2003). 
Swi6 is required for recruitment of cohesin to heterochromatic regions and 
establishment of cohesion at centromeres in fission yeast (Bernard et al., 2001; 
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Nonaka et al., 2002). Mutant cells expressing C-terminally truncated Dfp1, dfp1(1-
376), showed a centromere-specific defect in cohesion and, like in Swi6-null cells, 
showed a reduction in the levels of Rad21, an essential component of the cohesin 
complex, at centromeric heterochromatin but not at cohesion sites along the 
chromosome arms (Bailis et al., 2003). This result suggested that phosphorylation of 
Swi6 by Hsk1:Dfp1 promotes its association with other factors required to induce 
cohesion-competent heterochromatin (Bailis et al., 2003). 
 Cohesin, which is required for functional sister chromatid cohesion, is loaded 
onto chromosomes by the Scc2-Scc4 complex during G1 (Lengronne et al., 2006; 
Uhlmann and Nasmyth, 1998). Additionally, chromatin association of Scc2 and 
cohesin is dependent on establishment of pre-RCs at origins of replication in 
Xenopus egg extracts (Gillespie and Hirano, 2004; Takahashi et al., 2004). 
Consequently, Cdc7 kinase activity is required to recruit the Scc2-Scc4 complex to 
pre-RCs (Takahashi et al., 2008). Depletion of Cdc7 markedly reduced chromatin 
association of Scc2, Scc4 and Rad21 in Xenopus egg extracts (Takahashi et al., 
2008).  
 
1.15 Cdc7 is an emerging anticancer target 
The essential role of Cdc7 kinase in DNA replication coupled with its functions 
during the replication checkpoint make it a plausible target for cancer therapy (Sawa 
and Masai, 2009; Swords et al., 2010). Both Cdc7 and Dbf4/ASK are over-expressed 
in a number of cancer cell lines as well as primary patient tumour samples (Bonte et 
al., 2008; Clarke et al., 2009; Kaufmann et al., 2008; Kulkarni et al., 2009; Nambiar 
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et al., 2007). Moreover, a high correlation between mutated p53 and Cdc7 over-
expression was noted (Bonte et al., 2008). However, existing studies are 
contradictory as to whether increased Cdc7 expression is associated with accelerated 
cell cycle progression (Bonte et al., 2008; Kulkarni et al., 2009).  
Crucially, siRNA-mediated knockdown of Cdc7 expression in various cancer 
cell lines resulted in impaired progress through S phase and accumulation of nuclear 
damage, culminating in cell death by either p53-independent apoptosis or abortive 
mitosis (Im and Lee, 2008; Montagnoli et al., 2004). Depletion of Cdc7 likely causes 
defects in replication origin firing which halts DNA polymerisation and results in 
destabilisation of replication forks which eventually collapse (Montagnoli et al., 
2004). Furthermore, defects in checkpoint activation due to Cdc7 depletion coupled 
with the fact that checkpoint mechanisms, particularly those mediated by p53, are 
often partially abrogated in many cancers, suggests that transformed cells might not 
be able to overcome the effects of replication fork arrest. These cells would thus fail 
to inhibit cell cycle progression, which would then result in aberrant cell division and 
ultimately cell death (Im and Lee, 2008; Montagnoli et al., 2004). Indeed, cancer cell 
lines fail to elicit checkpoint responses following Cdc7 inhibition (Im and Lee, 2008; 
Montagnoli et al., 2004). In contrast, normal fibroblast cells could activate p53-
dependent and other checkpoint mechanisms, preventing progress through S phase in 
the absence of sufficient Cdc7:Dbf4 kinase activity (Im and Lee, 2008; Montagnoli 
et al., 2004). Thus, tumour cells harbouring defects in checkpoint related proteins 
may be more sensitive to Cdc7 inhibitors, allowing differential killing of tumour 
cells over normal cells (Sawa and Masai, 2009; Swords et al., 2010). 
Using high-throughput screening, the first group of Cdc7 kinase inhibitors, 
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the 2-heteroaryl-pyrrolopyridinones, were developed in 2008 (Vanotti et al., 2008). 
Following on from this, the lead compound PHA-767491 was further optimised and 
its effects were studied in pre-clinical models (Montagnoli et al., 2008). As expected, 
the compound impaired MCM2 phosphorylation at Cdc7-specific sites and blocked 
origin firing without impeding replication fork progression (Montagnoli et al., 2008). 
Additionally, the inhibitor did not trigger DNA damage responses. Treatment of 
multiple cancer cell types with PHA-767491 resulted in apoptotic cell death while 
use in pre-clinical cancer models showed that it inhibited tumour growth. These 
initial results indicated that Cdc7:Dbf4 kinase inhibitors are a promising new class of 
anti-cancer compounds (Sawa and Masai, 2009; Swords et al., 2010). 
 
1.16 Project Aim 
Although the role of LEDGF as a critical co-factor for lentiviral DNA integration has 
been extensively studied, very little is known about its natural cellular functions. The 
aim of this study is to investigate the cellular functions of LEDGF using two 
different approaches: gene expression profiling and proteomic analysis.  
 Results of gene expression profiling experiments carried out on LEDGF-null 
cells will be presented in Chapter III. The identification and characterisation of the 
interaction between LEDGF and the S phase kinase Cdc7:ASK will be presented in 
Chapter IV. 
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2 Chapter II: Materials and Methods 
 
2.1 General methods for DNA plasmid construction 
 
2.1.1 Polymerase chain reaction (PCR) for amplification of DNA 
Unless otherwise stated, PfuUltra II fusion hot start DNA polymerase (Stratagene) 
was used for PCR amplification. Typically, template DNA (50 – 500 ng) was added 
to a 100 µl PCR mixture containing 250 µM of each deoxyribo-nucleotide 
triphosphate (dNTP) [deoxyribo-adenosine triphosphate (dATP), deoxyribo-
thymidine triphosphate (dTTP), deoxyribo-cytidine triphosphate (dCTP), and 
deoxyribo-guanosine triphosphate (dGTP)], 100 pmol of each oligonucleotide primer 
and PfuUltra II fusion hot start DNA polymerase (1 µl) in 1x PfuUltra II reaction 
buffer (Stratagene) provided with the enzyme. All PCR amplifications were carried 
out in a GeneAmp PCR System 9700 thermocycler (Applied Biosystems). Typical 
PCR cycling conditions for 1-kilobase (kb) DNA products or larger were as follows; 
one cycle of denaturation at 95°C for 5 minutes (min), 30 or 35 cycles of 
amplification consisting of denaturation for 30 seconds at 95°C, primer annealing for 
45 seconds at 52 - 56°C followed by 2 min/kb template extension at 72°C and ending 
with incubation at 72°C for 7 min. PCR products were separated by electrophoresis 
in 1% (w/v) agarose made up in TAE buffer [40 mM Tris base, 20 mM acetic acid, 
50 mM ethylenediaminetetraacetic acid (EDTA)] and containing 0.6 µg/ml ethidium 
bromide. Typical PCR cycling conditions for 300 base pair (bp) DNA products or 
smaller were as follows; one cycle of denaturation at 95°C for 5 min, 45 cycles of 
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amplification consisting of denaturation for 30 seconds at 95°C, primer annealing for 
30 seconds at 55°C followed by 1 min template extension at 72°C and ending with 
incubation at 72°C for 7 min. PCR products were separated by electrophoresis in 2% 
(w/v) agarose and isolated using a QIAquick PCR purification kit (Qiagen) as per the 
manufacturer’s instruction. Briefly, PCR mixture was diluted in 5 volumes of Buffer 
PBI (supplied), which provides the high salt conditions required for binding to the 
silica-gel membrane of the QIAquick spin column. Contaminants pass through the 
column by centrifugation, while DNA remains bound. Purified DNA is eluted under 
low salt conditions. 
 
2.1.2 DNA digestion 
DNA digestion for plasmid construction 
PCR product or plasmid DNA (5 – 10 µg) was mixed with 2 – 4 µl of restriction 
enzyme(s) (approximately 40 – 80 units, New England BioLabs) in the presence of 
reaction buffer provided with each enzyme, made up to a final volume of 100 µl with 
double distilled water (ddH2O) and incubated at 37°C for 3 hours (h). If different 
reaction buffers were required for the enzymes, DNA digested with one enzyme was 
purified using a QIAquick PCR purification kit as per the manufacturer’s instruction 
(Section 2.1.1) before digestion with a second enzyme.  
 In some cases, singly-digested plasmid DNA was filled in using T4 DNA 
polymerase in the presence of dNTPs, to produce blunt ended DNA for ligation, as 
follows. Purified DNA (30 µl) was incubated with T4 DNA polymerase (4.5 units, 
New England BioLabs) and 250 µM of each dNTP in 50 mM NaCl, 10 mM Tris-
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HCl, pH 7.9, 10 mM MgCl2, 1 mM dithiothreitol (DTT), 0.1 µg/ul bovine serum 
albumin (BSA), made up to 50 µl with ddH2O, for 30 min at 18°C. 
Prior to ligation, DNA fragments were separated in 1 – 2 % (w/v) agarose and 
isolated using QIAquick gel extraction kit (Qiagen) as per the manufacturer’s 
instruction prior to DNA (Section 2.1.3). 
 
Analytical restriction digest 
For restriction analysis of plasmid DNA, 5 µl of plasmid (1/10 of the sample) was 
mixed with 1 µl of each restriction enzyme (approximately 20 units) in the presence 
of compatible reaction buffer provided with the enzymes, made up to a final volume 
of 20 µl with ddH2O and incubated at 37°C for 1 h. Digested product (10 µl) was 
analysed by electrophoresis through 1 – 2% (w/v) agarose. 
 
2.1.3 DNA purification from agarose gels 
DNA was extracted and purified from agarose gels using the QIAquick gel extraction 
kit (Qiagen) according to the manufacturer’s instruction. Briefly, the excised gel slice 
containing the required DNA was dissolved in 3 times its volume of Buffer QG 
(supplied) with incubation at 50°C for 10 min. The pH (< 7.5) and high salt 
concentration (KI) of buffer QG is optimised to allow DNA to bind to a QIAquick 
spin column that contains a filter coated with a silica-gel membrane. DNA binds to 
this membrane in the presence of high concentrations of salt and centrifugation of the 
column allows impurities to pass through the column. The column is then washed 
and purified DNA eluted in the presence of low concentrations of salt provided by 
Buffer EB (supplied). 
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2.1.4 DNA Ligation 
Purified DNA fragments were mixed in a 1:1 molar ratio and ligated using T4 DNA 
ligase (5 units, Invitrogen) in 50 mM Tris-HCl, pH 7.6, 10 mM MgCl2, 1 mM 
adenosine triphosphate (ATP) and 1 mM DTT in a final reaction volume of 10µl. 
The reactions were incubated at 16 °C overnight and1 µl was used to transform 
competent Escherichia coli cells. 
 
2.1.5 Bacterial transformation 
Ligated DNA fragments (1µl) or plasmid DNA (50 ng) were added to chemically 
competent E. coli (30 – 100 µl) and incubated on ice for 30 min. The bacteria were 
incubated at 42°C for 50 seconds, cooled on ice for 1 min, 300 µl SOC medium 
[casein enzymatic hydrolysate 20 g/L, yeast extract 5 g/L, NaCl 0.5 g/L, MgSO4 2.4 
g/L, KCl 0.186 g/L and 0.4% glucose] added and bacteria were agitated at 37°C for 1 
h before spreading onto selective LB agar plates. To isolate plasmid DNA, plates 
were incubated overnight at 37°C and single colonies used to inoculate 3-ml Luria-
Bertani broth (LB) cultures supplemented with antibiotics for selection. The cultures 
were grown overnight at 37°C and plasmid DNA was purified by small scale (mini) 
preparation (Section 2.1.7). Typically, XL1-Blue (Bullock et al., 1987) or DH5α 
(Meselson and Yuan, 1968) strains of E. coli were used to amplify and purify 
plasmid DNA. 
 
2.1.6 Screening bacterial clones for the intended plasmid constructs 
Typically, purified plasmid DNA was analysed by restriction digestion in order to 
determine if the desired insert was present (Section 2.1.2). In some case, bacterial 
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colonies were screened directly for the presence of plasmid DNA containing the 
desired insert by colony PCR or by single colony plasmid DNA isolation.  
 
 Colony PCR 
A fraction of a bacterial colony was added to a 20 µl PCR mixture containing 125 
µM of each dNTP, 10 pmol of each oligonucleotide primer (one that anneals in the 
vector and one that anneals in the insert), 0.5 units Taq DNA polymerase 
(Invitrogen) and 2 mM MgCl2 made up in 1x PCR buffer provided with the enzyme. 
Ligation reaction (0.5 µl) was used as a positive control. PCR cycling conditions 
were as follows; one cycle of 8 min at 95°C, 27 cycles consisting of denaturation for 
30 seconds at 95°C, primer annealing for 30 seconds at 53°C followed by 30 seconds 
template extension at 72°C and ending with incubation at 72°C for 7 min. The 
products were separated by electrophoresis in 2% (w/v) agarose. 
 
Single colony plasmid DNA isolation 
A bacterial colony was added to 10 µl lysis buffer [25 mM Tris-HCl, pH 7.5, 25 mM 
EDTA, 0.5 mg/ml lysozyme, 0.04 mg/ml RNase, 0.1% glycerol, 0.02% bromophenol 
blue] and bacteria lysed by vortexing. Phenol-chloroform (2 µl) was added, the lysate 
vortexed again and then centrifuged at 10,000g for 2 min before separation of 
plasmid DNA by electrophoresis in 1% (w/v) agarose. To identify insert-containing 
clones, migration of the DNA samples was compared to that of an empty vector. 
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2.1.7 Small scale preparation of plasmid DNA (miniprep) 
A single bacterial colony was used to inoculate 3 ml LB supplemented with the 
appropriate antibiotics and grown overnight at 37°C with vigorous shaking. Plasmid 
DNA was purified from the bacterial pellet by the Qiagen miniprep method. Briefly, 
bacteria were lysed by the modified alkaline lysis method (Birnboim and Doly, 1979) 
in Buffer P2 (supplied) and this lysate neutralised and the salt concentration adjusted 
to high-salt binding conditions with Buffer N3 (supplied). High salt conditions cause 
proteins, cellular debris and chromosomal DNA to co-precipitate while closed 
circular plasmid DNA is able to renature and remain in solution. The lysate, cleared 
by centrifugation, was then applied to the silica membrane within the QIAprep spin 
column, which binds DNA under high-salt conditions. After washing with PE buffer 
(supplied), pure plasmid DNA was eluted in 50 µl EB (supplied) or ddH2O. 
 
2.1.8 Large scale preparation of plasmid DNA (maxiprep) 
To prepare highly pure and concentrated plasmid DNA, a QIAfilter maxiprep kit 
(Qiagen) was used according to the manufacturer’s instruction. A single bacterial 
colony was used to inoculate a 300-ml LB culture supplemented with appropriate 
antibiotics and grown overnight at 37°C with vigorous shaking. Bacteria were 
collected by centrifugation, resuspended in 10 ml Buffer P1 (supplied) and lysed by 
the modified alkaline lysis method (Birnboim and Doly, 1979) in 10 ml Buffer P2 
(supplied). The lysate was then neutralised and precipitated proteins, cellular debris 
and chromosomal DNA were cleared by centrifugation followed by filtration by 
passing the lyaste through a QIAfilter Cartridge (supplied) directly onto a DNA 
purification column pre-equilibrated with 10 ml Buffer QBT (supplied). Plasmid 
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DNA binds to the anion-exchange resin within the column under low ionic strengths 
and low pH conditions allowing impurities to pass through the column. The column 
was washed twice with 30 ml Buffer QC (supplied) and the DNA was eluted under 
high salt conditions with 15 ml Buffer QF (supplied). Eluted DNA was precipitated 
by addition of 11.5 ml isopropanol. Purified DNA, collected by centrifugation and 
briefly washed with 5ml of 70% ethanol, was dissolved in 0.5 ml ddH2O.  
 
2.1.9 Preparation of chemically competent E. coli  
(Inoue et al., 1990) 
Bacteria were grown to an A600 of 0.8 at 18°C, collected by gentle centrifugation at 
4°C, re-suspended in 30 ml of ice-cold transformation buffer [TB: 10 mM 
piperazine-N,N’-bis-2-ethanesulfonic acid (PIPES) pH 6.7, 15 mM CaCl2, 250 mM 
KCl and 55 mM MnCl2] and incubated on ice for 10 min. Cells were pelleted by 
gentle centrifugation at 4°C, re-suspended in 8 ml TB and supplemented with 7% 
dimethyl sufoxide (DMSO). Following 10-min incubation on ice, the cells were 
aliquoted and snap-frozen in liquid nitrogen. 
 
2.2 DNA constructs 
Plasmids used in this study are listed in Table S3 (Appendix A). Oligonucleotide 
primers used in PCR and plasmid constructions are listed in Tables S1 and S2 
(Appendix A). All restriction enzymes were purchased from New England BioLabs. 
All plasmids generated in this work were verified by sequencing (MRC Clinical 
Sciences Centre Genomic Laboratory) to rule out unwanted mutations. Constructs 
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used for expression in mammalian cells were all purified by large-scale (maxi) 
preparation according to the manufacturer’s instruction (QIAfilter Plasmid Maxi kit, 
Qiagen; Section 2.1.8). 
 
2.2.1 Reverse transcription-PCR (RT-PCR) product cloning 
RT-PCR products were amplified from total cellular RNA in one step using a 
QuantiTect SYBR Green RT-PCR kit (Qiagen) (see Section 2.8 for details of this 
reaction) under the following cycling conditions. Reverse transcription was carried 
out at 50°C for 20 min followed by denaturation at 95°C for 5 min, and then 45 
cycles of amplification consisting of denaturation for 30 seconds at 95°C, primer 
annealing for 30 seconds at 58°C followed by 30 seconds template extension at 72°C 
and ending with incubation at 72°C for 7 min. Products of quantitative reverse 
transcription PCR (qRT-PCR) reactions were purified from 2% (w/v) agarose using a 
QIAquick gel extraction kit (Qiagen) as per the manufacturer’s instruction (Section 
2.1.3) and subcloned into pCR4-TOPO vector (Invitrogen) as per the manufacturer’s 
instruction. The resulting plasmids were used to generate standard curves in qRT-
PCR assays. Briefly, pCR4-TOPO is supplied as a linearised plasmid containing 
single 3’ thymidine (T) overhangs for TA cloning. Topoisomerase I is covalently 
bound to the vector by a phospho-tyrosyl bond between the T overhang and tyrosyl 
residue Tyr 274 of the enzyme. DNA inserts with 3’ adenosine (A) overhangs are 
ligated into the vector by attack of the phospho-tyrosyl bond with a hydroxyl group 
from the DNA insert.  
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2.2.2 DNA constructs for expression in human cells 
Plasmids used in this work but not described in this chapter have been created by 
others; the corresponding references can be found in Table S3 (Appendix A). 
 
LEDGF-cTAP fusion constructs 
A DNA fragment containing the entire coding sequence of human LEDGF was PCR-
amplified using Easy-A DNA polymerase (Stratagene) with primers SHp1 and 
SHp4; the product, digested with BamHI and HindIII was ligated between BamHI 
and HindIII sites of pGM-Mel18-cTAP (Elderkin et al., 2007) resulting in pGM-
hLEDGF-cTAP. Similarly, DNA fragments encoding LEDGF(1-176) and (326-530) 
were amplified using primer pairs SHp1/SHp2 and SHp3/SHp4, respectively, and 
subcloned into pGM-Mel18-cTAP to give pGM-hLEDGF(1-176)-cTAP and pGM-
hLEDGF(326-530)-cTAP. The sense primers SHp1 and SHp3 contained a start 
codon in a favourable context (CAGACACCATG) for efficient translation initiation 
in human cells.  
 
Retroviral vectors for ectopic expression of LEDGF and p52 
Plasmids pLB(N)CX-mp75-HA and pLB(N)CX-mp52-HA used for expression of 
influenza hemagglutinin (HA) epitope-tagged forms of mouse LEDGF and p52, 
respectively, were built in the following way. Fragments encoding mouse LEDGF 
and p52 with C-terminal HA tag (YPYDVPDYA) were constructed in two rounds of 
PCR amplification. First, LEDGF and p52 coding sequences (CDS) were amplified 
from Integrated Molecular Analysis of Genomes and their Expression (IMAGE) 
Consortium cDNA clone 6400529 (GenBank accession number BC043079; obtained 
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from GeneService, UK) with primer pairs PC343/PC344 and PC343/PC346, 
respectively. The PCR fragments served as templates in the second round of 
amplification with primers PC343 and PC345; resulting products were digested with 
HindIII and subcloned between HindIII and HpaI sites of the retroviral vector 
pLB(N)CX.  
 
HA-tagged constructs 
The plasmid pCPHA38, used for expression of HA-LEDGF(326-530), was made by 
inserting a PCR fragment encoding the C-terminal portion of human LEDGF 
between BglII and XhoI sites of pCPHA-NLS (Cherepanov et al., 2004). This 
construct was made by Dr. Peter Cherepanov. 
To make pCPHA-Dbf4, used for expression of full-length HA-tagged human 
ASK, the entire ASK CDS was PCR amplified using primers SH26 and SH46. 
Plasmid pCPHA-NLS was prepared as follows; firstly the vector was digested with 
BglII and then this site filled-in using T4 DNA polymerase in the presence of dNTPs 
(Section 2.1.2). This linearised vector was then digested with XhoI. ASK CDS 
amplified by PCR with primers SH26 and SH46 was digested with XhoI and ligated 
with the vector DNA to give pCPHA-Dbf4. Plasmid pCPHA-Dbf4(1-624), used for 
expression of the C-terminally truncated form of ASK, was constructed in the same 
way using primers SH26 and SH52. 
 
Flag-Cdc7 construct 
To obtain pcDNA3.1-Flag-Cdc7 used for the expression of Flag-tagged human Cdc7, 
the vector pcDNA3.1-Flag, a modified version of pcDNA3.1(-ve) encoding a Flag 
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tag (DYKDDDDK) between NotI and BamHI sites (obtained from Dr. M. Pizzato, 
unpublished), was prepared as follows. The vector, initially linearised with BamHI 
and filled-in using T4 DNA polymerase in the presence of dNTPs (Section 2.1.2) and 
digested with AflII. A PCR fragment spanning the CDS of human Cdc7 was 
amplified using primer pair SH27/SH28, digested with AflII and ligated between the 
blunted BamHI site and the AflII site of pcDNA3.1-Flag. 
 
Tetracycline-responsive expression of LEDGF 
The constructs pTRE-HA75-hyg and pTRE-75-hyg, used for inducible expression of 
HA-tagged and non-tagged human LEDGF, respectively, were obtained by 
subcloning PCR fragments encoding respective LEDGF variants between PvuII and 
NotI sites of pTRE2hyg (Clontech). 
 
EGFP-Cdc7 fusion construct 
To obtain pEGFP-Cdc7-C2, used for expression of EGFP-Cdc7 fusion protein, the 
CDS of Cdc7 was PCR amplified from a random primed HeLa cDNA library using 
primers PC430 and PC412, digested with SacI and SalI and ligated between SacI and 
SalI sites of pEGFP-C2 (Clontech). 
 
Retroviral vector for ectopic expression of full-length MCM2 
Retroviral vector pQFlag-MCM2-8xHis was used for stable expression of full length 
MCM2 containing N-terminal Flag (DYKDDDDK) and C-terminal octa-histidine 
tags. To make it, the entire MCM2 CDS was amplified from a random primed HeLa 
cDNA library in two consecutive rounds of PCR using primer pair SH47/SH50 
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followed by primer pair SH47/SH51, which served to add 24 bp encoding an oct-
histidine tag (GTGGTGGTGGTGGT) to the C-terminus of the MCM2 CDS. The 
PCR product, digested with XhoI and BamHI, was ligated between XhoI and BamHI 
sites of pQFlag, a derivative of pQCXIP (Clontech) with an insertion of a Flag tag 
CDS upstream of the XhoI site (Dr. G. Maertens, unpublished).  
 
2.2.3 DNA for protein expression in bacteria 
Plasmids used in this work but not described in this chapter have been created by 
others; the corresponding references can be found in Table S3 (Appendix A). 
 
Constructs for Cdc7:ASK co-expression 
To obtain pRSF-CDC7-S-Tag, expressing Cdc7 with a C-terminal S tag 
(KETAAAKFERQHMDS), a PCR fragment spanning the CDS of human Cdc7 
amplified using primers PC490 and PC491 was inserted between NcoI and XhoI 
sites of pRSFDuet1 (Novagen). 
 To make pCDF-His-Dbf4, used for production of full length hexahistidine-
tagged human ASK, a PCR fragment spanning the CDS of human ASK amplified 
from IMAGE Consortium cDNA clone 5273059 (GenBank accession number 
BC036045; obtained from GeneService, UK) using primers SH45 and SH46 was 
inserted between EcoRI and XhoI sites of pCDFDuet1 (Novagen). Plasmids pCDF-
His-Dbf4(1-350), pCDF-His-Dbf4(174-350), pCDF-His-Dbf4(174-674), pCDF-His-
Dbf4(1-541) and pCDF-His-Dbf4(1-624), used for production of hexahistidine-
tagged truncated forms of ASK, were constructed in the same way using primer pairs 
SH45/SH44, SH43/SH44, SH43/SH46, SH45/SH53 and SH45/SH52, respectively. 
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LEDGF expression 
To obtain pFT1-LEDGFΔIBD, expressing LEDGFΔIBD with a cleavable 
hexahistidine tag, the DNA fragment encoding human LEDGF lacking internal 
residues 347-430 was ligated between BamHI and EcoRI sites of pFT1-LEDGF 
(Vandegraaff et al., 2006), replacing the original insert. This construct was a kind gift 
from Dr. Alan Engelman (Harvard Medical School, Boston, MA). 
The plasmids pCPH6P-LEDGF(146-530), pCPH6P-LEDGF(226-530), 
pCPH6P-LEDGF(249-530), pCPH6P-LEDGF(291-530) and pCPH6P-LEDGF(347-
530), used for production of N-terminally truncated forms of LEDGF, were made by 
Dr. Peter Cherepanov, ligating corresponding PCR fragments between XmaI and 
BamHI sites of pCPH6P-BIV-IN (Cherepanov, 2007), replacing the IN CDS. 
 
GST-fusion proteins 
To make pCP-GST-MCM2(1-287), a DNA fragment encoding residues 1-287 of 
human MCM2 was PCR amplified using primers PC413 and PC414, digested with 
EcoRI and BamHI and ligating with EcoRI and BamHI digested pGEX-4T1 (GE 
Healthcare).  
 
2.2.4 Site-directed mutagenesis 
Plasmids pFT1-LEDGF(SDA), pFT1-LEDGF(ADA), pFT1-LEDGF(AEA), pFT1-
LEDGF(AEA/ADA), pFT1-LEDGF(S206A) and pFT1-LEDGF(S208A),  used for 
bacterial production of full-length LEDGF with various amino acid substitutions 
were obtained by mutagenising pFT1-LEDGF (Vandegraaff et al., 2006) using the 
QuickChange procedure (Stratagene) (Papworth et al., 1996). The following primer 
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pairs were used: SH35/SH36 (to make SDA), SH37/SH38 (ADA), SH39/SH40 
(AEA), PC590/PC591 (S206A) and PC592/PC593 (S208A). The pFT1-LEDGF 
template (100 ng) was denatured at 96°C for 3 min and was amplified for 18 cycles 
consisting of a 30 second denaturing step at 96°C, primer annealing for 1 min at 
54°C and template extension for 12 min at 72°C followed incubation at 72°C for 12 
min. The reactions were then digested with DpnI (New England BioLabs) to remove 
the template and the DpnI-treated DNA used to transform competent E. coli (Section 
2.1.5). Mutations were verified by sequencing of mini-scale plasmid DNA 
preparations (Section 2.1.7). To obtain pFT1-LEDGF (AEA/ADA), plasmid pFT1-
LEDGF(AEA) was mutagenised using primer pair SH37/38.  
 
2.3 Cell lines  
Cell lines used in this study are listed in Table S4 (Appendix A). Cells were cultured 
at 37 ˚C in a humidified, 5% CO2 atmosphere in Dulbecco’s modified Eagle’s 
medium (DMEM) (Invitrogen) supplemented with 10% foetal bovine serum (FBS) 
(Invitrogen), 100 units/ml penicillin and streptomycin (Invitrogen) and 5 µ/ml 
plasmocin (Invivogen). Tetracycline free FBS (Clontech) was used when culturing 
HeLa TetOff derived stable lines. 
Primary and transformed mouse embryonic fibroblast (MEF) lines were 
obtained from Dr. A. Engleman (Harvard Medical School, Boston, MA).  
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2.3.1 Stable cell lines generated by transfection 
LEDGF-cTAP stable lines 
To generate cells stably expressing full-length human LEDGF, LEDGF(1-176) or 
LEDGF(326-530) fused to C-terminal tandem affinity purification (cTAP) tag, 293T 
cells cultured in a 6-well tissue culture plate (Nunc) were transfected with the 
corresponding cTAP-fusion constructs, pGM-hLEDGF-cTAP, pGM-hLEDGF(1-
176)-cTAP or pGM-hLEDGF(326-530) respectively, using FuGene cationic lipid 
reagent (Roche) as per the manufacturer’s instruction. Prior to transfection, the 
plasmids were linearised by digestion with ScaI (New England BioLabs) to enhance 
efficiency of stable transfection. Twenty-four hours post-transfection, cells were 
trypsinised and plated into 10-cm dishes (Nunc) in the presence of 10 μg/ml 
blasticidin S (Invitrogen). Following approximately two weeks of selection, colonies 
of blasticidin S-resistant cells were harvested using trypsin-soaked filters, 
subcultured in 24-well plates (Nunc) and expanded to 6-well plates in the presence of 
7 g/ml blasticidin S. Cell lines expressing high levels of cTAP fusion constructs 
were identified by indirect immunofluorescence (Section 2.10.1) using rabbit anti-
calmodulin binding peptide (CBP) epitope tag antibody (Millipore) and Alexa Fluor 
488-conjugated goat anti-rabbit secondary antibody (Invitrogen). Protein expression 
was also confirmed by Western blot analysis of whole cell extracts (Section 2.5.4) 
using anti-CBP epitope tag antibody diluted 1:4,000. Resulting cell lines, hereafter 
referred to as 293T-LEDGF-cTAP, 293T-LEDGF(1-176)-cTAP and 293T-
LEDGF(326-530)-cTAP (Table S4, Appendix A), were cultured in the presence of 7 
ug/ml blasticidin S to maintain selective pressure. A control 293T-cTAP cell line 
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(Elderkin et al., 2007) stably expressing isolated cTAP tag was a kind gift from Dr. 
G. Maertens.  
 
Inducible expression of LEDGF 
To obtain stable cell lines for inducible expression of untagged and HA-tagged 
LEDGF, HeLa TetOff cells (Clontech) transfected with linearised pTRE-75-hyg and 
pTRE-HA75-hyg, respectively, were selected in the presence of 160 µg/ml 
hygromycin B (Invitrogen) and 5 µg/ml doxycycline (Melford). Single cell clones 
N3 and H3 that upon withdrawal of doxycycline showed robust expression of 
LEDGF and HA-LEDGF, respectively, were used for experiments described herein. 
 
2.3.2 Stable cell lines generated by retroviral transduction 
Production of retroviral vectors and ectopic expression of LEDGF and p52 
293T cells were seeded in 10-cm dishes such that they were 60 – 70% confluent on 
the following day. For expression of HA-tagged proteins, 293T cells were co-
transfected with the packaging construct pCG-GAG-POL (16 μg) and the envelope 
expressing pCG-VSV-G (16 μg) plus either pLB(N)CX-mp75-HA (16 μg), or 
pLB(N)CX-mp52-HA (16 μg) or pLB(N)CX (16 μg) using calcium phosphate 
(Ausubel et al., 2007) (Section 2.4). Retroviral vector particles harvested 24, 32 and 
48 h post-transfection were filtered through 0.45-m filters (Millipore). E1T(f/+) and 
E2T(-/-) MEF cells, grown in T25 tissue culture flasks (Nunc) were infected with 
fresh retroviral vector, diluted 1:2 in complete medium and supplemented with 4 
g/ml polybrene (Sigma-Aldrich) (1:1,000 final dilution). Stably transduced cells 
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expressing mouse LEDGF-HA or mouse p52-HA were selected with 10 μg/ml 
blasticidin S to give cell lines E1Tp75, E2Tp75, E1Tp52 and E2Tp52. Cell lines 
E1TV and E2TV transduced with empty vector were used as controls. 
 
HeLa-Flag-MCM2-His8 
For stable expression of human MCM2 with an N-terminal Flag and a C-terminal 
octa-histidine tag, HeLa cells were infected with retroviral vector produced by co-
transfecting 293T cells with pQFlag-MCM2-8xHis, pCG-GAG-POL and pCG-VSV-
G; stably transduced cells were selected in the presence of 1 µg/ml puromycin 
(Sigma-Aldrich) to obtain HeLa-Flag-MCM2-His8 cells. 
 
2.4 Calcium Phosphate transfection method  
(Ausubel et al., 2007) 
DNA (20 – 50 µg) diluted in 1/10 TE buffer [10 mM Tris-HCl, pH 7.5, 1 mM 
EDTA] to a final volume of 450 µl, to which 50 µl of 2.5 M CaCl2 was added, was 
then added drop-wise into 0.5 ml 2X HEPES phosphate buffer [HPB: 0.28 M NaCl, 
50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) pH 7.1, 1.5 
mM Na2HPO4] from a 1 cm height. The mixture (1 ml) was incubated at room 
temperature for 30 minutes to allow calcium phosphate crystals to form around the 
DNA solution and then added to cells growing in 9 ml DMEM supplemented with 
10% FBS in 10-cm tissue culture dishes by slowly dropping it from a 2 cm height. 
Cells were incubated for 24 or 48 h at 37°C before proceeding with experiments. 
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2.5 Protein Analyses 
 
2.5.1 Polyacrylamide gel electrophoresis (PAGE)  
(Laemmli, 1970) 
Polyacrylamide gels used to separate protein samples were composed of a 4% 
stacking gel layered on top of an 11% resolving gel. Resolving gels were prepared by 
supplementing the monomer mix [11% acrylamide, 0.29% bisacrylamide, 0.1% 
(w/v) sodium dodecyl sulphate (SDS) and 0.38 M Tris-HCl, pH 8.8] with 0.042% 
(w/v) ammonium persulphate and 0.084% (v/v) N,N,N’,N’-
Tetramethylethylenediamine (TEMED). The stacking gel was prepared by 
supplementing the corresponding monomer mix [4% acrylamide, 0.1% 
bisacrylamide, 0.1% (w/v) SDS and 0.12 M Tris-HCl, pH 6.8] with 0.046% (w/v) 
ammonium persulphate and 0.123% (v/v) TEMED.  
 Protein samples solubilised in Laemmli sample buffer [4x Stock: 8% (w/v) 
SDS, 40% (v/v) glycerol, 0.01% bromophenol blue, 250 mM Tris-HCl, pH 6.8] 
supplemented with 25 mM DTT were separated by SDS-PAGE (11% gel) run at 170 
V in Tris-Glycine-SDS buffer [TGS: 25 mM Tris base, 250 mM glycine, 0.1% (w/v) 
SDS]. 
Tricine gel 
10-20% Tricine gels (Invitrogen) were run at 120 V in 1x Tricine running buffer 
[100 mM Tris base, 100 mM Tricine, 0.1% (w/v) SDS]. 
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2.5.2 Coomassie staining 
Proteins separated in polyacrylamide gels were visualised by staining with 
Coomassie Blue. Gels were agitated in Coomassie Blue staining solution [40% (v/v) 
methanol, 10% (v/v) acetic acid, 0.1% (w/v) Coomassie R250] until protein bands 
were visible and then the staining solution replaced with destaining solution [40% 
(v/v) methanol, 5% (v/v) acetic acid] to obtain a clear background. 
 
2.5.3 Silver staining 
The Silver Stain Plus kit (Bio-Rad) was used for more sensitive detection of proteins 
separated in polyacrylamide gels. Briefly, gels were fixed in Fixative Enhancer 
Solution [50% (v/v) methanol, 10% (v/v) acetic acid, 10% (v/v) Fixative Enhancer 
Concentrate (supplied)] for 20 min and rinsed in ddH2O. Gels were then incubated in 
silver staining solution [5% (v/v) Silver Complex Solution (supplied), 5% (v/v) 
Reduction Moderator Solution (supplied), 5% (v/v) Image Development Reagent 
(supplied), 50% (v/v) Development Accelerator Solution (supplied)] prepared 
immediately before use. The reaction was stopped by replacing the staining solution 
with 5% acetic acid. Gels were incubated in stop solution for 15 min and then 
washed with ddH2O. 
 
2.5.4 Western blotting 
Sample preparation for Western blot analysis 
Preparation of whole cell and nuclear extracts 
To prepare whole cell extracts for Western blot analysis, cells harvested by 
trypsinisation were washed in phosphate buffered saline (PBS) supplemented with 
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0.1 mM Phenylmethylsulphonyl fluoride (PMSF) and then lysed in RIPA buffer [150 
mM NaCl, 50 mM Tris-HCl, pH 8.0, 0.1% SDS, 0.5% sodium deoxycholate, 1% 
Nonidet P-40 (NP40), 0.1 mM PMSF and EDTA-free protease inhibitor cocktail 
(Roche)].  
To prepare nuclear extracts, cells were lysed in extraction buffer [100 mM 
NaCl, 1 mM MgSO4, 10 mM HEPES pH 7.4 and EDTA-free protease inhibitor 
cocktail] supplemented with 0.5% NP40. Nuclei were pelleted by gentle 
centrifugation and nuclear proteins were then extracted using extraction buffer 
containing 450 mM NaCl. Protein concentration was determined using bicinchoninic 
acid (BCA) protein assay (Pierce) with a BSA standard according to the 
manufacturer’s instruction. 
 
Other preparations 
Protein complexes isolated by immunoprecipitation with specific antibodies (Section 
2.11), protein extracted by cell fractionation (Section 2.12) or purified recombinant 
proteins used in pull-down assays (Section 2.15) and kinase assays (Section 2.16) 
were analysed by Western blotting as outlined below.  
 
Electrotransfer 
General method 
Proteins separated in polyacrylamide gels were electroblotted onto PVDF 
membranes (Immobilon-P, Millipore) in Tobin transfer buffer [25 mM Tris base, 192 
mM glycine, 20% (v/v) methanol, 0.05% (w/v) SDS] using a TE 77 semi-dry transfer 
unit (GE Healthcare) for 1 – 2 h at 150 mA. Membranes were incubated for 1 h at 
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room temperature or overnight at 4°C in ECL advance blocking reagent (GE 
Healthcare) diluted 2% (w/v) in PBS/Tween [PBS supplemented with 0.1% Tween-
20 (Sigma-Aldrich)] to prevent non-specific antibody binding. Blocked membranes 
were incubated for 1 h at room temperature with the appropriate primary antibody 
(Section 2.5.4.1), washed with 3 changes of PBS/Tween to remove excess antibody, 
then incubated with the appropriate Horseradish peroxidase (HRP)-conjugated 
secondary antibody (Section 2.5.4.1) and washed again. All antibodies were diluted 
in ECL advance blocking reagent (2% (w/v) in PBS/Tween). Signals were developed 
with ECL, ECL-Plus or ECL-Advance chemiluminescent detection reagents (GE 
Healthcare) as per the manufacturer’s instruction and membranes exposed to Kodak 
BioMax film, which was developed using a Kodak X-OMAT processor. 
 
Phospho-specific Western blotting 
For phospho-specific Western blots, membranes were blocked with and antibodies 
diluted in 3% (w/v) BSA (Melford) in TBS/Tween [20 mM Tris-HCl, pH 7.4, 150 
mM NaCl, 0.1% Tween-20] and membranes washed with TBS/Tween. HRP-
conjugated secondary antibody signals were developed with ECL-Plus or ECL-
Advance chemiluminescent detection reagents. 
 
Western blots using alkaline phosphatase-conjugated secondary antibodies 
For Western blots used to analyse recombinant proteins, membranes were blocked 
with, and antibodies diluted in, 5% (w/v) skimmed milk powder in PBS/Tween and 
membranes washed with PBS/Tween. Alkaline phosphatase-conjugated secondary 
antibody signals were developed on PVDF membranes using 1.65 mg BCIP (5-
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bromo-4chloro-3-indolyl phosphate) and 3.3 mg NBT (p-nitroblue tetrazolium 
chloride) diluted in 10 ml alkaline phosphatase developing buffer [100 mM NaCl, 5 
mM MgCl2, 100 mM Tris-HCl, pH 9.5]. 
 
Stripping of PVDF membranes 
For re-probing PVDF membranes, the membranes were stripped as follows. Firstly 
the membrane was washed in PBS/Tween to remove the detection reagent and 
incubated in stripping buffer [71 mM β-mercaptoethanol (Bio-Rad), 2% (w/v) SDS, 
62.5 mM Tris-HCl, pH 6.8] for 30 min at 50°C. The membrane was then extensively 
washed with PBS/Tween and blocked for 1 h before proceeding with detection. 
 
2.5.4.1 Antibodies used for Western blotting 
Primary Antibodies 
The following primary antibody dilutions were used for Western blotting: rabbit anti-
T-bx1 (Invitrogen) 1:1,000, rabbit anti-calmodulin binding peptide (CBP) epitope tag 
antibody (Millipore) 1:4,000, mouse anti-HA antibody HA.11 (Covance, Princeton, 
NJ) 1:5,000, mouse anti-Cdc7 Kinase Ab-1 IgG1 (Lab Vision Corporation) 1:3,000, 
rabbit anti-JPO2/RAM2 (Maertens et al., 2006) 1:10,000, mouse anti-HP1γ IgG1 
(Millipore) 1:3,000, mouse anti-β actin (Sigma-Aldrich) 1:10,000, mouse anti-
Dbf4/ASK (H0010926-M01, Abnova) 1:300, mouse anti-PSIP1 IgG1κ (H00011168-
M01, Abnova) 1:2,000, rabbit anti-LEDGF/p75 antibody (A300-848A, Bethyl 
Laboratories) 1:3,000 or 1:1,000, mouse anti-LEDGF (BD Biosciences) 1:2,500, 
mouse anti-His5 (Qiagen) 1:3,000, mouse anti-Flag M2 (Sigma-Aldrich) 1:2,500, 
rabbit anti-phospho MCM2 (S53) A300-756A (Bethyl Laboratories) 1:1,000, rabbit 
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anti-β tubulin (H235, Santa Cruz Biotechnology) 1:1,000 and goat anti-lamin B (M-
20, Santa Cruz Biotechnology) 1:1,000. 
 
Secondary Antibodies 
Horseradish peroxidase-conjugated goat anti-rabbit, goat anti-mouse and anti-goat 
secondary antibodies (Jackson ImmunoResearch) were used at 1:10,000 dilutions 
and alkaline phosphatase-conjugated goat anti-rabbit and goat anti-mouse secondary 
antibodies (Sigma) were diluted 1:5,000. 
 
2.6 RNA extraction and purification 
RNA was extracted from MEFs using TRIzol reagent (Invitrogen) as per the 
manufacturer’s instruction with slight modifications. TRIzol reagent (2 ml) was used 
to lyse MEFs growing in T25 tissue culture flasks (Nunc) and processed 1 ml at a 
time as follows. Chloroform (0.2 ml) was added to the TRIzol reagent (1 ml) and 
RNA extracted into the aqueous phase by vigorously mixing the solutions and then 
incubating the mixture at room temperature for 3 min followed by centrifugation at 
9,600 g for 1 min at 4°C. The upper aqueous phase containing RNA was separated 
from the lower phenol-chloroform phase avoiding the opaque DNA-containing 
interphase. RNA was precipitated by addition of 0.5 ml isopropanol, the solution 
incubated at room temperature for 10 min and RNA pelleted by centrifugation at 
9,600 g for 10 min at 4°C. The pellet, washed with 75% ethanol (400 µl) and air 
dried was redissolved in 20 µl nuclease-free water (Sigma-Aldrich). RNA was then 
further purified using an RNeasy mini kit (Qiagen), including on-column digestion 
 99 
with DNase I (Qiagen) to remove traces of DNA according to the manufacturer’s 
RNA Cleanup protocol. Briefly, RNA extracted using the TRIzol method was made 
up to 100 µl with nuclease-free water, diluted with 350 µl Buffer RTL (supplied) and 
250 µl ethanol added to provide appropriate binding conditions. This solution was 
then applied to an RNeasy spin column containing a silica-based membrane to which 
RNA binds under high-salt conditions. After contaminants have been washed away, 
DNase I (30 Kunitz units) solution was applied directly to the membrane and the 
columns were incubated at room temperature for 15 min. Following extensive 
washing of the column with buffer RPE (supplied), RNA was eluted in 30 µl 
nuclease-free water. Prior to microarray analysis, quality of RNA samples was 
assessed using a Bioanalyser 2100 instrument (Agilent).  
 
2.7 Gene expression analysis 
Three or four independent RNA samples were isolated in parallel from pairs of 
primary Psip1
f/+
 (LEDGF+) and Psip1
-/-
 (LEDGF-) MEF lines. Cyanine 5 (Cy5) 
labelled sample and Cyanine 3 (Cy3) labelled control cRNA were prepared using 
linear amplification, labelling, and fragmentation reagents from Agilent. Spike-in 
mixes (Agilent) comprising 10 in vitro-synthesized, polyadenylated RNA transcripts 
in predetermined ratios were added to RNA samples prior to amplification and 
labelling. These transcripts hybridise to control probes on Agilent microarrays and 
allow monitoring of dynamic range, sensitivity and accuracy of the microarray 
experiment.  
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RNA extracted from MEFs (500 ng) (Section 2.6) was mixed with 2 l of 
spike-in mix B (1:3,200) and oligo-dT-T7 promoter primer in the final volume of 
11.5 l. Nucleic acids were denatured by incubation at 65˚C in a circulating water 
bath for 10 min. The samples were allowed to cool on ice for 5 min and mixed with 
8.5 μl cDNA master mix [4 μl 5X first strand buffer, 2 μl 0.1 M DTT, 1 μl 10 mM 
dNTP mix, 1 μl reverse transcriptase and 0.5 μl RNaseOUT inhibitor]; cDNA 
synthesis was carried out at 40˚C in a circulating water bath for 2 h. Following 
denaturation at 65˚C for 15 min, the samples were cooled on ice and mixed with 60 
μl transcription master mix [15.3 μl nuclease-free water, 20 μl 4X transcription 
buffer, 6 μl 0.1 M DTT, 8 μl NTP mix, 6.4 μl 50% polyethylene glycol, 0.5 μl 
RNaseOUT inhibitor, 0.6 μl inorganic pyrophosphatase, 0.8 μl T7 RNA polymerase 
and 2.4 μl Cy5-CTP]. Synthesis of Cy5-labelled cRNA was allowed to proceed for 2 
h at 40˚C. Cy3-labelled standard cRNA was produced using pooled mouse RNA 
(Stratagene) in a similar way, using spike-in mixture A and Cy3-CTP.  
RNA probes were purified using the cleanup protocol from Qiagen’s RNeasy 
mini kit (Section 2.6). RNA eluted in 25 μl nuclease-free water was quantified using 
a NanoDrop ND-1000 spectrophotometer; final cRNA yields were 825 ng or better, 
with at least 8.0 pmol/μg of Cy5 or Cy3. Cy3-labelled standard cRNA (825 ng) was 
added to each Cy5-labelled cRNA sample (825 ng) and the mixtures of Cy3-labelled 
sample cRNA and Cy5-labelled control cRNA (825 ng each) were supplemented 
with 11 μl 10X blocking agent (Agilent) and 2.2 μl 25X Fragmentation Buffer 
(Agilent) in a total volume of 55 μl and fragmented at 60˚C. After 30 min, 55 μl 
2xGEx hybridisation buffer HI-RPM (Agilent) was added to terminate fragmentation 
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reactions, and the resulting hybridisation mixtures were applied to 44K Whole 
Mouse Genome oligonucleotide arrays (4x44K format, Agilent) and hybridised at 
65˚C for 17 h. Following hybridisation, microarray slides were washed as per 
manufacturer’s instructions, dehydrated by immersing in acetonitrile and dried on 
air. The arrays were scanned using a G2502B microarray scanner (Agilent), Feature 
Extraction software version 9.5 (Agilent) was used to acquire and process expression 
data. Gene expression profiling experiments were carried out using equipment 
provided by Dr. Paul Kellam (Wellcome Trust Sanger Institute/University College 
London) in a collaborative manner. 
 
2.8 Quantitative RT-PCR 
Expression levels of putative LEDGF target genes were studied by quantitative RT-
PCR (qRT-PCR) using SYBR green chemistry. The dye fluoresces when bound to 
double-stranded DNA. Increasing amounts of double-stranded DNA product 
produced during PCR leads to an increase in fluorescence intensity, measured at each 
successive cycle of the PCR. qRT-PCR reactions were carried out using the 
QuantiTect SYBR Green RT-PCR kit (Qiagen) according to manufacturer’s 
instructions. Briefly, 100 ng of total cellular RNA and gene specific primers (1 μM 
final concentration) added to the QuantiTect master mix [containing Hotstar Taq 
DNA polymerase, Tris-HCl, pH 8.7, KCl, (NH4)2SO4, 5 mM MgCl2, dNTPs 
including dUTP (deoxyribo-uracil triphosphate), SYBR green, ROX and RT mix 
(containing a mixture of omniscript reverse transcriptase and sensiscript reverse 
transcriptase)] in a final volume of 20 μl were cycled in a LightCycler 1.5 real time 
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PCR instrument (Roche). Each sample was assayed in duplicate or triplicate to allow 
statistical tests. Primer pairs were designed to selectively amplify ~200bp fragments 
of target cDNAs. PCR products cloned into pCR4-TOPO vector (Invitrogen) 
(Section 2.2.1) were serially diluted 1/10 and used to generate standard curves. See 
Tables S1 and S3 (Appendix A) for full details of primers and standards used for 
qRT-PCR. Results were analysed using LightCycler software version 3.5. To adjust 
for differences in the mRNA content among samples, the results for each sample 
were normalised by PO mRNA (encoding acidic ribosomal phosphoprotein PO; 
primers PC259 and PC259 (Stettner et al., 2007)), which served as an internal 
control. Details of cycling conditions used for each target gene are given below.  
 
Program  Temperature 
(˚C) 
Hold Time 
(seconds) 
Detect 
 RT 50 1200  
 Activation 95 900  
 qPCR    
4
5
 c
y
c
le
s 
Denaturation 95 30  
Annealing 58 or 60
(a) 
30  
Extension 72 30  
Data 
acquisition 
72 or 79
(b)
 or 80
(c) 
5 or 10
(d) 
Single 
 Melting 
Curve 
95 10  
 60 30  
 95 0  
 Cooling 40 0  
 
Schematic of Quantitative RT-PCR cycling conditions: Standard qRT-PCR cycling conditions 
used for PO, Thbs4, Crabp1, Trim12, Esm1, Zfp536, Adam33 and Tbx1 transcripts. (a) annealing 
temperature used for Adam33 and Tbx1, (b) acquisition temperature for Adam33, (c) acquisition 
temperature for Tbx1, and (d) hold time before detection for Adam33 and Tbx1. 
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2.9 Large-scale tandem affinity purification (TAP)  
293T-LEDGF(326-530)-cTAP and the control line 293T-cTAP each grown to near 
confluence in twelve 500-cm
2
 cell culture dishes (Corning) were harvested by 
trypsinisation and washed twice in 50 ml of cold PBS supplemented with 0.1 mM 
PMSF. Isolation of cTAP-tagged complex was done according to published 
procedures (Elderkin et al., 2007; Puig et al., 2001) with minor modifications. Cells 
were resuspended in 12 ml of ice-cold TAP lysis buffer [50 mM Tris-HCl, pH 8.0, 1 
mM EDTA, 1.02 mM ZnCl2, 150 mM NaCl, 0.1 mM PMSF], supplemented with 
complete EDTA-free protease inhibitor cocktail. NP40 was added to a final 
concentration of 1% and cells were allowed to lyse on ice for 10 min. Nuclei were 
pelleted at 5,200g for 10 min at 4°C and the supernatant incubated with 100 μl 
(settled bead volume) glutathione sepharose (GE Healthcare) for 10 min at 4°C. 
Glutathione sepharose beads were removed by gentle centrifugation and the pre-
cleared extracts were incubated with 180 μl IgG sepharose (GE Healthcare) for 3 h at 
4°C with gentle rocking. Beads collected by gentle centrifugation were washed with 
several changes of TAP lysis buffer and equilibrated with TEV cleavage buffer [0.1 
% NP40, 10 mM Tris pH8.0, 0.5 mM EDTA, 0.52 mM ZnCl2, 150 mM NaCl, 1 mM 
DTT, and 0.1 mM PMSF]. Beads were resuspended in 300 μl of TEV cleavage 
buffer and incubated with 100 units of AcTEV Protease (Invitrogen) at room 
temperature for 2 h with gentle rocking. Beads were gently pelleted and the 
supernatant containing released protein collected. Residual cleaved protein was 
eluted with two changes of 300 μl and one of 200 μl CaBIND buffer [0.1 % NP40, 
50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM MgSO4, 2 mM CaCl2, and 1 mM 
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Imidazole, 14 mM -mercaptoethanol] and all the fractions pooled with the original 
supernatant. Pooled fractions were incubated with 60 μl (settled volume) calmodulin 
affinity resin (Stratagene) for 2 h at 4°C with gentle rocking. Beads were then 
washed four times with CaBIND buffer (1 ml) and the bound proteins were eluted 
with two changes of 500 μl EDTA elution buffer [0.1% NP40, 50 mM Tris-HCl, pH 
8.0, 150 mM NaCl, 5 mM EDTA]. Eluted proteins were precipitated with 17.5% 
(w/v) trichloroacetic acid (TCA) overnight. Precipitated proteins washed twice in 
ice-cold acetone (500 μl) were redissolved in 20 μl of 2x Laemmli sample buffer 
supplemented with 25 mM DTT. Proteins were separated on a 4-20% gradient tris-
glycine gel (Invitrogen) and detected by staining with colloidal Coomassie G-250 
(Pierce). Proteins were identified by in-gel trypsin digestion and liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) at the Taplin Biological 
Mass Spectrometry Facility (Harvard Medical School).  
 
2.10 Fluorescence microscopy 
 
2.10.1 Indirect immunofluorescence analyses 
Detection of endogenous LEDGF and Cdc7 proteins 
HeLa cells cultured in LabTek chamber slides (Nunc) were fixed for 10-15 min in 
4% formaldehyde in PBS at room temperature. After washing in blocking solution 
(10% FBS in PBS with 25 mM ammonium sulphate) cells were permeabilised in ice-
cold methanol. Cells were then washed and incubated with blocking solution for 30 
min at room temperature. Nuclear staining of endogenous LEDGF was done using 
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rabbit anti-LEDGF/p75 antibody A300-848A (Bethyl Laboratories) diluted 1:640 
and Alexa Fluor 488-conjugated goat anti-rabbit antibody (Invitrogen) diluted 1:200. 
Cdc7 was detected using mouse anti-Cdc7 kinase antibody (Lab Vision Corporation) 
diluted 1:640 and Alexa Fluor 555-conjugated goat anti-mouse antibody (Invitrogen) 
diluted 1:200. All antibody incubations were carried out at room temperature for 1 h 
followed by washing with several changes of blocking solution. 4',6-diamidino-2-
phenylindole (DAPI, diluted 1:2,000) was used to stain DNA. All reagents were 
diluted in blocking solution. Fluorescence was visualised using an LSM510 confocal 
laser scanning microscope (Carl Zeiss) at the Facility for Imaging by Light 
Microscopy (Imperial College London). 
 
Visualisation of cTAP-tagged proteins 
293T cells stably expressing cTAP-tagged LEDGF or LEDGF truncations were 
grown in 48-well tissue culture plates (Nunc), fixed in 4% formaldehyde and 
permeabilised with methanol as described above. Expression of cTAP-tagged 
proteins was detected using rabbit anti-CBP epitope tag antibody diluted 1:150 and 
Alexa Fluor 488-conjugated goat anti-rabbit antibody diluted 1:300. All reagents 
were diluted in blocking solution. Fluorescence was visualised using an Eclipse 
TE2000-S epifluorescence microscope (Nikon). 
 
Visualisation of Flag-MCM2-His8 
HeLa-Flag-MCM2-His8 cells cultured in a LabTek chamber slide were fixed in 4% 
formaldehyde and permeabilised with methanol as described above. Expression of 
Flag-tagged full-length human MCM2 was detected using mouse anti-Flag M2 
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(Sigma) diluted 1:200 and Alexa Fluor 555-conjugated goat anti-mouse antibody 
diluted 1:200. Endogenous LEDGF was detected as described above. All reagents 
were diluted in blocking solution. Fluorescence was visualised using an Eclipse 
TE2000-S epifluorescence microscope (Nikon). 
 
2.10.2 Visualisation of ectopically expressed fluorescent fusion proteins coupled 
with indirect immunofluorescence 
HeLa cells seeded in LabTek chamber slides such that they were confluent the 
following day were co-transfected with various combinations of pEGFP-CDC7-C2 
(0.1 µg), pCPHA-Dbf4 (0.2 µg), pCPHA-Dbf4(1-624) (0.2 µg), pHcRED1-p75 (0.1 
µg) and pHcRED1-p52 (0.1 µg), keeping the total amount of DNA transfected 
constant at 0.4 µg, using Lipofectamine 2000 transfection reagent (Invitrogen) as per 
the manufacturer’s instructions. Cells were incubated at 37°C for 24 h before being 
fixed in 4% formaldehyde and permeabilised with methanol as described above 
(Section 2.10.1). HA-tagged ASK and ASK truncations were detected using mouse 
anti-HA antibody HA.11 (Covance) diluted 1:200 and Alexa Fluor 555-conjugated 
goat anti-mouse antibody diluted 1:300. DAPI was used to stain DNA. All reagents 
were diluted in blocking solution. EGFP- and HcRED-fusion proteins, Alexa Fluor 
555 immuno-stained HA-tagged proteins and DAPI were visualised using an SP5 
MP/FLIM confocal laser scanning microscope (Leica) at the Facility for Imaging by 
Light Microscopy (Imperial College London). 
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2.11 Immunoprecipitation (IP) 
Small scale IP experiments used to confirm the interaction between LEDGF and 
Cdc7:ASK 
For small scale IP, HeLa cells were seeded in 10-cm tissue culture dishes such that 
they would be 70-80% confluent when transfected the following day. Cells were 
transfected with 20 μg or 5 μg pLB(N)CX-mp75-HA, pBHA-p75, pCPHA-NLS-38, 
pCPHA-HRP2, pLB(N)CX-mp52-HA, or pCPHA-NLS using calcium phosphate 
(Ausubel et al., 2007) (Section 2.4). Cells harvested by trypsinisation at 48 h post-
transfection were washed in PBS supplemented with 0.1 mM PMSF and then lysed 
in 800μl CSKL buffer [CSKc buffer (10% sucrose, 10 mM piperazine-N,N’-bis[2-
ethanesulfonic acid]-NaOH (PIPES) pH 6.8, 1 mM MgCl2, 0.5 mM DTT) 
supplemented with 450 mM NaCl, 0.5% NP40, 0.1 mM PMSF and EDTA-free 
protease inhibitors]. Nuclei were pelleted at 17,000 g for 10 min at 4°C, 50 µl 
supernatant taken for use as total soluble cell extract and the remainder of the 
supernatant pre-cleared by incubation with 30 µl (settled volume) of glutathione 
sepharose. For IP, 750 μl pre-cleared extracts were incubated with 10 - 15 μl (settled 
volume) monoclonal mouse antibody HA.11 IgG affinity matrix (Covance) for 2 – 3 
h at 4˚C with gentle rocking. Beads collected by centrifugation were washed 4 times 
in CSKc buffer supplemented with 150 mM NaCl, 0.1% NP40 and EDTA-free 
protease inhibitors and bound proteins were eluted in 200 μl 2x Laemmli sample 
buffer containing 25 mM DTT. Eluted proteins were detected by Western blotting 
(Section 2.5.4). 
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 For co-immunoprecipitation of Cdc7:ASK complex with LEDGF, HeLa 
TetOff cells stably expressing N-terminal HA-tagged LEDGF (clone H3) or non-
tagged LEDGF (clone N3) were lysed in 400 µl CSKL buffer supplemented with 1 
mM β-glycerophosphate, 1 mM NaF and 0.32 mM Na3VO4. Pre-cleared lysates were 
incubated with 20 μl (settled volume) monoclonal mouse antibody HA.11 IgG 
affinity matrix for 2 – 3 h at 4˚C with gentle rocking. Beads collected by 
centrifugation were washed 3 times in CSKc buffer supplemented with 150 mM 
NaCl, 0.1% NP40 and EDTA-free protease inhibitors. Dried beads were resuspended 
in CSKc buffer supplemented with 150 mM NaCl, 0.1% NP40 and EDTA-free 
protease inhibitors, giving a 50% suspension, to which 800 units phage λ protein 
phosphatase (λPPase, New England BioLabs) was added. The phosphatase treatment 
was carried out for 1 h at 4°C, the reaction stopped by addition of 20 μl 4x Laemmli 
sample buffer and eluted proteins detected by Western blotting (Section 2.5.4). 
For co-immunoprecipitation of LEDGF with Cdc7:ASK, HeLa TetOff cells 
stably expressing HA-LEDGF grown to 80% confluence in four T175 tissue culture 
flasks (Nunc) were pooled and lysed in 3 ml CSKL buffer supplemented with 1 mM 
β-glycerophosphate, 1 mM NaF and 0.32 mM Na3VO4. Nuclei were pelleted at 
5,200g for 10 min at 4°C, 200 µl supernatant taken for use as total soluble cell 
extract and the remainder of the supernatant divided into four equal aliquots of 740 
µl and pre-cleared by incubation with 20 μl (settled volume) Protein G agarose 
(Roche). Two aliquots of pre-cleared lysate were incubated with 20 μl (settled 
volume) Protein G agarose in the presence of 7.5µg rabbit anti-ASK antibody 
NB100-88114 (Novus Biologicals) and two aliquots of pre-cleared lysate were 
incubated with 20 μl (settled volume) Protein G agarose in the presence of 7.5µg 
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rabbit IgG control antibody for 3 – 4 h at 4˚C with gentle rocking. Beads collected by 
centrifugation were washed 4 times in CSKc buffer supplemented with 150 mM 
NaCl, 0.1% NP40 and EDTA-free protease inhibitors. Dried beads were resuspended 
in 60 µl CSKc buffer supplemented with 150 mM NaCl, 0.1% NP40 and EDTA-free 
protease inhibitors and one of each IP sample (anti-ASK IP and control IP) was 
incubated with 2,400 units λPPase in the presence of 1 mM MnCl2 for 2 h at 4°C and 
one of each IP sample left untreated. In parallel,  total soluble cell extract (3 x 20 µl) 
aliquots were incubated with 1,200 units λPPase in the presence of 1 mM MnCl2. 
Proteins were then eluted in 4x Laemmli sample buffer and immunoprecipitated 
ASK and co-precipitated HA-LEDGF detected by Western blotting (Section 2.5.4). 
For immunoprecipitation of endogenous LEDGF/p75, 293T cells grown to 
80% confluence in four T175 tissue culture flasks (Nunc) were pooled and lysed in 3 
ml CSKL buffer supplemented with 1 mM β-glycerophosphate, 1 mM NaF and 0.32 
mM Na3VO4. Nuclei were pelleted at 5,200g for 10 min at 4°C, 200 µl supernatant 
taken for use as total soluble cell extract and the remainder of the supernatant divided 
into four equal aliquots of 700 µl and pre-cleared by incubation with 20 μl (settled 
volume) Protein G agarose (Roche). Two aliquots of pre-cleared lysate were 
incubated with 20 μl (settled volume) Protein G agarose in the presence of 5µg rabbit 
anti-LEDGF/p75 antibody A300-848A (Bethyl Laboratories) and two aliquots of 
pre-cleared lysate were incubated with 20 μl (settled volume) Protein G agarose in 
the presence of 5µg rabbit IgG control antibody for 3 – 4 h at 4˚C with gentle 
rocking. Beads collected by centrifugation were washed 4 times in CSKc buffer 
supplemented with 150 mM NaCl, 0.1% NP40 and EDTA-free protease inhibitors. 
Dried beads were resuspended in 60 µl CSKc buffer supplemented with 150 mM 
 110 
NaCl, 0.1% NP40 and EDTA-free protease inhibitors and one of each IP sample 
(anti-LEDGF IP and control IP) was incubated with 2,400 units λPPase in the 
presence of 1 mM MnCl2 for 2 h at 4°C and one of each IP sample left untreated. In 
parallel, total soluble cell extract (3 x 20 µl) aliquots were incubated with 1,200 units 
λPPase in the presence of 1 mM MnCl2. Proteins were then eluted in 4x Laemmli 
sample buffer and immunoprecipitated LEDGF and co-precipitated Cdc7:ASK 
complex detected by Western blotting (Section 2.5.4). 
 
Large-scale IP for identification of LEDGF phosphorylation sites 
Asynchronously growing HeLa TetOff cells stably expressing HA-LEDGF (clone 
H3), cultured in the absence of doxycycline to about 75% confluency in four 500 cm
2
 
tissue culture dishes were harvested and lysed in 10 ml CSKL buffer supplemented 
with 1 mM β-glycerophosphate, 1 mM NaF and 0.32 mM Na3VO4 for 10 min on ice 
and nuclei pelleted. Proteins extracted into the soluble fraction were pre-cleared by 
incubation with 300 µl (settled volume) glutathione sepharose and then HA-LEDGF 
was captured on 75 μl (settled volume) monoclonal mouse antibody HA.11 IgG 
affinity matrix (Covance) for 2 – 3 h at 4˚C with gentle rocking. Beads collected by 
centrifugation were washed 4 times in CSKc buffer supplemented with 150 mM 
NaCl, 0.1% NP40, EDTA-free protease inhibitors, 1 mM β-glycerophosphate, 1 mM 
NaF and 0.32 mM Na3VO4. Bound proteins were eluted in a total of 525 µl 6 M 
NaSCN and precipitated with 25% TCA (w/v) overnight. Precipitated proteins 
washed twice in ice-cold acetone (500 μl) were redissolved in 10 μl of 2x Laemmli 
sample buffer, supplemented with 25 mM DTT. Proteins were separated by SDS-
PAGE (11% gel) and detected by staining with colloidal Coomassie G-250. The HA-
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LEDGF gel slice was excised and LEDGF phospho-peptides were identified by in-
gel trypsin digestion LC-MS/MS at the Taplin Biological Mass Spectrometry Facility 
(Harvard Medical School). For enrichment of S phase-specific LEDGF 
phosphopeptides, HeLa TetOff cells stably expressing HA-LEDGF (clone H3) were 
incubated in the presence of 4 µg/ml aphidicolin (Calbiochem) for 24 h and then 
released into S phase for 2 h before proceeding with IP as detailed above with one 
modification, CSK buffer was further supplemented with 25 mM iodoacetamide 
(Sigma-Aldrich). 
 
Large scale IP for purification of Flag-MCM2-His8 
Full-length Flag-tagged MCM2 protein was purified from HeLa-Flag-MCM2-His8 
cells grown in two 500-cm
2
 tissue culture dishes by large-scale IP using 50 µl 
(settled volume) EZview Red ANTI-FLAG M2 affinity gel (Sigma) following the 
protocol described above. Bound protein was eluted in 50µl CSKc buffer 
supplemented with 150 mM NaCl, 0.2 mg/ml Flag peptide (Sigma-Aldrich), 0.1% 
NP40, 1 mM β-glycerophosphate, 1 mM NaF, 0.32 mM Na3VO4. Eluted protein was 
analysed by SDS PAGE and used as a substrate for in vitro kinase assays (Section 
2.16). 
 
2.12 Cell fractionation 
To prepare Triton-soluble and insoluble fractions, 293T cells were transfected with 
various combinations of  pcDNA3.1-Flag-Cdc7 (8 µg), pCPHA-Dbf4 (20 µg), 
pIRES2-LEDGF-eGFP (12 µg), pIRES2-LEDGF(EEE)-eGFP, (12 µg) and pIRES2-
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LEDGFΔIBD-eGFP (12 µg), keeping the total amount of DNA constant at 40 µg, 
using calcium phosphate (Ausubel et al., 2007) (Section 2.4). Cells were harvested 
30 h post transfection and for each condition 2/3 of the cell pellet was lysed in 100 µl 
ice-cold CSKT buffer [150 mM NaCl, 0.5% Triton-X100, 1 mM MgCl2, 10% 
sucrose, 1 mM DTT, 10 mM NaF, 1 mM ATP, 0.1 mM PMSF, EDTA-free protease 
inhibitors and 10 mM PIPES-NaOH, pH 6.8] for 10 min, followed by centrifugation 
at 17,000 g for 10 min at 4°C. The supernatants were kept as the Triton-soluble 
fraction (100 µl), while the pellets (Triton-insoluble fraction) were washed in CSKT 
buffer (500 µl), re-suspended in 100 µl CSKT buffer and solubilised by boiling in 
Laemmli sample buffer. To obtain whole cell extracts, 1/3 of the cell pellet from 
each condition was boiled in 50 µl PBS supplemented with 1% SDS, 5 mM EDTA 
and 0.5 mM PMSF. Protein concentration was determined using BCA protein assay 
with a BSA standard and samples normalised according to protein concentration 
prior to Western blot analysis (Section 2.5.4). In addition, transfected cells (1x10
6
 
cells per condition) were fixed in 70% ethanol for cell cycle analysis by flow 
cytometry (Section 2.13). 
 
2.13 Cell cycle analysis using flow cytometry 
Cells (1x10
6
 cells per sample) were fixed in ice-cold 70% ethanol (1 ml) with 
vortexing to prevent cell clumping and stored at -20°C. For staining, fixed cells were 
washed with 1% (w/v) BSA in PBS (1 ml) and re-suspended in 500 µl propidium 
iodide (PI) solution [50 µg/ml propidium iodide (Sigma-Aldrich), 0.1 mg/ml RNase, 
0.05% Triton-X100 in PBS] and incubated at 37°C for 40 min. Stained cells were 
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pelleted and re-suspended in 500 µl 1% (w/v) BSA in PBS for analysis by flow 
cytometry on a CyAn ADP (Beckman Coulter). PI was excited by a 488 nm solid-
state laser (blue laser) and detected using 613/620 band pass filter. The threshold was 
triggered off the PI parameter at 10%. The acquired data were analysed using 
Summit 4.3 software. Following gating of the correct cell population on Forward 
Scatter vs Side Scatter plots, single cells were discriminated from cell doublets by 
gating on the PI area vs PI linear plot. The gated PI area histogram was used to 
analyse cell cycle profiles. 
 
2.14 Recombinant protein expression and purification 
All column purification steps were carried out using an ᾹKTA Purifier HPLC 
instrument (GE Healthcare). 
 
2.14.1 Production and purification of Cdc7:ASK heterodimer 
E. coli Rosetta-2 (DE3) cells (Novagen) co-transformed with pRSF-CDC7-S-Tag 
and pCDF-His-Dbf4 were used for production of the Cdc7:ASK holoenzyme. 
Bacteria were grown in LB medium supplemented with 50 µg/ml kanamycin and 100 
µg/ml spectinomycin in shake flasks at 30°C. The cultures were allowed to 
equilibrate to 18°C prior to reaching an A600 of 0.9-1.0, and protein expression was 
induced by addition of 0.3 mM isopropyl-β-D-thiogalactopyranoside (IPTG). 
Following 3-h induction at 18°C, cells were harvested and stored at -80°C. Thawed 
bacterial paste was sonicated in Buffer A1 [300 mM NaCl, 50 mM NaH2PO4, 10% 
glycerol, 0.025% NP40, pH 7.5] supplemented with 0.1 mM PMSF, complete 
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EDTA-free protease inhibitor mix, 1 mg/ml lysozyme, 1 mM NaF, 1 mM β-
glycerophosphate and additional 0.5% NP40. The lysates, clarified by centrifugation 
at 17,000g at 4°C using a Sorvall SS34 rotor, were supplemented with 20 mM 
imidazole and incubated with 3 – 4 ml Ni-NTA agarose (Qiagen) for 30 min at 4°C 
with gentle agitation. Following extensive washing with Buffer A1 supplemented 
with 20 mM imidazole, the protein was then eluted in Buffer A1 supplemented with 
200 mM imidazole. Fractions containing Cdc7:ASK complex were pooled, diluted 3-
fold in Buffer A2 [50 mM Tris-HCl, pH 7.5, 10% glycerol], and injected into to a 5-
ml HiTrapQ column (GE Healthcare). The protein was eluted with a linear 0.1 – 0.5 
M gradient of NaCl in 50 mM Tris-HCl, pH 7.5 and 10% glycerol. The gradient was 
developed over 35 min at a rate of 1 ml/min. The protein complex was then further 
purified by size exclusion chromatography over a HiLoad 16/60 Superdex-200 
column (GE Healthcare) operated in 150 mM NaCl, 50 mM Tris-HCl, pH 7.5 and 2 
mM NaF. Cdc7:ASK complex was concentrated on a Centriprep-YM3 device 
(Millipore), supplemented with 10 mM DTT, 1 mM NaF, 1 mM β-glycerophosphate 
and 10% glycerol and flash-frozen in liquid nitrogen. Cdc7:ASK(174-350), 
Cdc7:ASK(1-350), Cdc7:ASK(174-674), Cdc7:ASK(1-541) and Cdc7:ASK(1-624) 
were similarly purified from Rosetta-2 (DE3) cells co-transformed with pRSF-
CDC7-S-Tag and pCDF-His-Dbf4(174-350) or pCDF-His-Dbf4(1-350) or pCDF-
His-Dbf4(174-674) or pCDF-His-Dbf4(1-541) or pCDF-His-Dbf4(1-624), 
respectively. 
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2.14.2 LEDGF 
WT, truncated and mutant LEDGF proteins containing a cleavable N-terminal hexa-
histidine tag were produced according to established procedures (Hare et al., 2009b; 
Turlure et al., 2006) as follows. PC2 E. coli (Cherepanov et al., 2004) transformed 
with pFT1-LEDGF (or constructs expressing mutant LEDGF forms) were grown to 
an A600 of ~ 1 in the presence of 120 µg/ml ampicillin and induced with 0.3 mM 
IPTG at 25°C for 3 h. Cells were lysed by sonication in Core Buffer 1 [1 M NaCl, 50 
mM Tris-HCl, pH 7.4] supplemented with 0.5 mM PMSF and 0.5% Triton-X100, the 
lysate clarified by centrifugation was further supplemented with 20 mM imidazole 
before incubation with Ni-NTA agarose (Qiagen). Following extensive washing with 
Core Buffer 1 supplemented with 20 mM imidazole, captured protein was eluted in 
Core Buffer 1 supplemented with 200 mM imidazole. LEDGF containing fractions 
were pooled, protein concentration determined by Bradford assay (Bio-Rad) used 
according to the manufacturer’s instruction and pooled protein supplemented with 10 
mM DTT and 0.2 mM PMSF. To remove the hexahistidine tag, eluted protein was 
incubated with human rhinovirus 14 3C protease (Hare et al., 2009b) at 4°C 
overnight (1 mg of protease was added per 50 mg of eluted protein). Following 3C 
protease treatment, the protein mixture was diluted with 50 mM Tris-HCl, pH 7.4 to 
adjust NaCl concentration to 150 mM and injected into a 5-ml HiTrap SP cation 
exchange column (GE Healthcare). Following extensive washing, the protein was 
eluted with a linear 0.15 – 1 M gradient of NaCl in 40 mM Tris-HCl, pH 7.4. The 
protein was further purified by size exclusion chromatography over a HiLoad 16/60 
Superdex 200 column, equilibrated to 125 mM NaCl in 50 mM Tris-HCl, pH 7.4. 
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Concentrated protein was supplemented with 10 mM DTT and 10% glycerol and 
flash-frozen in liquid nitrogen. 
 
2.14.3 Glutathione-S-transferase (GST)-tagged proteins 
 GST-MCM2(1-287) was produced in Rosetta-2 (DE3) E. coli cells, transformed 
with pCP-GST-MCM2(1-287). Bacteria were grown to an A600 of ~1 in the presence 
of 120 µg/ml ampicillin and induced with 0.15 mM IPTG at 25°C for 5 h. Cells were 
lysed by sonication in Core Buffer 2 [0.5 M NaCl, 50 mM Tris-HCl, pH 7.4, 1 mM 
EDTA] supplemented with 2 mM DTT, 0.5 mM PMSF, 0.5% Triton-X100 and 
1mg/ml lysozyme. The fusion protein was captured on glutathione sepharose (GE 
Healthcare) and following extensive washing, was eluted in 0.5 M NaCl, 50 mM 
Tris-HCl, 50 mM glutathione, 10 mM DTT, pH 7.8. The protein was then dialysed 
against excess 0.5 M NaCl, 50 mM Tris-HCl, pH 7.4, 1 mM DTT, supplemented 
with 10% glycerol and flash-frozen in liquid nitrogen.  
Free GST was purified from Rosetta 2 E. coli transformed with pGEX-4T1 
using Core Buffer 3 [200 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1 mM EDTA] 
supplemented with 2 mM DTT, 0.5 mM PMSF, 0.5% Triton-X100 and 1mg/ml 
lysozyme, eluted with 50 mM glutathione in Core buffer 3, dialysed against excess 
200 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1 mM DTT and further supplemented with 
10 mM DTT and 10% glycerol before freezing. 
GST-LEDGF(347-471) and GST-HRP2(470-593) fusion proteins were 
produced according to established protocols (Cherepanov et al., 2004). Isolated IBD 
of LEDGF and integrase proteins were from (Hare et al., 2009b). 
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2.15 In vitro pull -down assays 
 
2.15.1 S-tag pull-down 
In a typical S-tag pull-down experiment, 25 µl of S-protein agarose (Novagen) was 
incubated with 10 µg (71 nmol) Cdc7:ASK, 10 µg (166 nmol) LEDGF and 10 µg 
BSA in 650 µl pull down buffer [PDB: 150 mM NaCl, 0.1% NP40, 40 mM 
BisTrisPropane pH 7.45, 1 mM β-glycerophosphate, 1 mM NaF, 2 mM DTT, 10 mM 
MgCl2] supplemented with complete EDTA-free protease inhibitor cocktail. Where 
indicated, PDB was supplemented with 4 mM adenosine 5’-triphosphate (ATP). 
Input quantities of Cdc7:ASK and LEDGF deletion mutants were adjusted to match 
molar inputs of the full-length proteins. When titrating in GST-LEDGF(347-471) and 
GST, the competing proteins were added in a range from 83 nmol to 830 nmol 
equivalent to an LEDGF:GST-LEDGF(1-287) molar ratio ranging from 1:0.5 to 1:5. 
Reactions were rocked at 4°C for 3 – 4 h. After gentle centrifugation, the beads were 
washed with several changes of ice-cold PDB. Bound proteins were eluted in 30 µl 
of 2x Laemmli sample buffer supplemented with 25 mM DTT, separated in 11% 
SDS PAGE gels and detected by staining with Commassie Blue R250 (Section 2.5.2) 
and Western blotting (Section 2.5.4).  
Where indicated, pre-treatment of Cdc7:ASK with 4 mM ATP or 2,000 units 
λPPase was carried out for 1 h at 4°C prior to use in pull-down assays. 
 
 118 
2.15.2 GST-tag pull-down 
Sixty  µl glutathione sepharose beads (GE Healthcare) were incubated overnight at 
4°C with 50 µg GST-LEDGF(1-287), GST-HRP2(470-593) or GST in 100 µl 150 
mM NaCl, 20 mM Tris-HCl, pH 7.4, 10 mM DTT. Beads collected by gentle 
centrifugation were washed with several changes of ice-cold PBD and 30 µl of 
glutathione sepharose pre-loaded with GST-LEDGF(1-287) or GST-HRP2(470-593) 
or GST was then incubated with 10 µg Cdc7:ASK and 10 µg BSA in 650 µl PDB 
and the pull-down assay continued out as outlined in the previous section. 
 
2.16 In vitro Kinase assays 
A standard 25-µl kinase reaction mixture contained 10 ng Cdc7:ASK (71 pmol) or 
corresponding molar equivalents of its truncated forms [Cdc7:ASK (10 ng), 
Cdc7:ASK(174-350) (6 ng), Cdc7:ASK(1-350) (7.4 ng), Cdc7:ASK(174-674) (8.7 
ng), Cdc7:ASK(1-624) (9.6 ng), Cdc7:ASK(1-541) (8.9 ng)] and 3 µCi of [γ-
32
P]ATP (3,000 Ci/mmol) in 40 mM HEPES-NaOH, pH 7.4, 1 mM β-
glycerophosphate, 1 mM NaF, 2 mM DTT, 10 mM MgSO4, complete EDTA-free 
protease inhibitor cocktail, 80 µg/ml BSA, 0.1% NP40 and 0.1 mM ATP. Substrates 
were used in the following quantities: 0.5 µg of GST-MCM2(1-287) (9.8 nmol), 0.5 
µg or 0.59 µg LEDGF (8 nmol or 9.8 nmol) or corresponding molar equivalents of 
its mutant forms; where indicated, 0.23 µg GST (8 nmol) was present as a negative 
control. When titrating LEDGF and its mutant forms, a starting concentration of 9.8 
nmol was used and the protein serially diluted 1 in 5 to 78.4 pmol. Kinase reactions, 
allowed to proceed for 30 min at 30°C, were stopped by addition of Laemmli sample 
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buffer supplemented with 25 mM DTT and heated to 95°C for 5 min. Reaction 
products, resolved by SDS-PAGE (11% gel), were analysed by phosphorescence 
imaging using a Storm-860 instrument (GE Healthcare). Detected signal was viewed 
and analysed using ImageQuant 5.0 software. 
To detect phosphorylation at Ser53 of MCM2 [0.5 µg of GST-MCM2(1-287) 
or 3 µl of full-length MCM2 immunoprecipitate], kinase reactions were carried out 
omitting [γ-32P]ATP and the products were analysed by Western blotting (Section 
2.5.4) using rabbit anti-phospho MCM2 (S53) antibody (A300-756A) diluted 
1:1,000. 
 
2.16.1 Identification of in vitro Cdc7-specific phosphorylation sites within 
LEDGF 
Full-length recombinant LEDGF (10 µg) was phosphorylated in vitro by 
recombinant Cdc7:ASK (0.2 µg) using the protocol outlined above but omitting [γ-
32
P]ATP. The reaction was stopped by addition of 20 mM EDTA and proteins were 
precipitated with 25% (w/v) TCA overnight. The pellets were washed twice in ice-
cold acetone (500 μl) and re-dissolved in 10 μl of 2x Laemmli sample buffer 
supplemented with 25 mM DTT. Proteins were separated by SDS-PAGE (11% gel) 
and detected by staining with colloidal Coomassie G-250. The LEDGF gel slice was 
excised and LEDGF phospho-peptides were identified by in-gel trypsin digestion 
LC-MS/MS at the Taplin Biological Mass Spectrometry Facility (Harvard Medical 
School). 
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3 Chapter III: Gene expression profiling of Psip1
f/+ 
and 
Psip1
-/-
 MEFs 
 
3.1 Introduction 
LEDGF/p75 was initially identified as a 75-kDa polypeptide (p75) by co-purification 
with transcriptional co-activator PC4 from HeLa cell extracts (Ge et al., 1998). In the 
same work, both LEDGF and its less abundant splice variant p52 were shown to 
facilitate transcriptional activation in vitro. Shinohara and colleagues have reported 
that LEDGF protects against stress-induced cell death via transcriptional co-
activation of stress related genes such as heat shock proteins, antioxidant protein 2 
and alcohol dehydrogenase (Fatma et al., 2001; Shin et al., 2008; Shinohara et al., 
2002; Singh et al., 2001). LEDGF was also reported to modulate the expression of 
vascular endothelial growth factor C (VEGF-C) during cellular stress (Cohen et al., 
2009). 
Additional, albeit circumstantial, evidence suggesting a role for LEDGF in 
transcription comes from virology. LEDGF is a critical targeting factor for HIV-1 
integration and accounts for the characteristic preference for lentiviruses to integrate 
within actively transcribed genes of the host genome (Ciuffi et al., 2005; Llano et al., 
2006a; Shun et al., 2007). These data coupled with earlier studies mapping the 
genomic distribution of lentiviral integration sites (Crise et al., 2005; Mitchell et al., 
2004; Schroder et al., 2002) suggests that LEDGF is associated with a large number 
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of  transcriptionally-active genes. Unpublished observations reported by Debyser’s 
and Ciuffi’s laboratories at recent meetings seem to confirm this conjecture.  
To determine whether LEDGF plays a direct role in gene transcription the 
gene expression profiles of mouse embryonic fibroblasts derived from LEDGF-
knockout animals and those derived from mice carrying an intact Psip1 allele, the 
gene that encodes for LEDGF, were compared. For this analysis a conditional Psip1 
knockout mouse model that had been developed in the laboratory of Dr. Alan 
Engelman (Harvard Medical School, Boston, MA) was used (Shun et al., 2007). 
DNA recombination sites for Cre recombinase were engineered to flank exon 3 of 
Psip1 and chimeric animals were created following implantation of transfected TC-1 
mouse embryonic stem cells (derived from the 129SvEv strain) and then mated to 
C57BL/6 mice. Animals carrying one or two floxed (f) Psip1 alleles developed 
normally and when crossed with Sox2Cre transgenic mice produced Psip1
f/+
 and 
Sox2Cre/Psip1
+/-
 offspring. Crossing Sox2Cre/Psip1
+/-
 and Psip1
f/f
 mice produced 
f/+, f/-, +/- and -/- embryos at expected frequencies (Shun et al., 2007). Although 
Psip1
-/-
 embryos produced in this way also contained the Sox2Cre allele, they are 
referred to as Psip1
-/-
 throughout this work. Of note, the knockout ablates the second 
coding exon of Psip1 and therefore nulls expression of both p75 and p52 LEDGF 
splice forms. MEFs carrying one or two floxed Psip1 alleles (f/+ or f/f) expressed 
LEDGF protein at levels similar to WT (Shun et al., 2007).  
An earlier study analysing gene expression changes in human embryonic 
kidney cells (HEK 293Ts) depleted of LEDGF using short hairpin RNA (shRNA) 
identified a subset of around 2,000 human genes affected by knockdown of LEDGF 
(Ciuffi et al., 2005). Our study used MEFs derived from Psip1
-/-
 embryos and 
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therefore allowed the analysis of gene expression in cells completely devoid of 
LEDGF. 
 
3.2 Gene expression analysis using oligonucleotide microarrays 
In order to identify mouse genes regulated by LEDGF, gene expression in mouse 
embryonic fibroblasts derived from Psip1
f/+
 and Psip1
-/-
 embryos was analysed using 
Agilent 44k oligonucleotide microarrays, which are capable of monitoring 
expression of ~28,500 mouse genes. Three pairs of primary cell lines isolated from 
littermates (Psip1
f/+
 and Psip1
-/-
) were used in this experiment. Three or four 
independent RNA samples were isolated in parallel from each partner in a pair of cell 
lines according to Table 3.1.  
Table 3.1 – RNA samples used for gene expression analysis 
Littermate-matched MEF lines 
Psip1
f/+
 (LEDGF+)                Psip1
-/-
 (LEDGF-) 
No. of RNA samples studied 
(for each MEF line in a pair) 
E1 E2 4 
E5 E6 3 
E4B E5B 3 
 
Extracted RNA was reverse transcribed to produce T7 promoter-tagged 
cDNA, which was used to generate Cy5-labelled cRNA probes by in vitro 
transcription using T7 RNA polymerase in the presence of Cy5-CTP. In parallel, 
reference Cy3-labelled cRNA was prepared using pooled RNA from various mouse 
tissues. The Cy5-labelled sample cRNA and Cy3-labelled reference cRNA were co-
hybridised to the oligonucleotide microarrays. The reference cRNA provided an 
internal standard for each individual spot on the microarray. In total, twenty 
microarrays were used to analyse quadruplicate (E1, E2) or triplicate (E5, E6, E4B, 
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E5B) samples. Following scanning and feature extraction, normalised (Cy5/Cy3) 
gene expression data from Psip1
f/+
 (LEDGF+) and Psip1
-/-
 (LEDGF-) MEFs were 
analysed using GeneSpring GX 7.3.1 (Agilent) and Rosetta Resolver 7.0 programs.  
A scatter plot of gene expression levels in Psip1
f/+
 (control genotype) versus 
Psip1
-/-
 (knockout) MEFs illustrates that relatively few genes show a 2-fold or more 
change in expression in response to LEDGF ablation (Figure 3.1). Although LEDGF 
expression is ablated in MEFs derived from Psip1
-/-
 embryos, mRNA transcripts 
expressed from the disrupted Psip1 gene can be detected using this method and 
appear as down-regulated in the LEDGF knockout genotype (Figure 3.1; LEDGF 
specific probes are circled in red on the scatter plot). This apparent down regulation 
of two defective LEDGF transcripts is likely related to nonsense-mediated mRNA 
decay (Silva and Romao, 2009).  
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The scatter plot shows normalised [log10(Cy5/Cy3)] and averaged expression data for every probe  
present on the array in Psip1
f/+ 
and Psip1
-/-
 MEFs. The graph illustrates that relatively few genes show 
a 2-fold or more change in gene expression following knockout of LEDGF. Genes circled in blue have 
been validated by qRT-PCR. Two red circles indicate positions of the LEDGF-specific probes 
A_51_P314111 and A_52_P109131. The plot was generated using GeneSpring GX 7.3.1 software. 
 
Normalised expression data from 20 arrays was analysed by an error-
weighted 1-way ANOVA resulting in a list of genes that were statistically 
significantly different (P0.01) between Psip1f/+ and Psip1-/- MEFs (Figure 3.2). 
These genes were subjected to a 2-D cluster analysis which resulted in f/+ (WT) and 
-/- (KO) MEF lines clustering into 2 separate groups based on their gene expression 
patterns (Figure 3.3), although, cluster analysis applied to the complete list of genes 
arrayed (data not shown) failed to distinguish between the genotypes of the MEF 
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Figure 3.1 – Effect of Psip1 knockout on gene expression in mouse embryonic fibroblasts (MEFs) 
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lines. This result indicates that even though differences in gene expression profiles 
between f/+ and -/- conditions appear subtle; they can be reliably detected using 
chosen techniques.  
 
 
 
Figure 3.2 – One-way analysis of variance (ANOVA) showing genes that are differentially 
expressed in Psip1
f/+
 and Psip1
-/-
 MEFs 
Normalised expression data from the two groups were compared using one-way ANOVA applying the 
Benjamin Hochberg false discovery rate (FDR) multiple test correction (5% cut-off). Genes that were 
statistically significantly different (P0.01) between Psip1f/+ and Psip1-/- MEFs were obtained from 
the ANOVA signature. Analysis was done using Rosetta Resolver 7.0 software. 
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Cluster analysis of statistically significant genes obtained by one-way ANOVA (Figure 3.2) shows 
that Psip1
f/+
 (LEDGF+) MEFs and Psip1
-/-
 (LEDGF-) MEFs separate into two distinct groups based 
on gene expression patterns. Genes highlighted in the orange boxes show the largest fold difference 
between the two groups, and include Trim12, Tbx1, Crabp1 and Adam33. Analysis was done using 
Rosetta Resolver 7.0 software. 
 
Gene expression data were grouped by genotype (f/+ and -/-) and the 
observed differences between the two groups of samples were subjected to a t-test 
with a 5 % false discovery rate (FDR) cut-off. Statistically significant genes that 
were differentially expressed in Psip1
f/+
 and Psip1
-/-
 MEFs identified by this analysis 
(See Appendix B for gene list) were similar to those identified by one-way ANOVA 
using Rosetta Resolver 7.0. Surprisingly, fewer than 200 genes displayed a greater 
than or equal to 1.5-fold change in gene expression (P0.05) in LEDGF-null cells 
(Gene list, Appendix B). Many of these putative LEDGF-regulated genes are known 
E5 
E1 
E4B 
Psip1
f/+ 
MEFs 
E2 
E5B 
E6 Psip1
-/-
 
MEFs 
   -2        0        2 
      Log(Ratio) 
ANOVA signature sequences 
Figure 3.3 – Cluster analysis of genes differentially expressed in Psip1f/+ and Psip1-/- MEFs 
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or thought to be involved in embryonic development. Of particular interest were 
Tbx1, a member of the T-box family of transcription factors known to function 
during mammalian heart development (Stennard and Harvey, 2005) and Trim12, the 
mouse orthologue of the retroviral restriction factor Trim5α (Stremlau et al., 2004). 
The former gene was slightly up-regulated, while expression of the latter was 
practically ablated in LEDGF-null cells. Following on from these results, qRT-PCR 
analyses were carried out to validate the results of gene expression analysis.  
 
3.3 Validation of putative LEDGF-regulated genes by quantitative 
RT-PCR 
Quantitative RT-PCR was used to compare expression levels of several putative 
LEDGF-regulated genes in Psip1
f/+
 and Psip1
-/-
 cells. Two pairs of matched MEF 
lines E1/E2 and E5/E6 (before and after immortalisation with SV40 large T antigen 
(indicated by T)) were studied (Table 3.2). Lack of LEDGF expression in Psip1
-/-
 
MEFs after transformation was confirmed by Western blotting (Figure 3.5A). 
Table 3.2 – MEF lines used in qRT-PCR 
Primary 
Littermate-matched MEF lines 
Psip1
f/+
 (LEDGF+)    Psip1
-/-
 (LEDGF-) 
Transformed (SV40 large T antigen) 
Littermate-matched MEF lines 
Psip1
f/+
 (LEDGF+)    Psip1
-/-
 (LEDGF-) 
E1 E2 E1T E2T 
E5 E6 E5T E6T 
 
Total RNA isolated from littermate-matched pairs of MEFs was reverse 
transcribed, and target-specific fragments were PCR-amplified in a real time PCR 
instrument (Figure 3.4C). PCR fragments for each target transcript were cloned into 
pCR4-TOPO vector, and serially diluted plasmid DNA was used to generate standard 
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curves (Figure 3.4A and B). Melting curves were recorded after each experiment to 
ensure that the desired sequences were specifically amplified and gave an indication 
as to the sensitivity of the assay (Figure 3.4D; see Appendix A for details of primers 
sets and standards used in qRT-PCR assays).  
 
(A) Trim12: real time PCR amplification of a serially diluted standard 
 
(B) Trim12: standard curve 
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(C) Trim12: real time PCR amplification from Psip1
f/+
 and Psip1
-/-
 samples 
 
(D) Trim12: melting curves 
 
Figure 3.4 – Analysis of Trim12 expression in Psip1f/+ and Psip1-/- MEFs using qRT-PCR 
Differences in expression levels of putative LEDGF target genes identified by gene expression 
profiling were confirmed by qRT-PCR. Plots shown above measuring Trim12 expression in Psip1
f/+
 
and Psip1
-/-
 MEFs are shown as examples.  
For analysis of Trim12 expression, a 144 bp sequence specific for the open reading frame of Trim12 
was cloned into pCR4-TOPO, the plasmid DNA was serially diluted 1/10 and qPCR performed using 
SYBR Green chemistry to generate a standard curve trace (A) and the standard curve (B). RNA 
extracted from primary and immortalised MEF pairs was reverse transcribed and qPCR using a target 
specific primer set performed to generate the sample trace (C) with Psip1
f/+
 (LEDGF+) samples 
shown in green and Psip1
-/-
 (LEDGF-) samples shown in purple. It is clear from the sample trace that 
Trim12 expression is greatly reduced in LEDGF-null cells. Melting curves (D) show that Psip1
f/+
 
samples (green) and standards (blue) amplify a specific product, however, Trim12 expression in 
Psip1
-/-
 MEFs (purple) is below the level of detection, as seen by amplification of non-specific 
products (D). 
 
 
Psip1
f/+ 
(LEDGF+)  Psip1
-/- 
(LEDGF-) 
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Our qRT-PCR results confirmed microarray gene expression data for several 
genes. In particular, Trim12, Thbs4, Crabp1, Esm1 and Adam33 expression were 
down-regulated, while Tbx1 and Zfp536 were up-regulated in LEDGF-null MEFs 
(Figure 3.5B and Figure 3.6) Changes in gene expression due to the absence of 
LEDGF were consistent between primary and early passage transformed MEFs for 
all genes studied. Furthermore, over-expression of T-box1 in immortalised LEDGF-
null MEFs (E2T) was verified by Western blotting (Figure 3.5C). However, not all 
differences in gene expression were stable after prolonged culturing of immortalised 
MEF lines. In particular, differences in Thbs4 and Crabp1 gene expression between 
f/+ and -/- cells were lost after an estimated 40-50 population doublings (passage 22) 
(Figure 3.6). This is not entirely unexpected, and illustrates that at least some of the 
affected genes are subject to regulation at multiple levels. The loss or acquisition of 
epigenetic markers associated with a subset of putative LEDGF-responsive genes 
might explain changes in their expression levels with passage number. 
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Figure 3.5 – Validation of putative LEDGF-regulated genes identified by gene expression 
profiling: Tbx1 and Trim12 
(A) Western blot (WB) analysis of nuclear extracts from Psip1
f/+
 (LEDGF+) and Psip1
-/-
 (LEDGF-) 
MEFs immortalised with the SV40 large T antigen confirmed the lack of LEDGF expression in cell 
lines E2T and E6T. (B) Relative gene expression levels for Trim12 and Tbx1 in primary (E1(f/+) and 
E2(-/-)) and transformed (E1T and E2T) MEFs were determined by qRT-PCR. Calculated 
concentrations for each sample were normalised against the ribosomal standard and relative changes 
in gene expression between different cell lines determined (Sample E1T #10 was set to have an 
expression level of 1 for each of the genes tested and relative expression levels in all the other samples 
compared to this). Psip1
f/+
 MEF lines are indicated in green, Psip1
-/-
 MEF lines are indicated in purple 
and # indicates passage number of transformed MEF cultures. (See Figure 3.6 for details of all other 
genes that were validated in the manner) (C) Western blot analysis of total cell lysates from NIH 3T3 
control MEFs, E1T(f/+) and E2T(-/-) MEF lines confirmed the over-expression of T-box1 protein in 
transformed LEDGF-null MEFs (E2T). 
 132 
Thbs4
0
0.5
1
1.5
2
2.5
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 L
e
v
e
l
E1.3
E2.3
E5.3
E6.3
E5T #4
E6T #4
E1T #22
E2T #22
Thbs4
1  2   3  4  5   6  7   8
Thbs4
0
0.2
0.4
0.6
0.8
1
1.2
R
e
la
ti
v
e
E
x
p
re
s
io
n
 L
e
v
e
l
E1T #10
E2T #10
Thbs4
9  10
Esm1
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 L
e
v
e
l
E1.3
E2.3
E1T #10
E2T #10
E1T #22
E2T #22
Esm1
1  2   3  4  5   6 
Crabp1
0
0.2
0.4
0.6
0.8
1
1.2
1.4
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 L
e
v
e
l
E1.3
E2.3
E5.3
E6.3
E5T #4
E6T #4
Crabp1
1   2  3   4  5   6  
Crabp1
0
0.2
0.4
0.6
0.8
1
1.2
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 L
e
v
e
l
E1T #10
E2T #10
E1T #22
E2T #22
Crabp1
7  8  9  10 
Adam33
0
0.5
1
1.5
2
2.5
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 L
e
v
e
l
E1.3
E2.3
E5.3
E6.3
E1T #10
E2T #10
E1T #22
E2T #22
Adam33
1   2  3   4  5   6  7   8
Zfp536
0
0.5
1
1.5
2
2.5
3
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 L
e
v
e
l
E1.2
E2.2
E1.3
E2.3
E1.4
E2.4
E1T #10
E2T #10
Zfp536
1   2  3  4   5  6  7   8   
Thbs4 Esm1 Crabp1 Adam33 Zfp536
1 E1 E1 E1 E1 E1.2
2 E2 E2 E2 E2 E2.2
3 E5 E1T #10 E5 E5 E1.3
4 E6 E2T #10 E6 E6 E2.3
5 E5T #4 E1T #22 E5T #4 E1T #10 E1.4
6 E6T #4 E2T #22 E6T #4 E2T #10 E2.4
7 E1T #22 E1T #10 E1T #22 E1T #10
8 E2T #22 E2T #10 E2T #22 E2T #10
9 E1T #10 E1T #22
10 E2T #10 E2T #22
R
e
la
ti
v
e
 E
x
p
re
s
s
io
n
 L
e
v
e
l
LEDGF+ MEFs (f/+)
LEDGF- MEFs (-/-)
 
Figure 3.6 – Validation of putative LEDGF-regulated genes by qRT-PCR: Thbs4, Esm1, Crabp1, 
Adam33 and Zfp536. 
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Relative gene expression levels in primary (E1(f/+), E2(-/-), E5(f/+) and E6(-/-)) and transformed 
(E1T, E2T, E5T and E6T) MEFs were determined by qRT-PCR. Calculated concentrations for each 
sample were normalised against the ribosomal standard and relative changes in gene expression 
between different cell lines determined (Sample E1T #10 was set to have an expression level of 1 for 
each of the genes tested). Psip1
f/+
 MEF lines are indicated in green, Psip1
-/-
 MEF lines are indicated in 
purple and # indicates passage number of transformed MEF cultures. 
 
3.4 Re-expression of LEDGF and p52 in Psip1
-/-
 MEFs 
We considered a possibility that the gene expression changes observed in Psip1
-/-
 
MEFs (Gene list, Appendix B) were not directly caused by LEDGF deficiency. 
Indeed, several genes up-regulated in LEDGF-null cells, in particular Tbx1, Hoxb5, 
Hoxb6, Cutl1, and Foxf1a amongst others, are known or presumed to be transcription 
factors, which would certainly cause a range of downstream effects. In addition, 
some of the effects could be due to absence of p52, the alternatively spliced form of 
LEDGF also ablated in Psip1
-/-
 MEFs. Furthermore, Psip1
-/-
 cells contain the 
Sox2Cre allele and produce low levels of Cre recombinase, which might potentially 
affect the gene expression landscape. Therefore, it was important to test whether (or 
which of) the putative LEDGF-responsive genes identified by microarray analyses 
are under direct control of LEDGF. To this end we attempted ectopic expression of 
LEDGF/p75 and p52 cDNAs in immortalised Psip1
-/-
 MEFs.  
Stable expression of C-terminally influenza hemagglutinin (HA)-tagged 
murine LEDGF or p52 in E1T(f/+) and E2T(-/-) MEFs was accomplished by 
retroviral transduction using retroviral vectors packaging pLB(N)CX-mp75-HA or 
pLB(N)CX-mp52-HA, respectively, followed by selection with blasticidin S. MEFs 
transduced with empty pLB(N)CX vector were prepared as controls (see Table 3.3 
for details of stable MEF lines). Western blot analysis confirmed that HA-tagged 
forms of LEDGF/p75 and p52 were expressed in transduced MEFs (Figure 3.7), 
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however the level of expression of LEDGF-HA (p75-HA) was somewhat lower than 
that of endogenous LEDGF in Psip1
f/+
 cells (Figure 3.7B).  
Table 3.3 – MEF lines stably re-expressing LEDGF and p52 
MEF line  Description  
E1TV  Psip1
f/+
 MEF line transduced with vector control (V)  
E1Tp52  Psip1
f/+
 MEF line ectopically expressing p52-HA  
E1Tp75  Psip1
f/+
 MEF line ectopically expressing LEDGF-HA  
E2TV  Psip1
-/-
 MEF line transduced with vector control (V)  
E2Tp52  Psip1
-/-
 MEF line ectopically expressing p52-HA  
E2Tp75  Psip1
-/-
 MEF line ectopically expressing LEDGF-HA  
 
50
70
100                      LEDGF-HA
p52-HA
WB: α HA 
A
LEDGF-HA
LEDGF
100
70
WB: α LEDGF 
B
 
Figure 3.7 – Western blot analysis of ectopically expressed LEDGF and p52 in Psip1-/- MEFs 
Psip1
f/+
 (E1T(f/+)) and Psip1
-/-
 (E2T(-/-)) MEFs stably expressing LEDGF-HA (p75), p52-HA (p52) 
or control MEFs transduced with an empty vector (V) were analysed by Western blotting.  
(A) Total cell lysates blotted for the HA tag show expression of LEDGF-HA and p52-HA in the 
desired lines, while control lines did not express any HA-tagged protein. (B) Nuclear extracts made 
from all stable lines were analysed for LEDGF expression and showed expression of endogenous 
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LEDGF in all Psip1
f/+
 (E1T) samples as well as expression of HA-tagged LEDGF in MEF lines 
E1Tp75 and E2Tp75. 
 
Expression of Tbx1, Trim12, Thbs4 and Crabp1 in MEFs stably expressing 
ectopic LEDGF-HA or p52-HA was measured by qRT-PCR and relative gene 
expression levels determined (Figure 3.8). Intriguingly, neither LEDGF-HA nor p52-
HA affected expression of any of the genes in the tested set. Relative gene expression 
levels in Psip1
-/-
 MEFs remained largely unchanged by ectopic expression of p52-
HA and LEDGF-HA (p75) (Figure 3.8; lanes 4 and 5 respectively) when compared 
to Psip1
-/-
 MEFs transduced with empty vector (Figure 3.8; lane 3). Expression of 
Tbx1 remained up-regulated while Trim12, Crabp1 and Thbs4 expression remained 
down-regulated in all the stable Psip1
-/-
 MEF lines (E2TV, E2Tp52 and E2Tp75), 
regardless of p52 or LEDGF/p75 expression. This result strongly indicated that the 
changes observed are not due to a direct effect of either protein on gene expression. 
The observed effects on gene expression may well be due to embryonic development 
in the absence of LEDGF and/or p52. 
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Figure 3.8 – Gene expression in Psip1-/- MEFs following re-introduction of LEDGF and p52 
Expression of Tbx1, Trim12, Thbs4 and Crabp1 in Psip1
-/-
 (E2T) and Psip1
f/+
 (E1T) MEFs ectopically 
expressing LEDGF-HA (p75) or p52-HA (p52) was determined by qRT-PCR. MEFs transduced with 
empty vector (V) were used as controls. Calculated concentrations for each sample were normalised 
against the ribosomal standard and relative changes in gene expression between different cell lines 
determined (Sample E1T V was set to have an expression level of 1 for each of the genes tested). 
Psip1
f/+
 MEF lines are indicated in green and Psip1
-/-
 MEF lines are indicated in purple. 
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3.5 Analysis of gene expression changes resulting from in vitro 
knockout of Psip1 
Thus far, the gene expression landscapes of MEFs derived by in utero knockout of 
Psip1 (such as E2 MEFs, derived from a Psip1
-/-
 embryo) have been analysed. We 
reasoned that, in vitro knockout of Psip1 which could be achieved by transduction of 
Psip1
f/f
 cells with Cre recombinase under tissue culture conditions, could provide a 
means of studying gene expression, independently of embryonic development. 
MEF(f/f) cells transduced with a vector expressing WT or R173K active site mutant 
Cre recombinase to give cell lines E6(-/-) and E6(f/f), respectively, were kindly 
provided by Dr. Alan Engleman (Shun et al., 2007). Western blot analysis confirmed 
that knockout cells E6(-/-) failed to express detectable levels of LEDGF protein 
while E6(f/f) cells, transduced with catalytically inactive Cre, maintained WT levels 
of Psip1 expression (Figure 3.9A).  
RNA was extracted in parallel from immortalised MEF lines E6(f/f) 
(LEDGF+) and E6(-/-) (LEDGF-), and relative gene expression levels were 
determined by qRT-PCR. Expression of Trim12, Tbx1 and Thbs4 in MEF pair 
E6(f/f)/E6(-/-) (in vitro knockout of Psip1) was compared to expression levels of 
these genes in MEF pair E1T/E2T (derived from Psip1
f/+
 and Psip1
-/-
 embryos, 
respectively) (Figure 3.9B). As expected, expression of Trim12 and Thbs4 were 
down-regulated in E2T cells (LEDGF-null) compared to E1T cells (LEDGF+) while 
Tbx1 expression was up-regulated in E2T cells compared to E1T cells (Figure 3.9B; 
lanes 1 and 2). However, expression of Trim12 was not down-regulated by in vitro 
knockout of Psip1. In fact, both E6(f/f) and E6(-/-) MEF lines expressed Trim12 at 
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comparable levels to E1T cells (Figure 3.9B; Trim12 bar graph, compare lanes 1, 3 
and 4). Similarly, expression levels of Tbx1 and Thbs4 remained largely unaffected 
by ablation of LEDGF expression under tissue culture conditions; expression of Tbx1 
and Thbs4 were barely detectable in either E6(f/f) or E6(-/-) MEF lines (Figure 3.9B; 
lanes 3 and 4). These data suggested that the expression of this test set of genes is not 
directly regulated by LEDGF or p52 and may go some way to explaining why 
ectopic re-expression of LEDGF and p52 (section 3.4) failed to rescue gene 
expression in LEDGF-null MEFs derived from Psip1
-/-
 embryos. Additionally, this 
indicates that the presence of the HA tag on ectopically expressed LEDGF and p52 
probably did not account for their inability to affect gene expression. These data 
supports the hypothesis that the changes in gene expression observed in MEFs 
derived from Psip1
-/-
 embryos is due to undergoing embryonic development in the 
absence of LEDGF and/or p52 rather than a direct affect of LEDGF or p52 on gene 
expression. 
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Figure 3.9 – Gene expression analysis of Psip1-/- MEFs obtained by in vitro knockout 
(A) Total cell extracts of MEF(f/f) cells after three rounds of exposure to WT or R173K active site 
mutant Cre recombinase, giving MEF lines E6(-/-) or E6(f/f), respectively, were analysed by Western 
blot. LEDGF expression is nulled following exposure to WT Cre recombinase. β-actin serves as a 
loading control. (B) MEF line E6(-/-) (lane 4) was derived by transduction of f/f cells with Cre 
recombinase under tissue culture conditions resulting in in vitro knockout of the Psip1 gene. The 
control line E6(f/f) (lane 3) was transduced with an R173K active site mutant Cre recombinase and 
thus retains expression of LEDGF. Expression of Trim12, Tbx1 and Thbs4 in MEF pair E6(f/f)/E6(-/-) 
was determined by qRT-PCR and gene expression compared to that of MEF pair E1T/E2T (derived 
from littermate matched Psip1
f/+
 and Psip1
-/-
 embryos; lanes 1 and 2 respectively). Calculated 
concentrations for each sample were normalised against the ribosomal standard and relative changes 
in gene expression between different cell lines determined (Sample E1T #9 was set to have an 
expression level of 1). Psip1
f/+
/Psip1
f/f
 MEF lines are indicated in green, Psip1
-/-
 MEF lines are 
indicated in purple and # indicates passage number of transformed MEF cultures.  
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3.6 LEDGF directs HIV-1 integration to a subset of highly expressed 
genes 
HIV-1 as well as other lentiviruses preferentially integrates within active 
transcription units (Ciuffi and Bushman, 2006). LEDGF is the major cellular co-
factor of HIV-1 IN and was proposed to function as a tether between IN and 
chromosomal DNA during strand transfer (Cherepanov et al., 2003; Llano et al., 
2004b; Maertens et al., 2003). Therefore, LEDGF is expected to affect distribution of 
HIV-1 integration sites on the genomic scale. This was indeed confirmed by Ciuffi et 
al using a partial knockdown of LEDGF to show that the frequency HIV-1 
integration into TUs was reduced in cells depleted of LEDGF (Ciuffi et al., 2005). 
The mouse Psip1-knockout model afforded studies of HIV-1 integration in the 
absence LEDGF, which was done in close collaboration with Dr. Alan Engelman’s 
laboratory. In Psip1
-/-
 cells, HIV-1 integration was significantly reduced (~10 fold) 
although not completely ablated. Analysis of HIV-1 integration sites isolated from 
primary MEFs, E1 (Psip1
f/+
) and E2 (Psip1
-/-
), in our laboratory, showed that in the 
absence of LEDGF HIV-1 lost its strong bias towards integrating into TUs and, 
further, displayed an increase affinity for promoter and CpG islands. Thus, the 
interaction with LEDGF accounts for the characteristic bias of lentiviruses to 
integrate within active transcription units of the host genome. 
Gene expression data determined by the candidate’s oligonucleotide 
microarray analyses (section 3.2) of primary MEF lines E1 (Psip1
f/+
) and E2 (Psip1
-/-
) were cross-correlated with HIV-1 integration data sets obtained from the same 
MEF lines (integration site sequencing data were obtained by others in our 
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laboratory). Ensembl TUs represented by probes on the arrays were divided into five 
equal bins based on relative expression level and integrations into TUs in each bin 
were counted (Figure 3.10). Integration strongly correlated with gene expression in 
E1 cells which express LEDGF endogenously (P ~ 10
-15
); this is consistent with 
published data showing that HIV-1 preferentially integrates into active genes 
(Mitchell et al., 2004; Schroder et al., 2002). The trend appears to break for genes 
expressed at the highest levels (Figure 3.10, f/+ bin 5) and this has also been noted in 
human cells (Mitchell et al., 2004). Overall, integration in E2 cells which are devoid 
of LEDGF displayed a weaker correlation with gene expression (P = 0.02 for the 
difference between E1 and E2). Although the frequency of integration into genes 
expressed at the lowest and highest levels (Figure 3.10, bins 1, 2 and 5) were not 
significantly affected by LEDGF ablation, there was an approximate 2-fold reduction 
in integration into genes expressed at medium to high levels (Figure 3.10, bins 3 and 
4). Thus, in LEDGF-null cells a large proportion of TU-specific integration events 
occured within genes that were expressed to lower levels. These results were 
published as part of collaborative work (Figure 5 in Shun et al., 2007). 
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Figure 3.10 – LEDGF directs HIV-1 integration to a subset of highly expressed genes 
Ensembl TUs ranked based on expression levels in E1 (f/+) and E2 (-/-) MEFs were divided into five 
equal bins of increasing expression: bin1 < bin2 < bin3 < bin4 < bin5; TUs that hosted HIV-1 or 
simulated random integration sites in each bin were counted.  The expression profile of E2 (-/-) cells 
were used to generate the random plot (dash line), which was almost indistinguishable from the plot 
generated using E1 (f/+) cell data (data not shown). (Note: 326 and 408 unique viral-chromosomal 
junctions were recovered from E1 and E2 cells, respectively, for use in integration site analyses.) 
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3.7 Discussion 
The initial isolation and characterisation of LEDGF suggested that it plays a role in 
transcriptional co-activation (Ge et al., 1998). Moreover, genomic distribution 
analyses of lentiviral integration sites suggest that LEDGF is associated with the 
majority of active transcription units (Mitchell et al., 2004; Schroder et al., 2002). 
Based on these observations, gene expression in LEDGF-null MEFs was studied in 
order to determine whether LEDGF plays a direct role in gene transcription.  
Gene expression profiling revealed that less than 200 genes were 
differentially expressed in LEDGF-null cells compared to controls. These analyses 
failed to identify specific pathways or target genes that would easily allow more 
detailed study of the possible cellular functions of LEDGF. The most striking result 
obtained from the gene expression profiling experiments was that very few genes 
were affected by ablation of LEDGF expression.  
The relatively small differences in gene expression profiles observed between 
Psip1
f/+
 and Psip1
-/-
 MEFs is in accord with the high prenatal survival rates of 
knockout animals (Sutherland et al., 2006). Interestingly, several of the genes 
identified as differentially expressed in LEDGF-null cells encode for proteins that are 
known to function during development, including members of the T-box (Tbx1), 
Homeo-box (Hoxb6, Hoxb5, Onecut2, Cutl1, Nkx6-1) and Forkhead-box (Foxf1a) 
families, bone morphogenic proteins (Bmp7) and proteins or targets linked to retinoic 
acid signalling (Crabp1, Rbp4, Mdk). Deregulation of these genes might explain the 
severe developmental abnormalities observed in LEDGF knockout mice (Sutherland 
et al., 2006) and suggests that LEDGF may have a role to play during embryonic 
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development. However, its specific function in development remains to be 
uncovered. 
Following identification of putative LEDGF-target genes by gene 
transcription profiling, relative expression levels of several of these genes were 
validated by qRT-PCR. Expression of a test set of genes in both primary and 
immortalised LEDGF-null and control MEFs was analysed. The majority of 
observed differences in gene expression were confirmed in primary and immortalised 
cells, withstanding at least 30 population doublings. Differences in gene expression 
levels were not stable following more than 22 passages of transformed MEF cultures 
for two of the genes studied (Crabp1 and Thbs4) indicating that changes in gene 
activity are not permanent in LEDGF-null cells. This observation suggests that at 
least some of the affected genes are regulated on several levels, some of which are 
independent of LEDGF.  
To further investigate the role of LEDGF in regulation of identified target 
genes and to distinguish its activity from that of p52, the Psip1
f/+ 
(LEDGF+) and 
Psip1
-/-
 (LEDGF-) MEFs were engineered to stably express HA-tagged forms of 
either LEDGF or p52. This approach was greatly hindered by the inability to obtain 
cells ectopically expressing LEDGF at levels close to that of endogenous protein in 
WT cells (Figure 3.7). Low-level expression of HA-tagged LEDGF in Psip1
-/-
 cells 
did not have a measurable effect on the expression of a set of model genes (Trim12, 
Tbx1, Thbs4 and Crabp1). Notably, expression of HA-tagged p52 in Psip1
-/-
 cells did 
not have an effect on expression of the tested genes either. One possible explanation 
is that expression of both LEDGF/p75 and p52 may be needed to affect gene 
expression; however, this is quite a remote one. 
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Failure to rescue gene expression in LEDGF-null cells by re-expressing 
LEDGF, albeit at levels below that of the endogenous protein, led to the hypothesis 
that the changes in gene expression observed may be linked to embryonic 
development in the absence of LEDGF and as such were irreversible in vitro. Thus 
far analysis of gene expression, by both transcription profiling and qRT-PCR, had 
been carried out using MEFs derived from Psip1
-/-
 embryos which had undergone 
stages of embryonic development in the absence of LEDGF and p52. To ascertain 
whether or not the identified gene expression changes were attributable to LEDGF 
(and/or p52) independently of embryonic development, expression of a set of model 
genes in Psip1
-/-
 MEFs, derived by transduction of Psip1
f/f
 MEFs with Cre 
recombinase under tissue culture conditions, was compared to that of Psip1
f/f
 MEFs 
transduced with catalytically impaired Cre. The expression level of Trim12 in Psip1
-/-
 
MEFs, derived by in vitro knockout methods, was equivalent to levels observed in 
control Psip1
f/f
 MEFs. This is in stark contrast to the effect seen in MEFs derived 
from Psip1
-/-
 embryos, in which the expression of Trim12 was practically ablated. 
Moreover, expression of Tbx1 was up-regulated 25- to 70-fold in MEFs derived from 
Psip1
-/-
 embryos while its expression was barely detectable in Psip1
-/-
 MEFs derived 
by in vitro knockout methods.  
Collectively, these data suggest that LEDGF does not directly control 
expression of the genes identified in this study. We hypothesise that the changes in 
gene expression observed in MEFs derived from Psip1
-/-
 embryos are due to these 
cells undergoing embryonic development in the absence of LEDGF and/or p52. In 
fact, many of the genes identified in this study as de-regulated in LEDGF-null MEFs 
are involved in developmental processes. 
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Several other possibilities need to be explored. Gene expression in cells that 
are not embryonic but rather derived from adult tissues may be affected differently 
by knockout or knockdown of LEDGF expression. Furthermore, several studies 
suggest a role for LEDGF in transcriptional activation of stress response genes 
(Fatma et al., 2001; Shin et al., 2008; Singh et al., 2001) and as such, analysis of 
gene expression in LEDGF-null and control cells that have been subjected to cellular 
stress may show a greater effect on gene expression than transcriptional profiling of 
cells growing under normal conditions. Additionally, the cells used in this study 
express HRP2, a close homologue of LEDGF (Cherepanov et al., 2004), which may 
compensate for the absence of LEDGF. 
Analyses of HIV-1 integration sites indicate that LEDGF is associated with a 
large body of active transcription units (Ciuffi et al., 2005; Crise et al., 2005; Llano 
et al., 2006a; Mitchell et al., 2004; Schroder et al., 2002; Shun et al., 2007). 
Furthermore, cross-correlation of gene expression and HIV-1 integration data 
obtained from LEDGF-null MEFs confirms that LEDGF directs integration to highly 
expressed genes. In spite of this association with transcriptionally active chromatin, 
LEDGF appears to have very little effect on gene transcription.  In this present study, 
less than 200 mouse genes were significantly up- or down- regulated in cells 
completely devoid of LEDGF suggesting that LEDGF does not play an essential role 
in regulation of gene expression, and it seems highly unlikely that LEDGF is a 
specific regulator of a subset of mouse genes. 
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4 Chapter IV: LEDGF interacts with the S-phase kinase 
Cdc7:ASK and stimulates its enzymatic activity 
 
4.1 Introduction 
The aim of this study was to identify novel cellular binding partners of LEDGF 
which could link it to an established cellular process. Similar approaches have 
previously led to the identification of other LEDGF-interacting proteins. LEDGF was 
found as a component of the menin:MLL (mixed-lineage leukaemia) histone methyl-
transferase complex and shown to be essential for MLL-dependent transcription 
regulation and oncogenesis (Yokoyama and Cleary, 2008). In addition, LEDGF is 
known to interact with JPO2 and PogZ, although the functions of either protein are 
currently unknown (Bartholomeeusen et al., 2009; Maertens et al., 2006). The 
identification of the heterodimeric S-phase kinase Cdc7:ASK as a novel cellular 
binding partner of LEDGF and functional analyses of this interaction will be 
presented in the chapter. 
 
4.2 Tandem Affinity Purification (TAP) of LEDGF interactors 
 
4.2.1 Development of human cells lines stably expressing cTAP-tagged proteins 
To identify novel cellular binding partners of LEDGF, human 293T cells were 
engineered to express cTAP-tagged forms of full-length LEDGF or its deletion 
mutants comprising its C-terminal (residues 326-530) or N-terminal (residues 1-176) 
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regions (Figure 4.1). The cTAP (C-terminal tandem affinity purification) tag used in 
this study consisted of two IgG-binding domains from Staphylococcus aureus protein 
A and a calmodulin binding peptide (CBP) separated by a tobaccoetch virus (TEV) 
protease cleavage site (Figure 4.1). The tag allows for the purification of protein 
complexes under native conditions and hence the identification of cellular interactors 
(Puig et al., 2001). 
 
PWWP IBD
NLS AT-hooks
1 93
148 156 178 197
347 429 530
LEDGF/p75 
CBP TEV ProtA
C-terminal TAP tag
CN
LEDGF1-176 LEDGF326-530
LEDGF1-530  
Figure 4.1 – Schematic of LEDGF-cTAP constructs 
Schematic showing the domain organisation of LEDGF indicating the PWWP domain, nuclear 
localisation signal (NLS), AT-hooks and the IN-binding domain (IBD). A schematic of the C-terminal 
tandem affinity purification (cTAP) tag is shown consisting of a calmodulin binding peptide (CBP) 
and two IgG-binding domains from Staphylococcus aureus protein A (ProtA) separated by a 
TobaccoEtch virus (TEV) protease cleavage site. Full-length LEDGF and its deletion mutants 
LEDGF(1-176) and LEDGF(326-530) are indicated. 
 
293T cells stably transfected with pGM-hLEDGF-cTAP, pGM-hLEDGF(1-
176)-cTAP or pGM-hLEDGF(326-530)-cTAP were selected with blasticidin S. 
Colonies of antibiotic-resistant cells were picked and expanded, and the resulting cell 
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lines were screened for expression of cTAP-tagged proteins by indirect 
immunofluorescence and Western blotting (Figure 4.2). Single cell clones termed 
293T-LEDGF-cTAP, 293T-LEDGF(1-176)-cTAP and 293T-LEDGF(326-530)-
cTAP were chosen for future experiments. The choice was based on the most 
uniform expression of the cTAP-tagged proteins as visualised by indirect 
immunofluorescence and high overall levels of protein expression as determined by 
Western blotting. 
LEDGF(1-176)- cTAP LEDGF(326-530)- cTAP LEDGF-cTAP
1      2      1    2    3    4       1      2 3
33 
73
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cTAP-tagged N 
and C-terminal  
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Figure 4.2 – Screening of 293T-cTAP stable clones by immunofluorescence and Western 
blotting 
(A) Expression of cTAP-tagged proteins, LEDGF(1-176)-cTAP, LEDGF(326-530)-cTAP and 
LEDGF-cTAP, in 293T stable clones was visualised by indirect immunofluorescence using anti-CBP 
primary and Alexa Fluor 488-conjugated secondary antibodies. (B) Detection of cTAP fusion proteins 
by Western blotting (WB). Migration positions of full-length LEDGF-cTAP, LEDGF(1-176)-cTAP 
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(N-terminal region), LEDGF(326-530)-cTAP (C-terminal region) and molecular mass markers are 
indicated. Cell lysate from untransfected parental 293T cells sereved as a negative control (first lane). 
(Note: Although LEDGF(1-176) and LEDGF(326-530) proteins are 176 amino acids and 205 amino 
acids, respectively, their predicted molecular mass is 20 kDa and 23 kDa, respectively. If the 
molecular mass of the cTAP tag is included (13 kDa), the difference in the electrophoretic mobility 
between proteins that are 33 kDa or 36 kDa is not distinguishable by Western blot. Furthermore, 
although full length LEDGF consistently migrates at 75 kDa by SDS-PAGE, its predicted molecular 
mass is 60 kDa, suggesting that other physical characteristics of this protein affect its electrophoretic 
mobility.) 
 
4.2.2 Tandem affinity purification of cellular proteins interacting with the C-
terminal portion of LEDGF 
The C-terminal portion of LEDGF (residues 326-530) encompasses the IBD 
(residues 347-429) (Cherepanov et al., 2004; Vanegas et al., 2005). Notably, the IBD 
not only mediates the interaction with lentiviral integrase proteins but is also required 
for interaction with cellular JPO2, PogZ and menin:MLL (Bartholomeeusen et al., 
2009; Maertens et al., 2006; Yokoyama and Cleary, 2008). The lack of the PWWP 
domain and A/T hooks, which collectively comprise the chromatin-binding module 
of LEDGF (Llano et al., 2006b; Shun et al., 2008; Turlure et al., 2006) allowed for 
gentle extraction of this protein fragment from cells without resorting to high-salt 
treatments. For these reasons, cell line 293T-LEDGF(326-530)-cTAP was chosen for 
identification of LEDGF interactors (Figure 4.3). 
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Figure 4.3 – Schematic of LEDGF(326-530)-cTAP 
 
293T-LEDGF(326-530)-cTAP and 293T-cTAP (expressing cTAP tag alone) 
cell lines were each grown to confluence in twelve 500-cm
2
 cell culture dishes. Cells 
were lysed and cTAP-tagged LEDGF fragment (with associated cellular proteins) 
was purified by successive capture on IgG sepharose beads, elution with TEV 
protease and binding to calmodulin affinity resin (a schematic of a cTAP tag-aided 
purification is given in Appendix C). Cellular proteins that bind the affinity resins or 
to the cTAP tag can be eliminated by comparison to proteins purified from 293T-
cTAP.  
Protein complexes isolated from 293T-LEDGF(326-530)-cTAP and 293T-
cTAP extracts were resolved on a 4-20% gradient polyacrylamide gel and detected 
by staining with colloidal Coomassie-G250 (Figure 4.4B). Three protein bands of 
interest from the 293T-LEDGF(326-530)-cTAP sample (Figure 4.4B: SH1, SH3 and 
SH5) approximately corresponding to migration positions of 70 kDa, 40 kDa and 22 
kDa were excised and submitted for identification by in-gel trypsin digestion 
followed by LC-MS/MS. Control slices from the 293T-cTAP sample (Figure 4.4B: 
SH2, SH4 and SH6) were analysed in parallel. Eight peptides unique to the 64 kDa 
protein cell division cycle 7 (Cdc7) kinase (Table 4.1) and one peptide unique to the 
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21 kDa heterochromatin protein 1γ (HP1γ: amino acids 21-34, 
KVEEAEPEEFVVEK) were identified in gel slices SH1 and SH5, respectively, and 
were absent from the equivalent control slices SH2 and SH6. In this analysis, only 
proteins yielding more than two unambiguous peptides were considered specific 
interactors. Cdc7 kinase was therefore identified as a strong candidate for further 
studies. 
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Figure 4.4 – Tandem affinity purification of proteins interacting with the C-terminal region of 
LEDGF 
Proteins interacting with the C-terminal region of LEDGF were purified from 293T cells engineered 
to express a cTAP-tagged form of LEDGF(326-530) by successive capture on IgG and calmodulin 
affinity resins.  
(A) Western blot analysis was used to monitor and optimise recovery of cTAP-tagged protein. cTAP-
tagged LEDGF(326-530) is detected in total cell lysate before purification (lane 1). Following binding 
of LEDGF(326-530)-cTAP to IgG, a portion of the protein is lost in the supernatant (lane 2). After 
extensive washing of unbound protein, LEDGF(326-530)-cTAP is cleaved from the IgG beads by 
TEV protease and can be detected in supernatant (lane 3). No protein is detected in the pelleted IgG 
beads after TEV protease treatment (lane 4), indicating complete cleavage. Similarly, no protein is 
detected in the supernatant following binding of cleaved LEDGF(326-530)-cTAP to the calmodulin 
resin (lane 5), indicating that all the protein has been efficiently captured. (B) Protein complexes 
isolated from 293T cells expressing LEDGF(326-530)-cTAP or the cTAP tag alone (control sample) 
were resolved on a 4-20% gradient polyacrylamide gel, stained with colloidal Coomassie-G250 and 
bands of interest (SH1 – SH6, indicated with arrows) were excised for analysis by in-gel tryptic 
digestion and LC-MS/MS. Protein bands highlighted in orange boxes indicate cTAP or LEDGF(326-
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530)-cTAP proteins. Candidate LEDGF-interacting protein Cdc7 kinase was identified from gel slice 
SH1 and was not detected in control slice SH2.  
 
Table 4.1 – Cdc7-specific peptides identified in the material co-purified with LEDGF(326-530)-
cTAP 
Cdc7-specific peptides were detected and confirmed by LC-MS/MS; their locations within the 
sequence of human Cdc7 are shown. 
 
Location  Sequence 
91-100 HLIPTSHPIR 
177-187 DVKPSNFLYNR 
228-244 SHIITGNKIPLSGPVPK 
258-268 RPYTNAQIQIK 
313-319 TVDVLSR 
417-431 ASDDLTALAQIMTIR 
475-492 LTSDIQGHASHQPAISEK 
549-557 LLDLNPASR 
 
 
4.3 LEDGF interacts with Cdc7:ASK in human cells 
 
4.3.1 Immunoprecipitation experiments confirm that LEDGF interacts with the 
Cdc7:ASK complex 
Following initial identification of Cdc7 as a cellular binding partner of LEDGF, a 
series of IP experiments were carried out to validate and analyse this interaction. 
Firstly, IP of HA-tagged LEDGF and Western blot analysis of co-
immunoprecipitated proteins confirmed the interaction of Cdc7 kinase with LEDGF. 
Whole cell extracts from HeLa cells transfected with HA-tagged forms of mouse 
LEDGF or p52, human LEDGF, LEDGF(326-530) or HRP2 were incubated with 
anti-HA affinity resin. Bound HA-tagged proteins and co-immunoprecipitated 
proteins were analysed by Western blotting (Figure 4.5). Whole cell extract from 
cells transfected with an empty vector was used as a negative control. Both HA-
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tagged mouse and human LEDGF as well as the C-terminal fragment of LEDGF co-
immunoprecipitated endogenous Cdc7 kinase (Figure 4.5, lanes 7, 8 and 9). Mouse 
and human LEDGF proteins are highly similar, sharing 92.3% amino acid sequence 
identity; furthermore, their IBD and PWWP domains are identical (Shun et al., 
2007). Importantly, Cdc7 kinase was not recovered with p52-HA, which lacks the 
IBD, or from the vector control condition (Figure 4.5, lanes 11 and 12). In addition, 
HA-HRP2 also co-immunoprecipitated Cdc7 kinase (Figure 4.5, lane 10). Similar to 
LEDGF, HRP2 contains a functional IBD within its C-terminal region (Cherepanov 
et al., 2004). In contrast, β-actin was not detected in any of the precipitates, 
confirming specificity of the co-IP experiments.  
As expected, JPO2, a known interactor of LEDGF (Maertens et al., 2006), co-
immunoprecipitated with full-length human and mouse LEDGF (Figure 4.5, lanes 7 
and 8). Interestingly, a significant fraction of JPO2 recovered in immunoprecipitates 
of human HA-LEDGF displayed an altered mobility in SDS PAGE gels (Figure 4.5, 
lane 8). Thus, over-expression of human HA-LEDGF probably results in a post-
translational modification of JPO2; the mobility change would be consistent with 
ubiquitination or sumoylation. JPO2 was also recovered from extracts containing 
HA-HRP2 (Figure 4.5, lane 10). The JPO2-HRP2 interaction was not unexpected 
due to the presence of a conserved IBD in the latter. Of note, expression of the C-
terminal portion of LEDGF (residues 326-530) resulted in reduction of endogenous 
JPO2 levels (experimental observations). This likely explains why JPO2 was neither 
co-purified with LEDGF(326-530)-cTAP (Section 4.2.2) nor co-immunoprecipitated 
with HA-LEDGF(326-530) (Figure 4.5, lane 9). In contrast, HP1γ did not co-
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immunoprecipitate with any of the HA-tagged proteins, which was not unexpected as 
only one HP1γ peptide was detected by LC-MS/MS analyses (Figure 4.5).  
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Figure 4.5 – Anti-HA IP experiments confirming the interaction between LEDGF and Cdc7 in 
human cells 
Total soluble cell extract (SCE) and anti-HA immunoprecipitate (IP) from HeLa cells expressing C-
terminal HA-tagged murine LEDGF (mLEDGF-HA), N-terminal HA-tagged human LEDGF (HA-
LEDGF), N-terminal HA-tagged LEDGF(326-530) (HA-LEDGF(326-530)), N-terminal HA-tagged 
HRP2 (HA-HRP2) and C-terminal HA-tagged murine p52 (mp52-HA) and from cells transfected with 
an empty vector control (mock) were analysed by Western blotting with anti-HA, anti-Cdc7, anti-
JPO2, anti-HP1γ and anti-β-actin antibodies. β-actin served as a specificity control. Migration 
positions of protein molecular mass standards (kDa) and the heavy chain of mouse IgG (IgG H) are 
indicated. 
 
During S phase, Cdc7 associates with its regulatory subunit Dbf4, typically 
referred to as activator of S-phase kinase (ASK) in humans, to phosphorylate 
components of the MCM complex (Masai and Arai, 2002). The following set of IP 
experiments was used to determine whether ASK is part of the LEDGF-Cdc7 
complex.  
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HeLa TetOff cells were engineered to stably express HA-tagged or non-
tagged LEDGF under the control of a tetracycline responsive promoter by 
transfection with linearised pTRE-HA75-hyg or pTRE-75-hyg. Single cell clones 
showing robust expression of HA-LEDGF (Cell line H3) or non-tagged LEDGF 
(Cell line N3) upon withdrawal of doxycycline were used for IP experiments. These 
cells could be routinely passaged in the absence of doxycycline and stably expressed 
HA-LEDGF or non-tagged LEDGF. 
Extracts from H3 or N3 cells were incubated with anti-HA affinity matrix and 
the resulting immunoprecipitate analysed by Western blotting (Figure 4.6A). To 
detect ASK, a hyperphosphorylated cellular protein, it was necessary to treat the 
immunoprecipitates with λPPase. Both Cdc7 and ASK co-precipitated with HA-
LEDGF (Figure 4.6A, lane 4). Importantly, neither Cdc7 nor ASK were recovered in 
anti-HA immunoprecipitates from N3 cell extracts (Figure 4.6A, lane 3).  
Reciprocally, extracts from cells stably expressing HA-LEDGF were 
incubated with a rabbit anti-ASK antibody or a rabbit IgG control antibody, the 
resulting immunoprecipitate was treated with λPPase and then analysed by Western 
blotting (Figure 4.6B). Endogenous ASK protein was successfully 
immunoprecipitated from these cells and Cdc7 was co-purified with its regulatory 
subunit as expected (Figure 4.6B, lane 2). A detectable, albeit relatively low, amount 
of HA-LEDGF could be co-immunoprecipitated with Cdc7:ASK (Figure 4.6B, lane 
2). Importantly, none of the proteins were immunoprecipitated using the control 
antibody (Figure 4.6B, lane 3).  
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Figure 4.6 – HA-LEDGF interacts with the Cdc7:ASK complex in human cells 
(A) Total soluble cell extract from HeLa TetOff cells stably expressing HA-LEDGF or non-tagged 
LEDGF were incubated with anti-HA affinity matrix and the resulting immunoprecipitate analysed by 
Western blotting. Samples were treated with λPPase to facilitate detection of ASK by Western blot. 
Both ASK and Cdc7 can be detected in the soluble cell extract of cells stably expressing non-tagged 
LEDGF (lane 1) or HA-LEDGF (lane 2). The Cdc7:ASK complex is co-immunoprecipitated with 
HA-LEDGF (lane 4) but not with non-tagged LEDGF (lane 3). (B) Total soluble cell extract from 
HeLa TetOff cells stably expressing HA-LEDGF were incubated with rabbit anti-ASK antibody (lane 
2) or a rabbit IgG control antibody (lane 3) in the presence of protein G agarose and the resulting 
immunoprecipitate analysed by Western blotting. Samples were treated with λPPase to facilitate 
detection of ASK by Western blot. Over-expressed HA-LEDGF is detected using anti-HA antibody. 
ASK, Cdc7 and HA-LEDGF are detected in the soluble cell extract (lane 1). As expected, endogenous 
Cdc7 is co-immunoprecipitated with endogenous ASK (lane 2) but not with the control antibody (lane 
3). HA-LEDGF is co-immunoprecipitated with the Cdc7:ASK complex (lane 2) but is not detected in 
the immunoprecipitate from the control antibody (lane 3). ASK protein bands are indicated by a star, 
immunoprecipitated HA-LEDGF is indicated by a cross. 
 
Finally, the interaction between LEDGF and Cdc7:ASK was confirmed by IP 
of endogenous proteins. Extracts from untransfected 293T cells were incubated with 
a rabbit anti-LEDGF antibody or a rabbit IgG control antibody and the resulting 
immunoprecipitates were treated with λPPase and analysed by Western blotting 
(Figure 4.7). Endogenous LEDGF was readily recovered using the anti-LEDGF 
antibody (Figure 4.7, lane 3), and both endogenous Cdc7 and ASK were co-
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immunoprecipitated (Figure 4.7, lane 3). Importantly, none of the proteins were 
detected in the control immunoprecipitate (Figure 4.7, lane 4).  
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Figure 4.7 – Endogenous LEDGF interacts with endogenous Cdc7:ASK complex in human cells 
Extracts from untransfected 293T cells were incubated with rabbit anti-LEDGF antibody (lane 3) or 
control rabbit IgG (lane 4) and protein G agarose, and the recovered proteins were analysed by 
Western blotting with anti-Cdc7 and anti-ASK antibodies. Lanes 1 and 2 contained total soluble cell 
extract; LEDGF, Cdc7 and ASK are readily detected. To improve detection of ASK, the samples in 
lanes 2-4 were treated with λPPase. Comparison of untreated and λPPase treated soluble cell extract 
shows the shift observed when ASK is dephosphorylated (compare lanes 1 and 2). λPPase treatment 
did not affect migration of LEDGF or Cdc7 (data not shown). Endogenous Cdc7:ASK complex is co-
immunoprecipitated with endogenous LEDGF (lane 3), while none of the proteins are detected in the 
immunoprecipitate from the control antibody (lane 4). The bands corresponding to ASK are indicated 
with a star. 
 
4.3.2 Intracellular distribution of endogenous LEDGF and Cdc7 proteins 
LEDGF is a nuclear protein that displays a heterogeneous distribution pattern and 
concentrates on condensed chromosomes during mitosis (Cherepanov et al., 2003; 
Maertens et al., 2003; Nishizawa et al., 2001; Ochs et al., 2000). Similarly, in 
accordance with its function during DNA replication, Cdc7 is a nuclear protein (Kim 
et al., 2007; Sato et al., 2003).  
The cellular distributions of endogenous LEDGF and Cdc7 kinase in HeLa 
cells were visualised by indirect immunofluorescence and confocal microscopy. 
With exception of cells in G2 and M phases of the cell cycle, endogenous LEDGF 
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and Cdc7 displayed similar intracellular distributions, co-localising in nuclei (Figure 
4.8B). During G2 and M phases however, LEDGF was tightly associated with, while 
Cdc7 was excluded from, condensed chromosomes (Figure 4.8A), indicating that the 
interaction between LEDGF and Cdc7 is cell cycle dependent. This result is not 
unexpected, as the function of Cdc7 and its activity fluctuate during the cell cycle. In 
particular, the abundance of its regulatory subunit, ASK, is lowest during G2/M 
(Kumagai et al., 1999). Moreover, in human cells, both Cdc7 and ASK chromatin 
association is maximal during S phase, while both proteins are excluded from 
chromatin during G2/M phase (Sato et al., 2003). Furthermore, Cdc7 starts to 
accumulate in nuclei when chromosomes become decondensed in early G1 phase 
while ASK starts to accumulate in nuclei at telophase (Sato et al., 2003).  
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Figure 4.8 – Intracellular distribution of endogenous LEDGF and Cdc7 proteins during the cell 
cycle 
Intracellular distribution of endogenous LEDGF and Cdc7 proteins in HeLa cells was visualised by 
indirect immunofluorescence and confocal laser-scanning microscopy.  
(A) Cdc7 appears to be excluded from condensed chromatin and exhibits a pan-cellular distribution, 
while LEDGF is tightly associated with condensed chromosomes during G2/M phase of the cell cycle. 
(B) LEDGF and Cdc7 show similar nuclear distributions in non-dividing cells. The insets in the 
bottom three micrographs in panel B show a portion of the nucleus at a higher magnification. 
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4.4 Expression and purification of recombinant Cdc7:ASK 
To characterise the interaction between LEDGF and the Cdc7:ASK complex, 
biochemical analyses using recombinant protein were undertaken. Firstly, a method 
had to be established for production of recombinant Cdc7:ASK heterodimer.  
 Our initial attempts involved separate production of Cdc7 and ASK proteins 
in SF9 insect cells using recombinant baculoviruses and in bacteria. Expression of 
Cdc7 and ASK was very low in SF9 insect cells and purification of the recombinant 
proteins was unsuccessful from this expression system (data not shown). On the 
other hand, bacterial expression appeared more promising and could eventually be  
optimised for production of high-quality preparations of Cdc7:ASK. 
Rosetta 2 (DE3) E. coli (Novagen) strain was chosen for protein expression. 
This host strain, derived from BL21 E. coli (Studier and Moffatt, 1986), expresses 
artificial tRNAs for 7 codons that are rarely used by E. coli but often occur in 
eukaryotic cDNAs and is therefore expected to enhance expression of eukaryotic 
proteins. Firstly, attempted purification of separately expressed His6-SUMO-Cdc7 
and His6-SUMO-ASK failed to produce either protein (data not shown). Next, N-
terminal glutathione S-transferase (GST) fusion proteins were produced. GST-Cdc7 
fusion protein was well expressed and very soluble, such that considerable quantities 
could be isolated from bacteria. Furthermore, following cleavage of the GST tag, 
non-tagged Cdc7 protein could be obtained. GST-ASK, however, was insoluble and 
could not be found in supernatants following disruption of bacteria. GST-ASK was 
therefore purified from the bacterial pellets by solubilisation with N-lauroyl 
sarcosine and the protein re-folded following extraction (Marston and Hartley, 1990). 
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Using this method, sufficient amounts of GST-ASK fusion protein was obtained, 
however, cleavage of the GST tag caused the protein to precipitate. The ability of 
bacterially produced GST-Cdc7:GST-ASK to phosphorylate MCM2(1-287), a 
known Cdc7:ASK substrate (Cho et al., 2006; Ishimi et al., 2001), was analysed by 
incorporation of radioactive phosphate in an in vitro kinase assay. This analysis 
showed that the kinase complex obtained by mixing the individually produced 
proteins was enzymatically incompetent (Figure 4.9, lane 4).  
Next, in order to obtain preparations of active kinase, co-expression of Cdc7 
and ASK was attempted. Several affinity tags were screened in various 
combinations; N-terminal hexa-histidine tagged ASK (His6-ASK) and GST-Cdc7 
were co-purified giving GST-Cdc7:His6-ASK and Cdc7:His6-ASK when the GST tag 
was cleaved, Cdc7 with a C-terminal S-tag (Cdc7-S-tag) was co-purified with N-
terminal maltose binding protein (MBP) tagged ASK giving Cdc7-S-tag:MBP-ASK 
and Cdc7-S-tag was co-purified with His6-ASK giving Cdc7-S-tag:His6-ASK. All 
kinase complexes produced by co-expression were active (Figure 4.9, lanes 1-3). 
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Figure 4.9 – Kinase activity of bacterially produced Cdc7:ASK complexes 
10 ng of GST-Cdc7:His6-ASK (lane 1), Cdc7-S-Tag:MBP-ASK (lane 2) or Cdc7-S-Tag: His6-ASK 
(lane 3) were incubated with 0.5 µg of GST-MCM2(1-287) in the presence of [γ-32P]ATP. In lane 4, 
10 ng of GST-Cdc7:GST-ASK complex obtained by combining the individually produced proteins 
was assayed under the same conditions described above. Reaction products, separated by SDS PAGE, 
were detected by phosphorescence imaging. Migration positions of phosphorylated His6-ASK (His6-
ASK-P), GST-Cdc7 (GST-Cdc7-P), GST-MCM2(1-287) (MCM2-P) and Cdc7-S-Tag (Cdc7-S-Tag-
P) are indicated.  
 
For optimised production of active kinase the following protocol was 
established. Rosetta 2 (DE3) E. coli (Novagen) were co-transformed with pRSF-
CDC7-S-Tag and pCDF-His-Dbf4 expressing Cdc7-S-Tag and His6-ASK, 
respectively. Protein expression in exponentially growing bacterial cultures (6 L) was 
induced by addition of 0.3 mM IPTG at 18°C for 3 hours. Reduced temperature and 
limited induction time were used to minimise protein degradation in the bacteria. 
Harvested bacteria were lysed in a phosphate buffer supplemented with glycerol 
which usually helps in purification of large protein complexes. Mild non-ionic 
detergent (NP40) was used to aid extraction of soluble protein. Additionally, 
phosphatase inhibitors were used throughout the purification. The kinase complex 
was purified from clarified bacterial lysate by capture of the hexa-histidine tag, 
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present at the N-terminus of ASK using Ni-NTA agarose. The kinase heterodimer 
was further purified by anion exchange followed by size exclusion chromatography 
to yield sufficient quantities of highly pure Cdc7:ASK holoenzyme (Figure 4.10 and 
Figure 4.11). Of note, recombinant Cdc7:ASK was consistently obtained in a 
partially phosphorylated form due to auto-phosphorylation during protein production 
in bacteria. ASK migrated as a diffuse double band in SDS PAGE gels indicating the 
presence of multiple phosphorylated forms (Figure 4.11B, discussed in more detail in 
Section 4.6).  
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Figure 4.10 – Anion exchange chromatography 
Recombinant Cdc7:ASK complex isolated from bacterial lysate by capture of the hexa-histidine tag at 
the N-terminus of ASK was eluted from Ni-NTA agarose with 200 mM imidazole and the diluted 
eluant applied to a 5-ml HiTrapQ column (GE Healthcare). Following extensive washing, charged 
proteins bound to the anion exchange resin were eluted with a linear 0.1 – 0.5 M gradient of NaCl. 
Chromatogram (A) shows protein contaminants and Cdc7:ASK complex eluted from the column (blue 
trace) with increasing salt concentration (the green line represents the applied salt gradient while the 
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brown line is an actual measure of the salt concentration flowing out of the column). Fraction numbers 
are indicated in red. (B) Protein fractions were analysed by SDS PAGE. Proteins separated by SDS-
PAGE (11% gel) were visualised with Commassie blue, Cdc7:ASK complex was present in fractions 
27-32. 
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Figure 4.11 – Size exclusion chromatography 
Recombinant Cdc7:ASK isolated from bacterial lysate by incubation with Ni-NTA agarose and then 
purified by anion exchange chromatography was further purified by size exclusion chromatography to 
yield a highly pure Cdc7:ASK holoenzyme. Proteins are separated by size with larger proteins (or 
protein complexes) eluting from the column first. Chromatogram (A) shows good separation of 
Cdc7:ASK complex from smaller contaminating proteins (blue trace). Fraction numbers are indicated 
in red. (B) Cdc7:ASK containing fractions were analyse by SDS PAGE. Proteins separated by SDS-
PAGE (11% gel) were visualised with Commassie blue. 
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4.5 The LEDGF-Cdc7:ASK interaction is mediated by the IBD of 
LEDGF and requires the C-terminus of ASK 
To characterise the interaction between LEDGF and Cdc7:ASK, a series of in vitro 
pull-down experiments using recombinant proteins were carried out. As it was 
necessary to co-express Cdc7 and ASK to obtain preparations of active kinase 
(Section 4.4), the interaction of these proteins with LEDGF was studied in the 
context of the Cdc7:ASK heterodimer.  
The holoenzyme, produced with an S-tag fused to the C-terminus of Cdc7 
could be efficiently captured on S-protein agarose resin. Typical pull-down 
experiments were therefore performed as follows; bacterially produced Cdc7:ASK 
and LEDGF proteins were incubated with S-protein agarose for 3 – 4 hours and 
following extensive washing, protein complexes captured by the resin were analysed 
by SDS PAGE and specific proteins monitored by Western blotting. 
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4.5.1 The IBD of LEDGF is minimally sufficient for the interaction with 
Cdc7:ASK 
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Figure 4.12 – Schematic of LEDGF deletion mutants 
 
 
Full-length LEDGF, LEDGFΔIBD and a series of N-terminal truncations of LEDGF 
(see Figure 4.12 for schematic of deletion mutants) were incubated with Cdc7:ASK 
in the presence of S-protein agarose. Captured proteins were separated by SDS 
PAGE and visualised by coomassie staining (Figure 4.13). Interactions were 
confirmed by Western blotting with anti-LEDGF antibodies. Cdc7:ASK partially 
recovered full-length LEDGF from solution (Figure 4.13, lanes 6 and 7). Of note, 
addition of ATP to pull-down reactions led to increased phosphorylation of Cdc7 and 
ASK subunits, manifesting as upward mobility shifts (discussed in more detail in 
Section 4.6), and modestly improved recovery of LEDGF (Figure 4.13, compare 
lanes 6 and 7). N-terminally truncated mutants LEDGF(146-530) and LEDGF(347-
530) were also pulled down with Cdc7:ASK (Figure 4.13, lanes 10-13; see Figure 
 169 
4.12 for schematic of deletion mutants) as were LEDGF(226-530), LEDGF(249-530) 
and LEDGF(291-530) (data not shown). These results are consistent with the original 
co-purification of the kinase with LEDGF(326-530)-cTAP (section 4.2.2) and co-IP 
experiments described in Section 4.3.1; the smallest LEDGF fragment used (residues 
347-530) retains the ability to interact with Cdc7:ASK as did LEDGF(326-530)-
cTAP and HA-LEDGF(326-530), all of which span the IBD. The interaction clearly 
requires the IBD, as Cdc7:ASK failed to pull down LEDGFΔIBD, lacking only the 
IBD (Figure 4.13, lanes 8 and 9). 
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Figure 4.13 – The interaction with Cdc7:ASK is mediated by the IBD of LEDGF 
S-tagged Cdc7:ASK was incubated with S-protein agarose and full-length LEDGF (1-530, lanes 6 and 
7), LEDGFΔIBD (lanes 8 and 9), LEDGF(146-530) (lanes 10 and 11) and LEDGF(347-530) (lanes 12 
and 13) in the absence (lanes 6, 8, 10 and 12) or presence (lanes 7, 9, 11 and 13) of 4 mM ATP. 
Proteins bound to beads were separated by SDS PAGE and visualised by staining with Coomassie 
Blue (top panel) and Western blotting with rabbit anti-LEDGF antibody recognising the C-terminus of 
LEDGF (bottom panel). Lanes 1-5 contained input quantities of Cdc7:ASK (lane 1), full-length 
LEDGF (lane 2), LEDGFΔIBD (lane 3), LEDGF(146-530) (lane 4) or LEDGF(347-530) (lane 5). 
Migration positions of molecular mass markers (kDa), LEDGF, LEDGF(146-530), LEDGF(347-530), 
ASK, Cdc7 and their hyperphosphorylated forms (ASK-P and Cdc7-P) are indicated. Asterisk 
indicates the band of full-length LEDGF on the Coomassie-stained gel. 
 
 Additional pull-down experiments confirmed that the IBD is minimally 
sufficient for the interaction with Cdc7:ASK. Firstly, Cdc7:ASK was incubated with 
isolated IBD (residues 347-435) and S-protein agarose in the presence of 4 mM ATP 
(Figure 4.14A). Captured proteins were separated on a tricine SDS PAGE gel, which 
allows for detection of smaller proteins, and visualised by silver staining. As 
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expected, Cdc7:ASK recovered isolated IBD from solution (Figure 4.14A, lane 5). 
As a negative control, isolated IBD was incubated with S-protein agarose in the 
absence of Cdc7:ASK and as expected was not pulled down (Figure 4.14A, lane 6). 
Additionally, full-length LEDGF was recovered from solution as expected (Figure 
4.14A, lane 4).  
 A reciprocal GST pull-down experiment was carried out with GST fusions of 
isolated LEDGF (residues 347-471) and HRP2 (residues 470-593) IBDs (Figure 
4.14B). GST-LEDGF(347-471), GST-HRP2(470-593) or GST alone were incubated 
with glutathione sepharose overnight, following which Cdc7:ASK was incubated 
with the pre-loaded beads in the presence of 4mM ATP. Captured proteins were 
separated by SDS PAGE and visualised by staining with Coomassie Blue and 
analysed by Western blotting (an anti-Cdc7 antibody was used to detect Cdc7 while 
an anti-His5 antibody was used to detect the hexa-histidine tag present at the N-
terminus of ASK). Both GST-LEDGF(347-471) and GST-HRP2(470-593), but not 
GST alone, recovered Cdc7:ASK from solution (Figure 4.14B, lanes 5, 6 and 7). 
Although visualisation of pulled down Cdc7 and ASK by Coomassie Blue was weak; 
Western blotting confirmed the interaction. 
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Figure 4.14 – The IBD is sufficient for the interaction with Cdc7:ASK 
Pull-down experiments showing that the IBD is minimally sufficient for the interaction with 
Cdc7:ASK.  
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(A) Isolated IBD was incubated with Cdc7:ASK and S-protein agarose in the presence of 4 mM ATP 
(lane 5). Isolated IBD incubated with S-protein agarose alone (lane 6) served as a negative control 
while LEDGF incubated with Cdc7:ASK and S-protein agarose (lane 4) served as a positive control. 
Lanes 1-3 contained input quantities of the indicated proteins. Proteins captured on beads were 
separated in a 10-20% Tricine gel and visualised by silver staining. The migration position of full-
length LEDGF is indicated with an asterisk. (B) Reciprocally, GST-fusions of isolated LEDGF and 
HRP2 IBDs can recover Cdc7:ASK from solution. Cdc7:ASK was incubated with glutathione 
sepharose beads preloaded with GST-LEDGF(347-471) (lane 5), GST-HRP2(470-593) (lane 6) or 
GST (lane 7). Proteins bound to the resin were separated by SDS PAGE and visualised by staining 
with Coomassie Blue (top panel) and Western blotting with anti-Cdc7 or anti-His5 antibodies (bottom 
panels). Lane 8 contains a mock pull-down in the absence of a GST protein. Lanes 1-4 contained input 
quantities of the indicated proteins. 
 
 Finally, GST-LEDGF(347-471) (GST-IBD) was shown to compete with full-
length LEDGF for binding to Cdc7:ASK. Cdc7:ASK and full-length LEDGF were 
incubated with increasing amounts of GST-LEDGF(347-471) (Figure 4.15, lanes 6 – 
9) or GST alone (Figure 4.15, lanes 10 – 13) in the presence of S-protein agarose and 
competition for binding to Cdc7:ASK analysed by in vitro pull-down. Increasing 
input of GST-LEDGF(347-471) inhibited recovery of LEDGF, with a concomitant 
increase of the competitor protein in the pull-down fraction (Figure 4.15, lanes 6 – 
9). In contrast, addition of GST to the pull-down reaction had no effect on recovery 
of LEDGF (Figure 4.15, lanes 10 – 13). 
 174 
130
100
70
55
35
LEDGF
GST-IBD
input
pull down (4 mM ATP)
WB: α LEDGF 
1 2 3 4 5 6 7 8 9 10 11 12 13
GST-IBD GST
kDa
 
Figure 4.15 – LEDGF IBD competes with full-length LEDGF for binding to Cdc7:ASK 
Cdc7:ASK (100 nM) was incubated with 200 nM LEDGF, 4 mM ATP and S-protein agarose in the 
absence (lane 5) or presence of 120-960 nM GST-LEDGF(347-471) (GST-IBD, lanes 6-9) or GST 
(lanes 10-13). Proteins bound to the beads were separated by SDS PAGE and visualised by staining 
with Coomassie Blue (top panel) or Western blotting with anti-LEDGF antibody (bottom panel). 
Lanes 1-4 contained input proteins. Migration of protein molecular mass standards is indicated to the 
left of the Coomassie-stained gel; migration of LEDGF and GST-IBD are indicated to the right. 
 
4.5.2 The C-terminus of ASK is required for the interaction with LEDGF 
Having established that the IBD of LEDGF mediates the interaction with Cdc7:ASK, 
truncation of the kinase regulatory subunit coupled with in vitro pull-down 
experiments was used to ascertain which parts of the Cdc7:ASK holoenzyme were 
important for the interaction with LEDGF.  
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Figure 4.16 – Schematic of ASK deletion mutants 
Domain organisation of full-length ASK (1-674) and its N- and C-terminal deletion mutants are 
shown with conserved Dbf4 motifs N, M and C indicated. 
 
 Dbf4/ASK orthologues from various species are surprisingly divergent with 
only three conserved regions identified, termed Dbf4 motifs N, M and C (Kumagai et 
al., 1999; Masai and Arai, 2000; Takeda et al., 1999). A small fragment of human 
ASK spanning motifs M and C (residues 174-350) was shown to be minimally 
sufficient for binging to and activation of Cdc7 kinase activity (Sato et al., 2003). 
Indeed, co-expression of Cdc7 with ASK(174-350) (see Figure 4.16 for schematic of 
ASK deletion mutants) in bacteria allowed isolation of a stable, enzymatically-
competent complex. However, in contrast to the WT heterodimer, Cdc7:ASK(174-
350) failed to interact with LEDGF (Figure 4.17, compare lanes 6 and 7). This 
indicated that the N- and/or C-terminal portions of ASK are required for the 
interaction with LEDGF. Two further kinase heterodimers were produced, 
Cdc7:ASK(1-350) and Cdc7:ASK(174-674) (Figure 4.16), containing C- and N-
terminally truncated ASK, respectively. Pull-down analyses revealed that the N-
terminal region of ASK was dispensable for the interaction with LEDGF, while 
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removing the C-terminal region of ASK ablated the interaction (Figure 4.17, lanes 8 
and 9).  
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Figure 4.17 – The C-terminal region of ASK is required for the interaction with LEDGF 
S-tagged Cdc7:ASK or its indicated mutant forms were incubated with S-protein agarose in the 
presence (lanes 6-9) or absence (lanes 10-13) of LEDGF. Lane 14 contains a mock pull-down of 
LEDGF with S-protein agarose. Input quantities of proteins (lanes 1-5) or proteins captured on the 
beads (lanes 6-14) separated by SDS PAGE were stained with Coomassie Blue (top panel) and 
analysed by Western blotting using anti-LEDGF antibody (bottom panel). LEDGF detected in pull-
down samples by Coomassie staining is indicated by an asterisk . 
 
To further define the region of ASK required for interaction with LEDGF, 
finer truncations of the C-terminal region of ASK were made. PHYRE structural 
prediction software (Kelley and Sternberg, 2009) was used to aid the design of 
truncation mutants (see Figure 4.16 for schematic of ASK truncations) and constructs 
were designed such that all truncations terminated with at least one hydrophilic 
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residue to aid protein folding and stability in bacteria. The C-terminal region of ASK 
is predicted to be largely unstructured, composed of several helical structures linked 
by coiled regions (Figure 4.18). Deletion of 50 residues from the C-terminus of ASK, 
eliminated a predicted α helical bundle at the very C-terminus of ASK, while 
preserving a helix spanning residues 615-623, resulted in ASK(1-624) construct 
(Figure 4.18A). Removal of 133 residues, eliminating a further three predicted α 
helices and a β-strand, resulted in ASK(1-541) (Figure 4.18B). 
178 
 
620 630 640 650 660 670
Residue no.
Sequence
T624
E541
Residue no.
Sequence
540 550 560 570 580 590 600 610 620 624
A
B
674
 
Figure 4.18 – Predicted secondary structure elements in the C-terminal region of ASK 
Phyre structural prediction software (Kelley and Sternberg, 2009) was used to predict the secondary folded structure of the C-terminal region of ASK based on its 
amino acid sequence using several available algorithms. Predicted structural motifs were used to guide truncation of the C-terminus. (A) Removal of 50 C-
terminal residues gives ASK(1-624) in which 2 predicted α-helices are removed. (B) Removal of 133 C-terminal residues gives ASK(1-541) in which a further 3 
predicted α-helices and a predicted β-strand are removed. Predicted α-helices (h) are shown in red, predicted β-strands (e) are shown in blue and coiled domains 
(c) are shown in grey. Residue numbering is shown atop the alignment. The bottom line gives the confidence (ranging from 1 to 9) of the predicted secondary 
structure.
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Co-expression of ASK(1-624) and ASK(1-541) with Cdc7 in bacteria 
produced ezymatically active kinases. Pull-down analyses revealed that deleting as 
few as 50 C-terminal residues of ASK was sufficient to ablate binding to LEDGF 
(Figure 4.19, compare lanes 6 and 7). Thus, residues 625-674 at the very C-terminus 
of ASK are essential for the interaction with LEDGF. 
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Figure 4.19 – Residues 625-674 of ASK are required for binding to LEDGF 
Deletion of 50 residues from the C-terminus of ASK is sufficient to ablate the interaction with 
LEDGF. Cdc7:ASK or its mutants were incubated with S-protein agarose in the presence (lanes 6-9) 
or absence (lanes 10-13) of LEDGF. LEDGF was incubated with S-protein agarose alone in lane 14. 
Lanes 1-5 contained input levels of the indicated proteins. Input quantities of proteins (lanes 1-5) or 
proteins captured on the beads (lanes 6-14) separated by SDS PAGE were stained with Coomassie 
Blue (top panel) and analysed by Western blotting using anti-LEDGF antibody (bottom panel). 
LEDGF detected in pull-down samples by Coomassie staining is indicated by an asterisk. 
 
4.6 Phosphorylation state of Cdc7:ASK affects its interaction with 
LEDGF 
Recombinant Cdc7:ASK was consistently purified in a partially phosphorylated 
form, due to auto-phosphorylation in bacteria and subsequent purification in the 
presence of phosphatase inhibitors. Notably, ASK migrated as a diffuse double band 
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in SDS PAGE gels (Figure 4.20, lane1), indicating the presence of multiple 
phosphorylated forms. Incubation of purified Cdc7:ASK heterodimer with 4 mM 
ATP prior to pull-down resulted in further auto-phosphorylation, observed as upward 
SDS PAGE mobility shifts of ASK and Cdc7 bands (Figure 4.20, compare lanes 3 
and 5). Conversely, dephosphorylation of the heterodimer with λPPase prior to pull-
down on S-protein agarose resulted in pronounced downward mobility shifts in SDS 
PAGE gels (Figure 4.20, compare lanes 3 and 7). Of note, dephosphorylation of 
Cdc7:ASK with λPPase resulted in both proteins migrating according to their 
predicted masses, 64 kDa and 77 kDa, respectively (Figure 4.20, lanes 7 and 8). 
Furthermore, this is in agreement with the migration position of dephosphorylated 
ASK detected in whole cell extracts and immunoprecipitates by Western blotting 
(Figure 4.7). 
 Pre-incubation of Cdc7:ASK heterodimer with ATP, or addition of ATP 
directly to the pull-down buffer consistently improved recovery of LEDGF in pull-
down assays (Figure 4.20, compare lanes 4 and 6; Figure 4.13, compare lanes 6 and 
7). In contrast, dephosphorylation of Cdc7:ASK abrogated the interaction with 
LEDGF (Figure 4.20, lane 8), indicating that the phosphorylation state of the kinase 
heterodimer is a critical factor for interaction with LEDGF in vitro. Interestingly, 
removal of 133 C-terminal residues of ASK (giving ASK(1-541)) resulted in a loss 
of hyperphosphorylation (Figure 4.19, lanes 3, 8 and 12), indicating that the C-
terminal region of ASK is targeted by the auto-phosphorylation activity.  
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Figure 4.20 – The phosphorylation state of Cdc7:ASK affects its interaction with LEDGF 
Cdc7:ASK, either untreated (lanes 3 and 4), pre-incubated with 4 mM ATP (lanes 5 and 6) or 
dephosphorylated with λPPase (lanes 7 and 8), was incubated with S-protein agarose in the presence 
(lanes 4, 6 and 8) or absence (lanes 3, 5 and 7) of LEDGF. Proteins captured on the beads were 
separated by SDS PAGE and detected by staining with Coomassie Blue (top panel) and Western 
blotting with anti-LEDGF antibody (bottom panel). LEDGF detected in pull-down samples by 
Coomassie staining is indicated by an asterisk. 
 
4.7 A positive patch on the surface of the IBD structure is involved 
in the interaction with Cdc7:ASK 
The structure of the IBD features a positively-charged patch formed by side chains of 
several lysine and arginine residues, most of which are invariant among LEDGF and 
HRP2 orthologues (Cherepanov et al., 2005b). LEDGF Lys401, Lys402 and Arg405 
contributing to this patch are known to mediate interactions with complementary 
acidic residues found within the N-terminal domains of lentiviral INs (Hare et al., 
2009b) (Figure 1.5). Triple mutations targeting the positively-charged surface within 
the IBD, K401A/K402A/R405A (AAA), K401E/K402S/R405E (ESE) and 
K401E/K402E/R405E (EEE), replacing the positively charged residues with neutral 
(alanine; A) or negatively charged (glutamic acid; E) residues, abrogates the 
interaction between LEDGF and IN (Hare et al., 2009b). Because the Cdc7:ASK-
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LEDGF interaction requires auto-phosphorylation of the kinase heterodimer, an in 
vitro pull-down assay was used to determine whether this interaction also depends on 
the positively-charged patch. 
Triple mutations affecting the positively-charged patch on the surface of the 
IBD ablated the interaction with Cdc7:ASK as LEDGF mutants AAA, ESE and EEE 
were not pulled down by Cdc7:ASK (Figure 4.21, lanes 7, 15 and 16). Additionally, 
a single mutation K360E also ablated the interaction with Cdc7:ASK while LEDGF 
mutant K392E maintained its ability to bind to Cdc7:ASK (Figure 4.21, lanes 8 and 
9); neither of these point mutations affect the LEDGF-IN interaction (Hare et al., 
2009b). These data show that the positively-charged surface within the IBD is indeed 
involved in the interaction with Cdc7:ASK and thus, its interface with LEDGF at 
least partly overlaps with that of IN. This result predicts that LEDGF would not be 
able to interact with HIV-1 IN and Cdc7:ASK simultaneously. 
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Figure 4.21 – The LEDGF-Cdc7:ASK interaction requires the positively charged patch on the 
surface of the IBD 
The positive patch on the surface of the IBD is important for the interaction with Cdc7:ASK. S-tagged 
Cdc7:ASK was incubated with S-protein agarose in the presence of WT or mutant LEDGF. Lanes 1-5, 
12 and 13 show input levels of indicated proteins. LEDGF and Cdc7:ASK were omitted from the 
samples in lanes 17 and 18, respectively. Proteins captured on the beads were separated by SDS 
PAGE and detected by staining with Coomassie Blue (top panel) and Western blotting with anti-
LEDGF antibody (bottom panel). LEDGF detected in pull-down samples by Coomassie staining is 
indicated by an asterisk. 
 
Incubation of S-tagged Cdc7:ASK with both LEDGF and HIV-1 IN in the 
presence of S-protein agarose followed by SDS PAGE analysis confirmed that 
LEDGF is pulled down with Cdc7:ASK while IN was not recovered from solution 
with the Cdc7:ASK:LEDGF complex (Figure 4.22, compare lanes 8 and 10). As 
expected, Cdc7:ASK did not interact with IN in the absence of LEDGF (Figure 4.22, 
lane 9). A single mutation within the IBD, D366N, ablates the interaction between 
LEDGF and IN (Cherepanov et al., 2005a), however, this LEDGF mutant maintained 
the ability to interact with Cdc7:ASK (Figure 4.22, lanes 11 and 12). Consequently, 
although the binding platforms for lentiviral INs and Cdc7:ASK on the IBD overlap, 
their mechanism of recognition is unlikely to be the same. 
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Figure 4.22 – IN is not pulled down by the LEDGF:Cdc7:ASK ternary complex 
S-tagged Cdc7:ASK was incubated with S-protein agarose and LEDGF in the absence (lane 8) or 
presence (lane 10) of IN,  Cdc7:ASK was incubated with S-protein agarose and LEDGF point mutant 
D366N in the absence (lane 11) or presence (lane 12) of IN or Cdc7:ASK was incubated with S-
protein agarose and IN in the absence of LEDGF (lane 9). Lanes 5-7 show Cdc7:ASK, LEDGF or IN 
alone incubated with S-protein agarose. Lanes 1-4 contained input quantities of the indicated proteins. 
Proteins captured on the beads were separated by SDS PAGE and detected by silver staining. 
 
4.8 Identification of Cdc7:ASK phosphorylation sites in LEDGF 
Following on from detailed biochemical analyses of the interaction between LEDGF 
and Cdc7:ASK, functional study of this interaction was undertaken using in vitro 
kinase assays. The ability of the kinase to phosphorylate LEDGF and its mutant 
forms was evaluated by monitoring incorporation of radioactive phosphate. 
 Although incubation of LEDGF with Cdc7:ASK did not alter its migration in 
SDS PAGE gels, using [γ-32P]ATP revealed robust phosphorylation of LEDGF by 
the kinase heterodimer (Figure 4.23, compare lanes 1, 8 and 11). Impressively, under 
conditions of the in vitro kinase assays, LEDGF was phosphorylated more readily 
than the model Cdc7:ASK substrate GST-MCM2(1-287) (Figure 4.23, lane 9). 
Removal of the IBD reduced phosphorylation of LEDGF at least 5-fold (Figure 4.23, 
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lane 7). The EEE mutation similarly diminished phosphorylation of full-length 
LEDGF (Figure 4.24, lane 7), indicating that the reaction was dependent on the IBD-
mediated interaction with Cdc7:ASK. 
 To begin mapping Cdc7:ASK phosphorylation sites in LEDGF, equimolar 
amounts of N-terminally truncated LEDGF mutants (see Figure 4.12 for schematic of 
LEDGF deletion mutants) were incubated with the kinase and their phosphorylation 
quantitatively assessed (Figure 4.23). The N-terminal 146 residues of LEDGF were 
clearly dispensable for its function as a Cdc7:ASK substrate; in fact, LEDGF(147-
530) was a better substrate for phosphorylation compared to the full-length protein 
(Figure 4.23, lane 2). Removal of 225 N-terminal residues or more considerably 
reduced incorporation of radioactive phosphate (Figure 4.23, compare lane 1 to lane 
3), indicating that the major phosphorylation site is located between LEDGF residues 
146 and 225.  
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Figure 4.23 – LEDGF is phosphorylated by Cdc7:ASK in vitro 
Full-length LEDGF (lane 1), its N-terminal truncation mutants (lanes 2-6), LEDGFΔIBD (lane 7), 
GST-MCM2(1-287) (lane 9) or GST (lane 10) were incubated with Cdc7:ASK in the presence of [γ-
32
P]ATP. Reaction products, separated by SDS PAGE, were detected by phosphorescence imaging. 
Full-length LEDGF was incubated with [γ-32P]ATP in the absence of Cdc7:ASK in lane 8 (mock); 
Cdc7:ASK was incubated with [γ-32P]ATP in the absence of protein substrates in lane 11. 
Concentrations of full-length LEDGF, LEDGF deletion mutants and GST were adjusted to 0.3 µM; 
GST-MCM2(1-287) was used at 0.4 µM. Quantification of radioactivity incorporation, relative to full-
length LEDGF, is shown to the right of the gel. 
 
 To more precisely map Cdc7:ASK phosphorylation sites within LEDGF, 
recombinant LEDGF was phosphorylated in vitro using recombinant kinase and 
subjected to phosphopeptide analysis by LC-MS/MS, resulting in identification of 
four LEDGF phosphopeptides (Table 4.2).  
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Table 4.2 – LEDGF phosphopeptides and their locations within the amino acid sequence 
Tryptic peptides were derived from recombinant LEDGF phosphorylated in vitro with Cdc7:ASK, or 
HA-LEDGF isolated from asynchronously growing or S-phase H3 cells. Phosphorylation sites, 
compatible with results of tandem mass spectrometry analyses, are underlined, and those assigned 
with confidence are printed in bold type.  
Location In vitro phosphorylation 
with Cdc7:ASK 
Asynchronous cells S-phase cells  
57-67 DIFPYSENKEK1   
101-113  QSNASSDVEVEEK
1 QSNASSDVEVEEK1 
QSNASSDVEVEEK2 
101-
113/127 
 QSNASSDVEVEEKETSVSKEDTDHE
EK1 
QSNASSDVEVEEKETSVSKEDTDHE
EK1 
QSNASSDVEVEEK1 
 
114/128-
135 
 ETSVSKEDTDHEEKASNEDVTK
1 
ETSVSKEDTDHEEKASNEDVTK2 
ETSVSKEDTDHEEK1 
ETSVSKEDTDHEEK1 
ASNEDVTK1 
136-143  AVDITTPK
1 AVDITTPK1 
156-179  QVETEEAGVVTTATASVNLKVSPK
1 QVETEEAGVVTTATASVNLKVS
PK1 
202-218 QPCPSESDIITEEDKSK1  QPCPSESDIITEEDK1 
267-286 TGVTSTSDSEEEGDDQEGEK
1
 
TGVTSTSDSEEEGDDQEGEK1 
TGVTSTSDSEEEGDDQEGEK2 
TGVTSTSDSEEEGDDQEGEK1 
TGVTSTSDSEEEGDDQEGEK2 
344-351   RETSMDSR
1 
510/511-
524 
 KKPSSEERETEISLK
1 KPSSEERETEISLK1 
518-530 ETEISLKDSTLDN1   
1
singly-phosphorylated 
2
doubly-phosphorylated 
 
 
LEDGF mutants, eliminating serine residues identified by the phosphopeptide 
analysis as Cdc7:ASK target sites, were produced and incorporation of radioactive 
phosphate  was used to determine the dominant site(s). Initially, two double LEDGF 
mutants, S206A/S208A (AEA) and S273A/S275A (ADA), were tested in our in vitro 
kinase assay (Figure 4.24). The AEA mutation resulted in a substantial decrease in 
phosphorylation of LEDGF by Cdc7:ASK (Figure 4.24, lane 4). Combining AEA 
and ADA mutations (AEA/ADA, S206A/S208A/S273A/S275A) resulted in the 
poorest phosphorylation substrate of all the Ser substitution mutants studied (Figure 
4.24, lane 6), although the loss of phosphorylation achieved by mutating Ser273 and 
Ser275 was modest.  
In the amino acid sequence of LEDGF, both Ser206 and Ser208 are followed 
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by acidic residues (Glu207 and Asp209, respectively), consistent with the consensus 
for Cdc7:ASK phosphorylation sites observed in MCM2 (Cho et al., 2006). Mutation 
of Ser206 alone was sufficient to reduce in vitro phosphorylation of LEDGF to the 
levels of the AEA mutant, while targeting Ser208 had only a modest effect (Figure 
4.24, lanes 2 and 3). These results suggested that LEDGF Ser206 constitutes the 
dominant Cdc7:ASK target in vitro, corroborating results of the deletion mutagenesis 
experiments which indicated that LEDGF is phosphorylated at a site located between 
residues 146 and 225 (Figure 4.23).   
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Figure 4.24 – LEDGF residue Ser206 is the major Cdc7:ASK phosphorylation target in vitro 
WT LEDGF, S206A, S208A, AEA, ADA, AEA/ADA or EEE LEDGF mutants were incubated with 
Cdc7:ASK in the presence of [γ-32P]ATP. Reaction products, separated by SDS PAGE, were detected 
by phosphorescence imaging (
32
P, top panel) and stained with Coomassie blue (bottom panel). 
Concentrations of full-length LEDGF and LEDGF deletion mutants were used at 0.3 µM. 
Quantification of radioactivity incorporation, relative to full-length LEDGF, is shown to the right of 
the gels. 
 
To determine whether LEDGF is phosphorylated at Ser206 in vivo, 
asynchronously growing H3 cells stably expressing HA-LEDGF were harvested, 
lysed in the presence of phosphatase inhibitors, and HA-LEDGF was purified from 
this whole cell extract using anti-HA affinity resin. Recovered proteins were 
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separated by SDS PAGE and a gel slice containing LEDGF was submitted for LS-
MS/MS phosphopeptide analysis. Additionally, phosphopeptide analysis was carried 
out on HA-LEDGF isolated from H3 cells synchronised in S phase. The 
synchronisation was achieved by culturing H3 cells in the presence of 4 µg/ml 
aphidicolin for 24 h, followed by release into the S phase for 2 h. LEDGF 
phosphopeptides identified in extracts from asynchronous or S-phase cells are listed 
in Table 4.2. Remarkably, although the majority of the LEDGF phosphopeptides 
identified were common to both conditions, the phosphopeptide containing Ser206 
was identified in S-phase synchronised cells only (Table 4.2). In addition, while 
similar sets of LEDGF phosphorylation sites have been identified by global 
phosphoproteome studies of asynchronous or G1- and M- phase arrested HeLa cells, 
phosphorylation of Ser206 was not observed (Table 4.3) (Dephoure et al., 2008; 
Olsen et al., 2006). These results suggest that the modification of Ser206 might be 
specific to S-phase, which would coincide with the peak of Cdc7:ASK activity.  
Table 4.3 – LEDGF phosphopeptides reported in global phosphoproteome studies and their 
locations within the amino acid sequence 
Assigned phosphorylation sites are printed in bold type and underlined.  
Location 
 
Olsen et al. 2006  
(HeLa) 
Dephoure et al., 2008 
(HeLa, G1) 
Dephoure et al., 2008 
(HeLa, G2) 
101-113 QSNASSDVEVEEK 
QSNASSDVEVEEK 
QSNASSDVEVEEK QSNASSDVEVEEK 
101-127   QSNASSDVEVEEKETSVSKEDTDHE
EK 
114-127 ETSVSKEDTDHEEK   
136-143 AVDITTPK AVDITTPK AVDITTPK 
267-
286/288 
TGVTSTSDSEEEGDDQEG
EK 
TGVTSTSDSEEEGDDQEG
EK 
TGVTSTSDSEEEGDDQEGEK 
TGVTSTSDSEEEGDDQEGEKK
R 
TGVTSTSDSEEEGDDQEGEK 
TGVTSTSDSEEEGDDQEGEKK 
TGVTSTSDSEEEGDDQEGEK 
TGVTSTSDSEEEGDDQEGEKKR 
TGVTSTSDSEEEGDDQEGEK 
TGVTSTSDSEEEGDDQEGEKK 
425-448   NMFLVGEGDSVITQVLNKSLAEQR 
NMFLVGEGDSVITQVLNKSLAEQR 
510-524 KKPSSEERETEISLK   
518-530   ETEISLKDSTLDN 
ETEISLKDSTLDN 
ETEISLKDSTLDN 
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4.9 LEDGF stimulates Cdc7:ASK kinase activity in vitro 
Functional analysis of the LEDGF-Cdc7:ASK interaction has thus far established 
that LEDGF is a substrate of the kinase heterodimer. To further explore the function 
of this interaction, the kinase activity of Cdc7 in complex with N- or C-terminally 
truncated forms of ASK both in the absence and presence of LEDGF was 
investigated. 
 WT Cdc7:ASK, along with heterodimers containing N- and/or C-terminally 
truncated forms of ASK were tested for their ability to phosphorylate GST-MCM2(1-
287) in vitro. This substrate was chosen based on published observations that human 
Cdc7:ASK phosphorylates the N-terminal region of MCM2 (Cho et al., 2006; Ishimi 
et al., 2001). Both WT Cdc7:ASK and Cdc7:ASK(174-674) generated detectable 
levels of phosphorylated GST-MCM2(1-287) (Figure 4.25, lanes 1 and 4). 
Surprisingly, Cdc7:ASK(174-350) and Cdc7:ASK(1-350) mounted dramatically 
higher activities compared to the WT heterodimer in this assay format (Figure 4.25, 
lanes 2 and 3), suggesting that the C-terminal region of ASK negatively regulates the 
kinase activity. Because the same region of ASK is also involved in the interaction 
with LEDGF (Figure 4.17), the ability of the various kinase heterodimers to 
phosphorylate GST-MCM2(1-287) in the presence of LEDGF was assessed. 
Strikingly, addition of LEDGF lead to a dramatic stimulation of WT Cdc7:ASK 
activity (Figure 4.25, compare lanes 1 and 5) in a concentration-dependent manner 
(Figure 4.26, lanes 2-5), increasing phosphorylation of MCM2 in vitro by more than 
10-fold. In the presence of LEDGF, the abilities of WT Cdc7:ASK and 
Cdc7:ASK(174-674) (Figure 4.25, lanes 5 and 8) to phosphorylate GST-MCM2(1-
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287) were comparable to those of Cdc7:ASK(174-350) or Cdc7:ASK(1-350) (Figure 
4.25, lanes 2 and 3). As expected, the hyperactive mutants, which both lack the C-
terminal portion of ASK, were not stimulated by LEDGF (Figure 4.25, lanes 6 and 7 
and Figure 4.26, lanes 11-14). Reciprocally, the EEE LEDGF mutant, unable to 
interact with Cdc7:ASK, failed to significantly enhance the activity of WT 
Cdc7:ASK (Figure 4.26, lanes 6-9). These results confirm that the stimulation of 
Cdc7:ASK kinase activity by LEDGF strictly depends on the protein-protein 
interaction. Furthermore, because the AEA/ADA LEDGF mutant retained the ability 
to stimulate Cdc7:ASK kinase activity in a concentration dependent manner and the 
levels of MCM2 phosphorylation were comparable to conditions using WT LEDGF 
(Figure 4.27, lanes 2-5), this effect did not depend on phosphorylation of LEDGF by 
the kinase. 
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Figure 4.25 – LEDGF stimulates Cdc7:ASK kinase activity in vitro 
WT Cdc7:ASK or its mutant forms (3 nM) were incubated with 0.4 µM GST-MCM2(1-287) and [γ-
32
P]ATP in the absence (lanes 1-4) or presence (lanes 5-8) of 0.4 µM LEDGF. Reaction products, 
separated by SDS PAGE, were detected by phosphorescence imaging. Migration positions of 
phosphorylated ASK (ASK-P) or its truncated forms ASK(174-674) (ASK(174-674)-P), ASK (174-
350) (ASK (174-350)-P), LEDGF (LEDGF-P) and GST-MCM2(1-287) (MCM2(1-287)-P) are 
indicated. 
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Figure 4.26 – Stimulation of Cdc7:ASK kinase activity by LEDGF is concentration dependent 
and requires interaction with the IBD 
WT Cdc7:ASK (lanes 1-9) or Cdc7:ASK(174-350) (lanes 10-14) were incubated with GST-MCM2(1-
287) and [γ-32P]ATP in the absence (lanes 1 and 10) or presence of indicated concentrations of WT 
(lanes 2-5, 11-14) or EEE (lanes 6-9) LEDGF. Reaction products, separated by SDS PAGE, were 
detected by phosphorescence imaging (A). Migration positions of phosphorylated ASK (ASK-P), 
LEDGF (LEDGF-P) and GST-MCM2(1-287) (MCM2(1-287)-P) are indicated.  Quantification of 
GST-MCM2(1-287) phosphorylation, relative to phosphorylation of MCM2 by WT Cdc7:ASK in the 
absence of LEDGF (lane 1), is shown in B. 
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Figure 4.27 – Stimulation of Cdc7:ASK kinase activity is independent of the phosphorylation 
state of LEDGF 
Phosphorylation of GST-MCM2(1-287) in vitro by Cdc7:ASK in the absence (lane 1) or presence of 
400-3.2 nM WT (lanes 6-9) or AEA/ADA (lanes 2-5) LEDGF. Reaction products, resolved by SDS 
PAGE, were visualised by phosphorescence imaging (left). Migration positions of phosphorylated 
ASK (ASK-P), LEDGF (LEDGF-P) and GST-MCM2(1-287) (MCM2(1-287)-P) are indicated. 
Quantification of GST-MCM2(1-287) phosphorylation, relative to the condition without LEDGF (lane 
1), is shown on the right. 
 
4.9.1 LEDGF enhances phosphorylation of MCM2 at the Cdc7-specific site 
Ser53 
MCM2 residue Ser53 was shown to be the major target of phosphorylation by Cdc7 
both in vitro and in vivo (Cho et al., 2006; Montagnoli et al., 2006). To test whether 
modulation of Cdc7:ASK activity by LEDGF affects phosphorylation at the specific 
site, kinase heterodimers were incubated with GST-MCM2(1-287) and ATP in the 
absence or presence of LEDGF. The products were analysed by Western blotting 
using an antibody specific to MCM2 containing phospho-Ser53 (pSer53). As 
expected, prior to incubation with the kinase, the phospho-specific antibody failed to 
react with bacterially produced GST-MCM2(1-287) (Figure 4.28, lane 1), and the 
phosphorylated species were highlighted following incubation with Cdc7:ASK and 
ATP (Figure 4.28, lane 2). Corroborating results of the radioactive kinase assays, 
addition of LEDGF resulted in a marked increase of the substrate phosphorylated at 
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Ser53 (Figure 4.28, lane 3). Similar high levels of Ser53 phosphorylation were 
observed with Cdc7:ASK(174-350), but the activity of the hyperactive mutant, as 
predicted, was not enhanced by LEDGF (Figure 4.28, lanes 4 and 5). Both C-
terminal truncation mutants Cdc7:ASK(1-624) and Cdc7:ASK(1-541) were more 
active than WT Cdc7:ASK and did not respond to addition of LEDGF (Figure 4.28, 
lanes 6-9). Furthermore, GST-fusions of LEDGF(347-471) and HRP2(470-593), but 
not GST alone, were able to promote the specific activity of Cdc7:ASK kinase 
(Figure 4.28, lanes 10-12), indicating that the IBD is sufficient for this effect. 
 
WB: α pSer53 MCM2
- - + - + - + - + - - - LEDGF
- - - - - - - - - - + - LEDGF(347-471)
- - - - - - - - - - - + HRP2(470-593)
- - - - - - - - - + - - GST
1 2 3 4 5 6 7 8 9 10 11 12
 
Figure 4.28 – LEDGF enhances Cdc7:ASK-dependent phosphorylation of bacterially produced 
MCM2(1-287) at residue Ser53 
GST-MCM2(1-287) was incubated in the absence (lane 1) or presence (lanes 2-12) of 3 nM WT or 
indicated mutant forms of Cdc7:ASK; 0.4 µM LEDGF, GST-LEDGF(347-471), GST-HRP2(470-593) 
or GST were added as indicated; ATP (4 mM) was present in all reactions. Reaction products, 
resolved by SDS PAGE, were detected by Western blotting with a phosphospecific anti-Ser53 MCM2 
antibody. 
 
To ascertain that these observations could be extended to phosphorylation of 
the full-length substrate, HeLa cells stably expressing a Flag-tagged form of human 
MCM2 were generated. The cell line, termed HeLa-Flag-MCM2-His8, was obtained 
by infecting HeLa cells with a retroviral vector packaging pQFlag-MCM2-8xHis and 
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stably transduced cells were selected in the presence of 1 µg/ml puromycin. The 
nuclear localisation of Flag-tagged MCM2 was confirmed by immunofluorescence 
using an anti-Flag antibody (Figure 4.29A). Flag-MCM2 was isolated from whole 
cell extract using Flag-affinity resin and in parallel, a mock purification was carried 
out on extract from parental cells and the resulting sample was used as a negative 
control in the following experiments. As expected, MCM2 preparations from human 
cells contained detectable levels of pSer53, as highlighted by Western blotting using 
the phospho-specific antibody (Figure 4.29C, lanes 2, 3 and 7). Recombinant 
Cdc7:ASK was able to weakly phosphorylate full-length MCM2 at Ser53 (Figure 
4.29C, lane 4), and the activity was robustly enhanced in the presence of LEDGF 
(Figure 4.29C, lane 5). Moreover, similar levels of Ser53 phosphorylation were 
achieved by hyperactive Cdc7:ASK(174-350) (Figure 4.29C, lane 6). 
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Figure 4.29 – LEDGF enhances Cdc7:ASK-dependent phosphorylation of full-length MCM2 at 
Ser53 
(A) Nuclear localisation of Flag-tagged MCM2 and LEDGF in HeLa cells stably expressing Flag-
MCM2-His8 was confirmed by immunofluorescence. Flag-tagged MCM2 was detected using anti-
Flag primary and Alexa Fluor 555-conjugated secondary antibodies, endogenous LEDGF was 
detected using anti-LEDGF primary and Alex Flour 488-conjugated secondary antibodies, DAPI was 
used to stain DNA. (B) Full-length MCM2, purified from HeLa cells stably expressing Flag-tagged 
MCM2 using anti-Flag affinity agarose, compared to mock-purified material from parental HeLa 
cells. (C) Phosphorylation of full-length MCM2 by Cdc7:ASK in vitro. Flag-MCM2 was incubated in 
the absence (lane 3) or presence of 3 nM Cdc7:ASK (lanes 4 and 5) or Cdc7:ASK(174-350) (lane 6); 
0.3 µM LEDGF was added to the reaction in lane 5. Lanes 2 and 7 contain input quantity of untreated 
Flag-MCM2 and lane 1 an equivalent amount of mock-purified material. Reaction products were 
analysed by Western blotting with anti-pSer53 MCM2 and anti-Flag antibodies.  
 
4.10 LEDGF tethers ASK to chromatin 
To begin to analyse the interaction between LEDGF and Cdc7:ASK in the nuclei of 
human cells, co-localisation studies were carried out (Figure 4.30). HeLa cells were 
co-transfected with constructs expressing EGFP-Cdc7 and HA-ASK or HA-ASK(1-
624) together with HcRed1-LEDGF or HcRed1-p52. HA-tagged proteins were 
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detected using an anti-HA primary antibody and an Alexa Fluor 555-conjugated 
secondary antibody, and DNA was visualised using DAPI.  
 When over-expressed in HeLa cells, HcRed1-LEDGF displayed a striking co-
localisation with HA-ASK, while nuclear distribution of EGFP-Cdc7 was less 
defined (Figure 4.30, top row). Importantly, no co-localisation was observed between 
HA-ASK and p52, although distribution of both HcRed1 –LEDGF and –p52 proteins 
closely mirrored that of chromosomal DNA (Figure 4.30, top and middle rows 
respectively). Moreover, unlike the full-length protein, HA-ASK(1-624), which lacks 
the C-terminal portion required for interaction with LEDGF, did not co-localise with 
HcRed1-LEDGF, displaying a more diffuse nuclear distribution (Figure 4.30, bottom 
row). The remarkable co-localisation of HA-ASK and HcRed1-LEDGF coupled with 
the fact that their distribution closely matched that of chromosomal DNA indicated 
that LEDGF might be able to tether ASK or the Cdc7:ASK complex to chromatin. 
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Figure 4.30 – Intracellular distribution of over-expressed LEDGF, ASK and Cdc7 
Confocal laser scanning microscopy images of HeLa cells transfected with expression constructs for 
EGFP-Cdc7, full-length HA-ASK (top and middle rows of images), HA-ASK(1-624) (bottom row), 
HcRED1-LEDGF (top and bottom rows) and/or HcRed1-p52 (middle row). HA-tagged proteins were 
detected using anti-HA primary and Alexa Fluor 555-conjugated secondary antibodies, DAPI was 
used to stain DNA. 
 
 To test this hypothesis, 293T cells transiently expressing Flag-Cdc7:HA-ASK 
alone or co-expressed with LEDGF or its mutant forms, EEE or ΔIBD, were lysed 
and fractionated into Triton -soluble and -insoluble fractions. The Triton-insoluble 
fraction is enriched in chromatin-bound proteins (Sato et al., 2003). The extracts 
were prepared 30 hours post-transfection and analyses of propidium iodide-stained 
cells by flow cytometry failed to highlight significant differences between cell cycle 
profiles of the different transfection conditions (Figure 4.31B). Over-expression of 
WT LEDGF resulted in considerable enrichment of both Flag-Cdc7 and HA-ASK in 
the chromatin-containing fraction (Figure 4.31A, compare lanes s2 and i2). In 
contrast, LEDGF mutants EEE and ΔIBD (lacking residues 347-430), neither of 
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which interact with Cdc7:ASK, failed to enrich the kinase subunits this fraction 
(Figure 4.31A, lanes s3 and i3 and lanes s4 and i4, respectively). Of note, the 
experiment was repeated several times using 293T and HeLa cells, and enrichment of 
Cdc7:ASK in the Triton insoluble fraction in the presence of over-expressed LEDGF 
was observed reproducibly (data not shown). 
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Figure 4.31 – ASK and Cdc7 are enriched in the chromatin-containing Triton-insoluble fraction 
when co-over-expressed with LEDGF 
(A) 293T cells were transfected with expression vectors for Flag-Cdc7:HA-ASK (lanes w1-w4, s1-s4, 
i1-i4), WT LEDGF (lanes w2, s2 and i2), LEDGF EEE mutant (lanes w3, s3 and i3), LEDGFΔIBD 
(lanes w4, s4 and i4) or empty vector (lane w0). Whole cell extracts (WCE, lanes w0-w4), TritonX100 
–soluble (lanes s1-s4) and –insoluble (lanes i1-i4) fractions were analysed by Western blotting using 
anti-HA, Cdc7, LEDGF, lamin B (indicating the nuclear/chromatin fraction) and β-tubulin (indicating 
the cytoplasmic/soluble fraction) antibodies. (B) Untransfected 293T cells and 293T cells co-
transfected with expression constructs for Flag-Cdc7:HA-ASK (1), Flag-Cdc7:HA-ASK and WT 
LEDGF (2), Flag-Cdc7:HA-ASK and LEDGF EEE mutant (3) or Flag-Cdc7:HA-ASK and 
LEDGFΔIBD (4) were stained with propidium iodide (PI) and their cell cycle profiles analysed by 
flow cytometry. G1-, S- and G2/M- phase of the cell cycle are indicated. PI stains DNA, thus cells 
which have duplicated their DNA and are in G2/M phase have double the fluorescence intensity of 
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cells in G1. Cells in S phase, which are in the process of duplicating their DNA, have fluorescence 
intensities that are intermediate between G1 and G2/M.   
 
4.11 Discussion 
The role of LEDGF in HIV-1 replication has been well characterised, however, its 
cellular functions remain poorly understood. This study describes the discovery and 
the initial characterisation of the interaction between LEDGF and the S-phase kinase 
Cdc7:ASK.  
Tandem affinity purification was used to identify novel cellular binding 
partners of LEDGF to allow the analysis of LEDGF function in the context of a 
known cellular pathway. This strategy identified Cdc7 kinase as a co-purifying 
partner of LEDGF. Both IP and in vitro pull-down experiments showed that LEDGF 
interacts with the heterodimeric Cdc7:ASK complex and that this interaction is 
mediated by the IBD of LEDGF. Interestingly, the interaction extends to HRP2, 
another IBD-containing protein. Importantly, the LEDGF-Cdc7:ASK interaction was 
confirmed by co-immunoprecipitation of endogenous proteins. 
 Analyses using recombinant proteins showed that the IBD of LEDGF is 
essential and minimally sufficient for the interaction with Cdc7:ASK. Reciprocally, 
the C-terminal 50 residues of ASK are required for binding to LEDGF and the 
interaction is dependent on auto-phosphorylation of the kinase heterodimer. In 
mammalian cells, ASK protein levels oscillate during the cell cycle, reaching a 
maximum in S phase, which coincides with the peak of Cdc7 kinase activity 
(Kumagai et al., 1999). Furthermore, phosphorylation of ASK depends on binding to 
the catalytic subunit (Kumagai et al., 1999); while truncation of the C-terminal 
region of ASK undertaken in this study has shown that this region is auto-
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phosphorylated. Moreover, this is in agreement with an earlier study in which 
deletion of ASK residues 614-674 eliminated the pronounced upward SDS PAGE 
mobility shift, typical of the full-length protein, indicating that the C-terminal 
segment of ASK is hyperphosphorylated (Sato et al., 2003). Thus, the interaction 
between LEDGF and the Cdc7:ASK heterodimer is probably limited to S phase of 
the cell cycle during which the kinase is active. Moreover, confocal laser scanning 
microscopy imaging of endogenous LEDGF and endogenous Cdc7 showed that 
while LEDGF was tightly associated with chromatin during G2/M-phase, Cdc7 was 
excluded (Figure 4.8A). Taken together, these data suggested that LEDGF 
preferentially interacts with the active kinase heterodimer. 
 Notably, the IBD was also shown to mediate the interaction of LEDGF with 
cellular proteins JPO2, PogZ and menin:MLL as well as lentiviral INs 
(Bartholomeeusen et al., 2009; Busschots et al., 2007; Cherepanov, 2007; 
Cherepanov et al., 2004; Maertens et al., 2006; Yokoyama and Cleary, 2008). Akin 
to its effect on HIV-1 IN, LEDGF is required for chromatin association of JPO2 and 
menin:MLL (Llano et al., 2004b; Maertens et al., 2003; Maertens et al., 2006; 
Yokoyama and Cleary, 2008). In this study, co-over-expression of LEDGF increased 
the presence of Cdc7 and ASK on chromatin in human cells (Figure 4.31A). This 
effect clearly depended on the interaction with the IBD of LEDGF, as LEDGF 
mutants EEE and ΔIBD had no effect. Additionally, HcRed1-LEDGF and HA-ASK 
showed striking co-localisation, which in turn closely matched the distribution of 
chromosomal DNA (Figure 4.30). The co-localisation required both the IBD and the 
C-terminus of ASK (Figure 4.30), in accord with results of in vitro pull-down 
experiments. Thus, LEDGF appears to act as a multifunctional adaptor with the 
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ability to tether a plethora of cellular machinery involved in genome expression and 
maintenance.  
It appears that ASK and Cdc7 are independently imported into the nucleus 
where the active complex is then assembled (Sato et al., 2003). The interaction 
between LEDGF, a component of chromatin, and the C-terminus of ASK may serve 
to recruit and/or tether the active Cdc7:ASK complex to transcriptionally-active 
chromatin in human cells. Similarly, Swi6, a component of heterochromatin, has 
been shown to interact with Dfp1 to recruit Hsk1:Dfp1 (fission yeast orthologue of 
Cdc7:ASK) to heterochromatic loci in S. pombe (Hayashi et al., 2009). Additionally, 
perhaps other factors help to mediate binding of Cdc7:ASK to areas of chromatin 
where LEDGF is not present. In particular, Dbf4 motif-N has been implicated in the 
interactions with the replication machinery and replication origins in S. cerevisiae 
(Dowell et al., 1994; Duncker et al., 2002; Ogino et al., 2001) and the N-terminus of 
Dbf4 was shown to mediate binding to pre-RC bound MCM (Francis et al., 2009). 
Studies using Xenopus laevis egg extracts suggested that association of Cdc7 with 
chromatin is dependent on Dbf4 (Edwards et al., 2002; Jares and Blow, 2000; Jares 
et al., 2004). Based on studies of Dbf4/ASK orthologues in yeast and Xenopus, the 
conserved Dbf4 N-motif present in human ASK (residues 48-92) may also mediate 
interactions with chromatin, however, a direct interaction has not been reported. Our 
results suggest that in addition to the N-motif, the interaction between the C-terminus 
of ASK and LEDGF may serve to tether Cdc7:ASK to chromatin. 
 Cdc7:ASK kinase can phosphorylate LEDGF at a number of Ser residues in 
vitro, with Ser206 being the main target site (Table 4.2) and the phosphorylation of 
LEDGF depends on the LEDGF-Cdc7:ASK interaction. Indeed, phosphorylation of 
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EEE and ΔIBD LEDGF mutants, unable to bind Cdc7:ASK, was very inefficient 
(Figure 4.23, Figure 4.24). The phosphorylation site is located within a largely 
unstructured inter-domain region of LEDGF (Cherepanov et al., 2004) and is 
separated from the IBD by ~140 amino acid residues. Therefore, binding to and 
phosphorylation of LEDGF by the kinase are spatially uncoupled, with the IBD 
acting as a docking domain. A similar mechanism has been proposed for 
phosphorylation of MCM4 in S. cerevisiae, where the Dbf4-dependent kinase 
docking domain (MCM4 residues 175-333) serves to recruit the S-phase kinase 
which then phosphorylates the N-terminal region of MCM4 (Sheu and Stillman, 
2006). In vivo, phosphorylation of LEDGF at Ser206 could only be detected when 
the population of S-phase cells was enriched by pre-treatment with aphidicolin 
(Table 4.2). Similarly, this modification was not discovered by earlier studies that 
analysed phosphoproteomes of unsynchronised, G1- or M-phase cells, nonetheless 
collectively detecting all remaining LEDGF phosphorylation sites identified in this 
study (Table 4.3) (Dephoure et al., 2008; Olsen et al., 2006). Thus, phosphorylation 
of LEDGF at Ser206 appears to be restricted to S phase, coinciding with the 
maximum activity of Cdc7:ASK (Kumagai et al., 1999). Future work shall focus on 
the functional consequences of LEDGF phosphorylation by Cdc7:ASK. Because 
Ser206 is in close proximity to the second AT-hook motif of LEDGF (residues 191-
197), phosphorylation at this position could modulate its DNA binding properties.  
LEDGF residues Ser271, Ser273 and Ser275, all of which have been 
identified as phospho-sites (Dephoure et al., 2008; Han et al., 2008; Hughes et al., 
2010; Kim et al., 2005; Olsen et al., 2006), have been reported to be important for 
LEDGF co-factor activity during HIV-1 infection (Garcia-Rivera et al., 2009). 
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Mutation of all three of these residues to alanine (S271A/S273A/S275A) resulted in 
a decrease in HIV-1 infectivity, although individual point mutations had little effect 
(Garcia-Rivera et al., 2009). In the present study, LEDGF residues Ser273 and 
Ser275 were shown to be minor targets of Cdc7:ASK kinase activity (Figure 4.24). It 
would be interesting to determine if phosphorylation of the major Cdc7:ASK target, 
Ser206, is also important for LEDGF function as a lentiviral DNA integration co-
factor. 
LEDGF potently stimulated the specific kinase activity of Cdc7:ASK in vitro, 
enhancing phosphorylation of bacterially-produced GST-MCM2(1-287) and full-
length MCM2 purified from a human cell line alike. Importantly, under in vitro 
kinase assay conditions, LEDGF bolstered phosphorylation of MCM2 at Ser53 
(Figure 4.28 and Figure 4.29), a natural Cdc7 target site in this protein (Cho et al., 
2006; Montagnoli et al., 2006). The stimulation strictly depended on the protein-
protein interaction, as the LEDGF mutant EEE, unable to bind Cdc7:ASK (Figure 
4.21), also failed to promote its kinase activity (Figure 4.26). Moreover, deleting 
residues 625-674 at the C-terminus of ASK ablated the interaction with LEDGF 
(Figure 4.19 and Figure 4.30), at the same time rendering the kinase hyperactive 
(Figure 4.28). These results indicate that the interaction with LEDGF relieves 
autoinhibition of the Cdc7:ASK complex, imposed by the C-terminus of ASK 
(Figure 4.32). Of note, this mechanism likely requires auto-phosphorylation of the C-
terminus of ASK within the Cdc7:ASK complex in order to promote binding to 
LEDGF.  
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Figure 4.32 – The interaction between LEDGF IBD and the C-terminus of ASK relieves 
autoinhibition of Cdc7:ASK kinase activity 
Schematic of Cdc7:ASK kinase activity in the absence (A) or presence (B) of LEDGF. The regulatory 
peptide (RP) at the C-terminus of ASK autoinhibits kinase activity (A). Interaction between the C-
terminal RP of ASK and the IBD of LEDGF results in full activation of Cdc7:ASK kinase activity 
leading to an increase in phosphorylation of MCM complexes (B). Cdc7 is shown as a light blue 
rectangle. ASK domains are shown as dark blue circles; the smaller circle is the RP. Purple ovals are 
LEDGF PWWP and IBD domains; the MCM2-7 protein complex is shown as green hexagons (P 
indicates phosphorylation). 
 
Notably, the kinase activities of Cds1 and Chk1, both effector kinases in the 
DNA replication checkpoint pathway, were shown to be negatively regulated by their 
C-termini (Chen et al., 2000; Katsuragi and Sagata, 2004; Xu and Kelly, 2009). Cds1 
is the orthologue of human Chk2 in S. pombe and undergoes a two stage mechanism 
of activation (Xu et al., 2006b). Phosphorylation of Cds1 by cooperation of the 
checkpoint kinase Rad3 and mediator Mrc1 is referred to as priming and promotes 
dimerisation. A second auto-activation stage, in which dimeric Cds1 trans-auto-
phosphorylates, results in an active kinase. Removal of 27 C-terminal residues of 
Cds1 resulted in a dramatic increase in kinase activity, indicating that the C-terminal 
tail of Cds1 autoinhibits kinase activation by suppressing trans-auto-phosphorylation  
(Xu and Kelly, 2009). The kinase domain of Chk1 is blocked by its autoinhibitory C-
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terminal domain and phosphorylation by Rad3 removes this inhibitory effect (Chen 
et al., 2000; Guo et al., 2000; Lopez-Girona et al., 2001). Thus, autoinhibition of 
Cdc7:ASK kinase activity by its C-terminus and the requirement for phosphorylation 
to relieve this inhibition mirrors some aspects of the regulatory mechanisms of other 
kinases. 
Future work shall focus on determining whether the C-terminus of ASK is 
minimally sufficient for the interaction with LEDGF. Additionally, identification of 
residues within the C-terminus of ASK that are targeted for auto-phosphorylation, 
and mutational analysis to determine the importance of this phosphorylation for 
interaction with LEDGF will be carried out. To validate our model for Cdc7:ASK 
kinase activation, the C-terminal regulatory peptide of ASK can be expressed and 
purified in isolation and used to inhibit the activity of hyperactive Cdc7:ASK(1-624). 
Moreover, other MCM proteins can be tested as substrates in addition to MCM2, 
either uncomplexed or as part of the MCM heterohexamer. Prior phosphorylation of 
MCM2 within the MCM2-4-6-7 complex by CDKs has been shown to increase the 
efficiency of MCM2 phosphorylation by Cdc7:ASK (Kihara et al., 2000; Masai et 
al., 2000), therefore, the ability of LEDGF to stimulate phosphorylation of pre-
phosphorylated substrates will also be analysed.  
Overall, apart from the short Dbf4 motifs N, M and C, there is surprisingly 
little sequence conservation between known Dbf4/ASK orthologues (Masai and Arai, 
2000). In particular, the extended C-terminal tail following Dbf4 motif C is only 
found in metazoans (Guo and Lee, 2001; Jares et al., 2004; Landis and Tower, 1999; 
Masai and Arai, 2000) (Figure 4.33), and the same species are known to possess 
LEDGF and/or HRP2 (Cherepanov et al., 2004). Dbf4 from budding yeast, 
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Him1/Dfp1 from fission yeast and nimO from Aspergillus do not possess a C-
terminal tail, rather Dbf4 motif C is located very close to the C-terminus in these 
molecules (Figure 4.33) (James et al., 1999; Masai and Arai, 2000). Thus, an 
additional level of S-phase kinase regulation, mediated by the autoinhibitory C-
terminus of ASK and interaction with LEDGF, may be conserved among and limited 
to higher eukaryotes. 
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Figure 4.33 – Schematic of Dbf4/ASK orthologues 
Schematic of Dbf4 from S. cerevisiae, Him1/Dfp1 from S. pombe and human ASK. Locations of 
conserved Dbf4 motifs -N, -M and -C are indicated. The ASK C-terminal regulatory peptide (RP) is 
indicated in red. Modified from Masai and Arai, 2000. 
 
To support the hypothesis that the C-terminus of ASK is a regulatory peptide 
(RP) conserved amongst metazoan orthologues, analysis of Dbf4/ASK protein 
sequences from various species was carried out. Multiple sequence alignment of 
Dbf4/ASK proteins from mammals, birds, fish and amphibians readily identified 
highly conserved regions corresponding to Dbf4 motifs N, M and C (Figure 4.34A). 
The corresponding regions of the mammalian orthologues share ~85%, 60% and 
77% amino acid identity, respectively (Figure 4.34A). An additional small conserved 
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domain was present within the C-termini of these proteins (Figure 4.34A). 
Mammalian ASK orthologues show ~70% identity in this region, which also 
coincides with the portion of ASK required for interaction with LEDGF (Figure 
4.34). Secondary structure prediction algorithms suggested the existence of a pair of 
α-helices within the RPs of mammalian ASK proteins (Figure 4.18). Interestingly, 
this C-terminal RP is linked to the C-motif by an area of low sequence conservation 
(~28.4% identity for mammalian ASK orthologues) (Figure 4.34A); indicating that 
the C-terminal tail present in metazoan orthologues of Dbf4/ASK consists of a 
largely unstructured linker followed by a small folded domain at the C-terminus. 
These analyses lend weight to the hypothesis that the C-terminus of Dbf4/ASK may 
play a role in regulating kinase activity in higher eukaryotes. The mechanism of 
regulation of Cdc7:ASK kinase activity by LEDGF and the functional significance of 
this interaction in vivo will form the basis of future studies. 
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Figure 4.34 – Sequence conservation of the C-terminus of Dbf4/ASK in metazoans 
(A) Sequence conservation between mammalian, avian, fish and amphibian orthologues of 
Dbf4/ASK. Percentage of identical residues along the alignment calculated in windows of 25 residues 
is plotted. Sequence numbering corresponds to the avian protein. Dbf4/ASK N-, M- and C- motifs and 
the C-terminal Regulatory Peptide are indicated; percentage identity and similarity between amino 
acid sequences of mammalian orthologues (excludes red jungle fowl, zebra fish and frog proteins) are 
given below. The taxonomic alignment is: human, Homo sapien; chimpanzee, Pan troglodyte; 
Chinese hamster, Cricetulus griseus; mouse, Mus musculus; horse, Equus caballus; rhesus monkey, 
Macaca mulatta; red jungle fowl, Gallua gallus; zebra fish, Danio rerio; frog, Xenopus laevis. 
Sequences with the following GenBank accession numbers were used: NM_006716.3 (human), 
XM_528041 (chimpanzee), AF292400 (Chinese hamster), NM_013726.2 (mouse), XM_001489324.2 
(horse), XM_001104753 (rhesus monkey), XM_418638.2 (red jungle fowl), NP_001128607 (zebra 
fish), NM_001089137 (frog). (B) Multiple sequence alignment of the C-terminal 50 residues of 
mammalian Dbf4/ASK orthologues. Amino acid residues identical between all aligned sequences are 
highlighted in yellow. Similar residues are highlighted in green. α-Helical regions for human ASK as 
predicted using Phyre structural prediction software (Kelley and Sternberg, 2009) are shown as red 
boxes above the alignment.  
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Interestingly, the C-terminal tail of ASK was not required for short-term 
survival of mouse embryonic stem (ES) cells (Yamashita et al., 2005). However, it 
should be noted that, in addition to ASK, ES cells likely express its close homologue 
Drf1 (Montagnoli et al., 2002; Takahashi and Walter, 2005; Yoshizawa-Sugata et al., 
2005), the presence of which could have attenuated phenotypes of some mutations in 
ASK. The amino acid sequences of Drf1 and ASK share significant similarity within 
their N-terminal halves, however, their C-terminal portions are highly divergent 
(Montagnoli et al., 2002). The ability of LEDGF to interact with Cdc7:Drf1 will be 
ascertained in future studies. 
Similarly, although LEDGF is not essential in vivo (Llano et al., 2006a; Shun 
et al., 2007; Sutherland et al., 2006), its functions might be redundant with those of 
HRP2. Indeed, both LEDGF and HRP2 can interact with Cdc7:ASK (Figure 4.5 and 
Figure 4.14B) and stimulate its kinase activity (Figure 4.28). In addition, HRP2 can 
also interact with JPO2 (Figure 4.5) (Maertens et al., 2006), indicating that cellular 
proteins that are able to bind to the IBD of LEDGF can similarly interact with HRP2. 
 In S. Pombe, Swi6 (the S. pombe counterpart of heterochromatin protein 1 
(HP1)) was shown to promote early replication of a subset of origins within 
heterochromatin via a direct interaction with Dfp1 (Hayashi et al., 2009). Swi6/HP1 
activates replication origins by recruiting Hsk1:Dfp1, the S. pombe equivalent of 
Cdc7:ASK, and stimulating Hsk1:Dfp1-dependent loading of the replication factor 
Sld3 (Hayashi et al., 2009). Furthermore, tethering Hsk1:Dfp1 to selected origins in 
Swi6-deficient cells restored the early replication of the targeted loci (Hayashi et al., 
2009). These results set the first precedent for a chromatin-associated protein 
regulating initiation of DNA replication via an interaction with the S-phase kinase, 
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which might be a paradigm of a more general mechanism. Moreover, in budding 
yeast, loading of Cdc45 on replication origins, which is dependent on Cdc7 kinase 
activity, correlates with replication timing (Aparicio et al., 1999; Zou and Stillman, 
2000). Cdc45 associates with early origins in G1, but does not bind to late origins 
until mid-S phase accounting for the late initiation of replication at these origins 
(Aparicio et al., 1999). Recruitment and activation of Cdc7:ASK kinase by LEDGF 
could be a way to control origin firing in higher eukaryotes. Indeed, Hsk1:Dfp1 was 
shown to regulate origin efficiency in a concentration-dependent manner (Patel et al., 
2008). Tethering Hsk1:Dfp1 near an origin increased the efficiency of that origin 
(Patel et al., 2008).  
Although the distribution of LEDGF along human chromatin has not been 
reported, it is well established that a direct interaction with IN channels HIV-1 
integration into active transcription units (Ciuffi et al., 2005; Marshall et al., 2007; 
Shun et al., 2007). Moreover, LEDGF interacts with menin:MLL histone 
methyltransferase which applies epigenetic marks that maintains chromatin in a state 
conducive for transcription (Li et al., 2007; Yokoyama and Cleary, 2008). 
Furthermore, a positive correlation between early DNA replication and gene 
expression has been well established (Farkash-Amar et al., 2008; Goldman et al., 
1984; Jeon et al., 2005; White et al., 2004; Woodfine et al., 2004). Consequently, 
recruitment and stimulation of Cdc7:ASK by LEDGF may increase firing efficiency 
of local origins, thereby encouraging actively-transcribed loci to replicate early in S 
phase (Farkash-Amar et al., 2008; White et al., 2004; Woodfine et al., 2004). An 
important goal for future studies will be to establish whether LEDGF and/or HRP2 
are involved in the regulation of Cdc7:ASK function and DNA replication timing.  
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The question remains as to the implications of this novel cellular function of 
LEDGF for lentiviral biology. Gene density and gene transcription correlate with 
DNA replication timing, that is, early replicated DNA is gene rich and is more likely 
to be expressed than later-replicated DNA (Jeon et al., 2005; White et al., 2004; 
Woodfine et al., 2004). Perhaps integration into early-replicating DNA is 
advantageous for expression of viral genes by providing a favourable chromosomal 
environment. Future studies focussing on the cellular function of the LEDGF-
Cdc7:ASK interaction and its role in DNA replication timing may provide insight 
into the role of LEDGF as a co-factor for lentiviral integration. 
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5 Chapter V: Conclusions 
To date, the role of LEDGF as a critical co-factor for HIV-1 replication has been 
extensively examined. Several studies have validated LEDGF as a targeting factor 
for lentiviral integration, likely functioning as a tether between retroviral IN and 
chromosomal DNA during strand transfer (Ciuffi et al., 2005; Llano et al., 2006a; 
Shun et al., 2007). Moreover, the interaction with LEDGF was shown to account for 
the characteristic bias of lentiviruses towards integration within active transcription 
units (Ciuffi et al., 2005; Shun et al., 2007). In contrast, the natural cellular functions 
of LEDGF remain poorly understood. This study sought to gain insight into the 
cellular functions of LEDGF using two approaches, gene expression profiling and 
proteomic analysis.  
 Gene expression profiling of MEFs derived from Psip1
-/-
 and Psip1
f/+
 animals 
revealed that very few genes were differentially expressed in LEDGF-null cells 
compared to controls. This result was surprising given that based on genomic 
distribution analyses of lentiviral integration sites LEDGF is hypothesised to be 
associated with a large number of active transcription units. Nevertheless, data from 
this study suggests that LEDGF does not play a direct role in regulation of gene 
expression. Moreover, the changes in gene expression observed in LEDGF-null 
MEFs derived from Psip1
-/-
 embryos were not reproduced when expression was 
ablated under tissue culture conditions. Furthermore, the changes in gene expression 
could not be reversed by ectopic expression of LEDGF or p52 in MEFs derived from 
Psip1
-/-
 embryos. Collectively, these results suggested that the observed changes in 
gene expression are likely due to embryonic development in the absence of LEDGF 
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and/or p52. Thus, extrapolating from this, LEDGF may play a role in embryonic 
development, and indeed LEDGF knockout mice have been described as having a 
range of developmental abnormalities (Sutherland et al., 2006). However, the 
specific function of LEDGF in development remains to be determined.  
 A proteomic strategy was used to identify the Cdc7:ASK holoenzyme as a 
cellular binding partner of LEDGF. Cdc7:ASK is an essential S-phase kinase, 
functioning to activate individual origins of replication throughout S-phase and thus 
is required for DNA replication (Masai and Arai, 2002). As there is a large body of 
experimental evidence detailing the role of Cdc7:ASK in the cell cycle, this 
discovery allows the study of LEDGF function in the context of a known cellular 
pathway. 
Biochemical analyses determined that the IBD of LEDGF interacts with the 
C-terminus of ASK and this interaction requires auto-phosphorylation of the kinase. 
Furthermore, LEDGF potently stimulated Cdc7 kinase activity while removing the 
C-terminal region of ASK, involved in the interaction with LEDGF, resulted in a 
hyper-active kinase. These data suggests that the C-terminus of ASK functions as a 
regulatory peptide, autoinhibiting Cdc7 kinase activity, while the interaction with 
LEDGF relieves this inhibition thus promoting kinase activity. The results further 
indicated that LEDGF can tether Cdc7:ASK to chromatin, similar to its effect on the 
cellular localisation of JPO2, menin:MLL and IN (Maertens et al., 2003; Maertens et 
al., 2006; Yokoyama and Cleary, 2008). Thus, LEDGF appears to act as a 
multifunctional adaptor, interacting with cellular proteins and IN via its C-terminal 
IBD and associating with chromatin via its N-terminal region.  
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Future work will focus on fully establishing the mechanism of regulation of 
Cdc7:ASK kinase activity by LEDGF and the functional significance of this in vivo. 
As actively transcribed chromatin tends to be replicated early during S-phase and 
LEDGF is known to direct HIV-1 integration into active transcription units, the 
interaction between LEDGF and Cdc7:ASK may affect the replication timing of 
euchromatin (Ciuffi and Bushman, 2006; White et al., 2004; Woodfine et al., 2004). 
Thus, we hypothesise that upon engaging chromatin bound LEDGF, activation of 
Cdc7:ASK kinase activity may increase the firing efficiency of local origins, thereby 
encouraging actively transcribed chromatin to replicate early during S-phase.  
In conclusion, while this study has provided much needed insight into the 
cellular function of LEDGF, more work is required to fully understand the biological 
role of this ubiquitously expressed protein. Understanding the role of LEDGF in 
Cdc7:ASK kinase regulation and DNA replication during S-phase of the cell cycle is 
a promising avenue of investigation highlighted by the work carried out in this study. 
Continuing elucidation of the natural cellular functions of LEDGF may provide 
insight into its role as a co-factor for HIV-1 integration. Moreover, such knowledge 
would be invaluable when designing novel anti-viral strategies targeting the LEDGF-
IN interaction or when using LEDGF chimeras to target lentiviral DNA integration 
during gene therapy. 
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Appendix A: Supplementary Tables 
 
 
Table S1: Oligonucleotides used for qRT-PCR 
 
Oligo 
 
Sequence 5’-3’ Usage/Description Reference 
PC258 CGACCTGGAAGTCCAACTAC pCR4-TOPO PO construction and Ribosomal 
Protein PO control for qRT-PCR 
Stettner et al., 
2007  
PC259 ATCTGCTGCATCTGCTTG pCR4-TOPO PO construction and Ribosomal 
Protein PO control for qRT-PCR 
Stettner et al., 
2007  
PC268 TCAGTTCTACATCAAGACATCCACTACTGTG pCR4-TOPO Crabp1 construction and Crabp1 
qRT-PCR 
This study 
PC269 TGTGTGCAGTGAATCTTGTTCTCATTC pCR4-TOPO Crabp1 construction and Crabp1 
qRT-PCR 
This study 
PC276 GCACAGGAGACTTTAATCGAC pCR4-TOPO Thbs4 construction and Thbs4 
qRT-PCR 
This study 
PC277 GGACTGAAAGCTGAGAGGAC pCR4-TOPO Thbs4 construction and Thbs4 
qRT-PCR 
This study 
PC286 CCAGGACCACAAGGGTAG pCR4-TOPO Adam33 construction and Adam33 
qRT-PCR 
This study 
PC287 GCCCTCTAGGAGAATTGTG pCR4-TOPO Adam33 construction and Adam33 
qRT-PCR 
This study 
PC292 AATGGATCCCATGGCCGACTACAT pCR4-TOPO Tbx1 construction and Tbx1 qRT-
PCR 
This study 
PC293 TTTCATCCACTGTGCGCCCTTA pCR4-TOPO Tbx1 construction and Tbx1 qRT-
PCR 
This study 
PC317 AGTATGCAGCAGCCAAATCTC pCR4-TOPO Esm1 construction and Esm1 qRT-
PCR 
This study 
PC318 AGCGTTCCCTTCTCCAATC pCR4-TOPO Esm1 construction and Esm1 qRT-
PCR 
This study 
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PC327 CATCGCCAGGGAACAAAG pCR4-TOPO Trim12 construction and Trim12 
qRT-PCR 
This study 
PC328 GAGGGTCCAAAGATGTGTGC pCR4-TOPO Trim12 construction and Trim12 
qRT-PCR 
This study 
SH9 AAGCGCCCAAGAGGATAG pCR4-TOPO Zfp536 construction and Zfp536 
qRT-PCR 
This study 
SH10 GATGGGAAGTCCGGAAAG pCR4-TOPO Zfp536 construction and Zfp536 
qRT-PCR 
This study 
 
 
Table S2: Oligonucleotides used in plasmid construction 
 
Oligo 
 
Sequence 5’-3’ Usage/Description Restriction 
site 
Reference 
PC343 GGCCGAAGCTTACAGACACCATGACTCGCGATTTCAAACCTGG mLEDGF/mp52-HA construction HindIII This study 
PC344 GGCACGTCGTAAGGGTAGTTATCTAGTGTAGACTCTTTCAGAG mLEDGF-HA construction None This study 
PC345 AACCTAGGCGTAGTCGGGCACGTCGTAAGGGTA mLEDGF/mp52-HA construction None This study 
PC346 GGCACGTCGTAAGGGTACTGTAGATTACATGTTGTTTGGTGCT 
CAGTTTCCATTTGTTCC 
mp52-HA construction None This study 
PC412 GGTCGTCGACTCACAAGCTCATATCTTTAAAAAATGGATG pEGFP-CDC7-C2 construction SalI This Study 
PC413 GCGTGGATCCATGGCGGAATCATCGGAATCCTTCACCATGG pCP-GST-MCM2(1-287) 
construction 
BamHI This Study 
PC414 GGCCGAATTCTCAGTGGGAGATGCGGACATGGATGTGGTTGG pCP-GST-MCM2(1-287) 
construction 
EcoRI This Study 
PC430 GGACGAGCTCAATGGAGGCGTCTTTGGGGATTCAGATGG pEGFP-CDC7-C2 construction SacI This Study 
PC490 GCCAGCCCATGGAGGCGTCTTTGGGGATTC pRSF-CDC7-S-tag construction NcoI This Study 
PC491 GGAGCCTCGAGCAAGCTCATATCTTTAAAAAATGGATGCAAC pRSF-CDC7-S-tag construction XhoI This Study 
PC590 GTAAAACAGCCCTGTCCTGCAGAGAGTGACATCATTAC LEDGF(S206A) mutagenesis None This Study 
PC591 GTAATGATGTCACTCTCTGCAGGACAGGGCTGTTTTAC LEDGF(S206A) mutagenesis None This Study 
PC592 CCCTGTCCTTCAGAGGCTGACATCATTACTG LEDGF(S208A) mutagenesis None This Study 
PC593 CAGTAATGATGTCAGCCTCTGAAGGACAGGG LEDGF(S208A) mutagenesis None This Study 
SHp1 GCGCGGATCCGACACCATGACTCGCGATTTCAAACCTGG hLEDGF and hLEDGF(1-176)- 
cTAP construction 
BamHI This study 
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SHp2 GCGCAAGCTTCACTTTTAGATTAACAGATGCTGTTGC hLEDGF(1-176)-cTAP 
construction 
HindIII This study 
SHp3 GCGCGGATCCGACACCATGCAGCAGAATAAAGATGAAGGAAAGAAG hLEDGF(326-530)-cTAP 
construction 
BamHI This study 
SHp4 GCGCAAGCTTGTTATCTAGTGTAGAATCCTTCAGAGATATTTC hLEDGF and hLEDGF(326-530)-
cTAP construction 
HindIII This study 
SH26 TATGAACTCCGGAGCCATGAGGATCCACAG ASK sense primer for blunt cloning 
into pCPHA-NLS 
None This Study 
SH27 CATGGAGGCGTCTTTGGGGATTCAG Cdc7 sense primer for blunt 
cloning into pcDNA3.1-Flag 
None This Study 
SH28 GGTCCTTAAGTCACAAGCTCATATCTTTAAAAAATGGATG Cdc7 anti-sense primer for 
construction of pcDNA3.1-Flag-
Cdc7 
AflII This Study 
SH35 CAACCTCCGATGCGGAAGAAGAAGG LEDGF(SDA) mutagenesis: 
S275A 
None This Study 
SH36 CCTTCTTCTTCCGCATCGGAGGTTG LEDGF(SDA) mutagenesis: 
S275A 
None This Study 
SH37 GGGTTACTTCAACCGCGGATGCGGAAGAAGAAGGAG LEDGF(ADA) mutagenesis: 
S273A/S275A 
None This Study 
SH38 CTCCTTCTTCTTCCGCATCCGCGGTTGAAGTAACCC LEDGF(ADA) mutagenesis: 
S273A/S275A 
None This Study 
SH39 CTCCTTCTTCTTCCGCATCCGCGGTTGAAGTAACCC LEDGF(AEA) mutagenesis: 
S206A/S208A 
None This Study 
SH40 CTCTTCAGTAATGATGTCCGCTTCCGCAGGACAGGGCTGTTTTAC LEDGF(AEA) mutagenesis: 
S206A/S208A 
None This Study 
SH43 GGACGAATTCGGACATTAGATACTACATTGAACAAAAG ASK sense primer (Ser followed by 
residue 174) 
EcoRI This Study 
SH44 GGTCCTCGAGCTATCTTTTCTTTTTAGGTGTGTCCTTTTC Anti-sense primer for ASK ending 
at residue 350 
XhoI This Study 
SH45 GGACGAATTCGATGAACTCCGGAGCCATGAGGATC ASK sense primer (Ser followed by 
residue 1) 
EcoRI This Study 
SH46 GGTCCTCGAGCTAAAAGCCAGTAAATGTAGAAGTTGAAGG ASK anti-sense primer  XhoI This Study 
SH47 GGACCTCGAGATGGCGGAATCATCGGAATCCTTC pQFlag-MCM2-8xHis contruction XhoI This Study 
SH50 TGGTGGTGGTGGTGGAACTGCTGCAGGATCATTTTCCTTTTC pQFlag-MCM2-8xHis contruction None This Study 
SH51 GAGGGATCCCTAGTGGTGGTGGTGGTGGTGGTGGTGGAACT pQFlag-MCM2-8xHis contruction BamHI This Study 
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SH52 GGTCCTCGAGCTAAGTCTGAAACAAGTCTAGTAAAGACTG Anti-sense primer for ASK ending 
at residue 624 
XhoI This Study 
SH53 GGTCCTCGAGCTACTCTTGTGAACTGTTTATTGTTATC Anti-sense primer for ASK ending 
at residue 541 
XhoI This Study 
 
 
Table S3: Plasmid Constructs 
 
Plasmid Name 
 
Use/Description Host Reference 
pCR4-TOPO Crabp1 Standard for qRT-PCR N/A This Study 
pCR4-TOPO Thbs4 Standard for qRT-PCR N/A This Study 
pCR4-TOPO Adam33 Standard for qRT-PCR N/A This Study 
pCR4-TOPO Tbx1 Standard for qRT-PCR N/A This Study 
pCR4-TOPO Trim 12 Standard for qRT-PCR N/A This Study 
pCR4-TOPO Esm1 Standard for qRT-PCR N/A This Study 
pCR4-TOPO PO Standard for qRT-PCR N/A This Study 
pCR4-TOPO Zfp536 Standard for qRT-PCR N/A This Study 
pGM-Mel18-cTAP cTAP fusion vector. Used for construction of cTAP tagged constructs M Elderkin et. al., 2007 
pGM-hLEDGF-cTAP Expression of cTAP tagged human LEDGF  M This Study 
pGM-hLEDGF(1-176)-cTAP  Expression of LEDGF(1-176) with a C-terminal TAP tag  M This Study 
pGM-hLEDGF(326-530)-
cTAP 
Expression of  LEDGF(326-530) with a C-terminal TAP tag M This Study 
pLB(N)CX Retroviral vector M Borger and DeCaprio 
2006 
pLB(N)CX-mp75-HA  Expression of C-terminal HA tagged mouse LEDGF M This Study 
pLB(N)CX-mp52-HA Expression of C-terminal HA tagged mouse p52  M This Study 
pCPHA-NLS HA-fusion vector M Cherepanov et al., 2004  
pBHA-P75  Expression of N-terminal HA tagged human LEDGF M Cherepanov et al., 2004  
pCPHA38 Expression of the LEDGF(336-350) having an N-terminal HA tag   M Dr. Peter Cherepanov 
pCPHA-HRP2 Expression of N-terminal HA tagged human HRP2 M Cherepanov et al., 2004  
pCPHA-Dbf4 Expression of N-terminal HA-tagged ASK (human Dbf4) M This Study 
pCPHA-Dbf4(1-624) Expression of N-terminal HA-tagged ASK(1-624) M This Study 
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pcDNA3.1-Flag Vector for cloning and expressing Flag tagged proteins  M Dr. Massimo Pizzato 
(unpublished) 
pcDNA3.1- Flag-Cdc7 Expression of N-terminal Flag tagged Cdc7.   M This study 
pHcRed1-p75 Expression of HcRed-LEDGF fusion protein M Maertens et al., 2003  
pHcRed1-p52 Expression of HcRed-p52 fusion protein M Maertens et al., 2003  
pEGFP-C2 Vector for cloning and expressing GFP fusion proteins M Clontec 
pEGFP-CDC7-C2 Expression of EGFP-Cdc7 fusion protein M This Study 
pIRES2-LEDGF-eGFP Expression of non-tagged WT human LEDGF M Hare et al., 2009b  
pIRES2-LEDGF(EEE)-eGFP Expression of full length human LEDGF K401E/K402E/R405E mutant M Hare et al., 2009b  
pIRES2-LEDGFΔIBD-eGFP Expression of non-tagged human LEDGF lacking residues 347-430 M Obtained from Dr. Alan 
Engelman (Harvard 
Medical School) 
pTRE2hyg Tretracycline-responsive protein expression vector M Clontech 
pTRE-HA75-hyg Tetracycline-responsive expression of HA-tagged human LEDGF M This Study 
pTRE-75-hyg Tetracycline-responsive expression of non-tagged human LEDGF M This Study 
pQFlag Derivative of pQCXIP (Clontech) with an insertion of a Flag tag CDS upstream 
of the XhoI site. Retroviral vector used for stable expression of Flag-tagged 
proteins. 
M Dr. Goedele Maertens 
(unpublished) 
pQFlag-MCM2-8xHis Retroviral vector for expression of full-length human MCM2 with both an N-
terminal Flag tag and a C-terminal octa-Histidine tag 
M This Study 
pCG-VSV-G  Envelope expression for retroviral vector production M Ulm et al., 2007  
pCG GAG-POL Gammaretroviral packaging construct M Ulm et al., 2007  
pRSFDuet1 Vector for protein co-expression in E. coli E Novagen 
pCDFDuet1 Vector for protein co-expression in E. coli E Novagen 
pRSF-CDC7-S-tag Expression of human Cdc7 with C-terminal S-tag E This Study 
pCDF-His-Dbf4 Expression of full-length human ASK with an N-terminal His6 tag E This Study 
pCDF-His-Dbf4(1-350) Expression of human ASK(1-350) with an N-terminal His6 tag E This Study 
pCDF-His-Dbf4(174-674) Expression of human ASK(174-674) with an N-terminal His6 tag E This Study 
pCDF-His-Dbf4(174-350) Expression of human ASK(174-350) with an N-terminal His6 tag E This Study 
pCDF-His-Dbf4(1-624) Expression of human ASK(1-624) with an N-terminal His6 tag E This Study 
pCDF-His-Dbf4(1-541) Expression of human ASK(1-541) with an N-terminal His6 tag E This Study 
pFT1-LEDGF Expression of full-length human LEDGF with a cleavable His6 tag E Vandegraaff et al., 2006  
pFT1-LEDGFΔIBD Expression of human LEDGF lacking residues 347-430 with a cleavable His6 tag E Obtained from Dr. Alan 
Engelman (Harvard 
Medical School) 
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pCPH6P-LEDGF(146-530) Expression of human LEDGF(146-530) with a cleavable His6 tag E Dr. Peter Cherepanov 
pCPH6P-LEDGF(226-530) Expression of human LEDGF(226-530) with a cleavable His6 tag E Dr. Peter Cherepanov 
pCPH6P-LEDGF(249-530) Expression of human LEDGF(249-530) with a cleavable His6 tag E Dr. Peter Cherepanov 
pCPH6P-LEDGF(291-530) Expression of human LEDGF(291-530) with a cleavable His6 tag E Dr. Peter Cherepanov 
pCPH6P-LEDGF(347-530) Expression of human LEDGF(347-530) with a cleavable His6 tag E Dr. Peter Cherepanov 
pGEX-4T1 Vector for expression of GST fusion proteins E GE Healthcare 
pCP-GST-MCM2(1-287) Expression of MCM2(1-287) with an N-terminal GST tag E This Study 
pCP-GST-81 Expression of GST-LEDGF(347-471) E Cherepanov et al., 2004  
pCP-GST-HRP2-IBD Expression of GST-HRP2(470-593) E Cherepanov et al., 2004  
pFT1-LEDGF(SDA) Expression of full-length human LEDGF S275A mutant E This Study 
pFT1-LEDGF(ADA) Expression of full-length human LEDGF S273A/S275A mutant E This Study 
pFT1-LEDGF(AEA) Expression of full-length human LEDGF S206A/S208A mutant E This Study 
pFT1-LEDGF(AEA/ADA) Expression of full-length human LEDGF S206A/S208A/S273A/S275A mutant E This Study 
pFT1-LEDGF(S206A) Expression of full-length human LEDGF S206A mutant E This Study 
pFT1-LEDGF(S208A) Expression of full-length human LEDGF S208A mutant E This Study 
pFT1-LEDGF(EEE) Expression of full-length human LEDGF K401E/K402E/R405E mutant E Hare et al., 2009b  
pFT1-LEDGF(ESE) Expression of full-length human LEDGF K401E/K402S/R405E mutant E Hare et al., 2009b  
pFT1-LEDGF(AAA) Expression of full-length human LEDGF K401A/K402A/R405A mutant E Hare et al., 2009b  
pFT1-LEDGF(K360E) Expression of full-length human LEDGF K360E mutant E Hare et al., 2009b 
pFT1-LEDGF(K392E) Expression of full-length human LEDGF K392E mutant E Hare et al., 2009b 
 
Host for expression: M = Mammalian, E = Escherichia coli 
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Table S4: Cell Lines  
 
Cell Line Name 
 
Description Reference 
HEK 293T (referred to as 293T) Adenovirus transformed human embryonic kidney cells containing the SV40 large T antigen Graham et al., 1977  
HeLa Human cervical epithelioid carcinoma-derived cell line Jones et al., 1971  
HeLa TetOff HeLa cell line expressing the tetracycline-controlled transactivator. Inducible gene 
expression is generated by stably transfecting cells with a plasmid or infecting cells with a 
virus that expresses the gene of interest under the control of a Tet Response Element  
Clontech 
NIH 3T3 Mouse embryonic fibroblasts Todaro and Green 1963  
E1 Primary mouse embryonic fibroblast cell line derived from Psip1
f/+
 (LEDGF+) mice Shun et al., 2007 
E2 Primary mouse embryonic fibroblast cell line derived from Psip1
-/-
 (LEDGF-) mice Shun et al., 2007 
E5 Primary mouse embryonic fibroblast cell line derived from Psip1
f/+
 (LEDGF+) mice Shun et al., 2007 
E6 Primary mouse embryonic fibroblast cell line derived from Psip1
-/-
 (LEDGF-) mice Shun et al., 2007  
E4B Primary mouse embryonic fibroblast cell line derived from Psip1
f/+
 (LEDGF+) mice Shun et al., 2007  
E5B Primary mouse embryonic fibroblast cell line derived from Psip1
-/-
 (LEDGF-) mice Shun et al., 2007  
E1T MEF line E1 immortalised by transformation with SV40 large T antigen This study 
E2T MEF line E2 immortalised by transformation with SV40 large T antigen This study 
E5T MEF line E5 immortalised by transformation with SV40 large T antigen This study 
E6T MEF line E6 immortalised by transformation with SV40 large T antigen This study 
E1TV MEF line E1T transduced with pLB(N)CX vector (control cell line) This study 
E1Tp75 MEF line E1T stably expressing mouse LEDGF with a C-terminal HA tag. (transduced with 
pLB(N)CX-mp75-HA) 
This study 
E1Tp52 MEF line E1T stably expressing mouse p52 with a C-terminal HA tag. 
(transduced with pLB(N)CX-mp52-HA) 
This study 
E2TV MEF line E2T transduced with pLB(N)CX vector (control cell line) This study 
E2Tp75 MEF line E2T stably expressing mouse LEDGF with a C-terminal HA tag. 
(transduced with pLB(N)CX-mp75-HA) 
This study 
E2Tp52 MEF line E2T stably expressing mouse p52 with a C-terminal HA tag. 
(transduced with pLB(N)CX-mp52-HA) 
This study 
E6
f/f Immortalised MEF line derived from Psip1
f/f
 (LEDGF+) mice and transduced with 
catalytically inactive Cre recombinase in vitro 
Shun et al., 2007  
E6
-/- Immortalised MEF line derived from Psip1
f/f
  mice and transduced Cre recombinase in vitro 
– LEDGF knocked out in vitro (LEDGF-) 
Shun et al., 2007 
 242 
293T-cTAP 293T cell line stably expressing cTAP tag alone This study 
293T-LEDGF-cTAP 293T cell line stably expressing cTAP-tagged full length human LEDGF This study 
293T-LEDGF(326-530)-cTAP 293T cell line stable expressing the C-terminal region of LEDGF (residues 326-530; 
encompassing the IBD) with a C-terminal TAP tag.  
This study  
293T-LEDGF(1-176)-cTAP 293T cell line stably expressing the N-terminal region of LEDGF (residues1-176; 
encompassing the PWWP domain) with a C-terminal TAP tag 
This study 
N3 HeLa TetOff line stably expressing non-tagged LEDGF under the control of a doxycycline 
responsive promoter. Used for inducible expression of non-tagged LEDGF. 
This study 
H3 HeLa TetOff line stably expressing HA-tagged LEDGF under the control of a doxycycline 
responsive promoter. Used for inducible expression of HA-LEDGF. 
This study 
HeLa-Flag-MCM2-His8 HeLa cell line stably expressing full length human MCM2 with an N-terminal Flag tag and a 
C-terminal octa-histidine tag 
This study 
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Appendix B: Genes affected by Psip1 knockout in mouse 
embryonic fibroblasts 
 
Upregulated Genes 
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Downregulated Genes 
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Appendix B: List showing genes that are up- or down-regulated in Psip1
-/-
 
(LEDGF-null) MEFs 
A subset of less than 200 genes display a greater than or equal to 1.5-fold change in 
gene expression (P<0.05) in the absence of LEDGF. Genes highlighted in blue have 
been validated by qRT-PCR.  
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Appendix C: Schematic of Tandem Affinity Purification 
(TAP) 
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Adapted from Puig et al., 2001 
